#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Model-Free Functional Connectivity and Impulsivity Correlates of Alcohol Dependence: A Resting-State Study
1-1	0-10	Model-Free	_	
1-2	11-21	Functional	_	
1-3	22-34	Connectivity	_	
1-4	35-38	and	_	
1-5	39-50	Impulsivity	_	
1-6	51-61	Correlates	_	
1-7	62-64	of	_	
1-8	65-72	Alcohol	_	
1-9	73-83	Dependence	_	
1-10	83-84	:	_	
1-11	85-86	A	_	
1-12	87-100	Resting-State	_	
1-13	101-106	Study	_	

#Text=Background
2-1	107-117	Background	_	

#Text=Alcohol dependence is characterized by impulsiveness toward consumption despite negative consequences. Although neuroimaging studies have implicated some regions underlying this disorder, there is little information regarding its large-scale connectivity pattern. This study investigated the within- and between-network functional connectivity (FC) in alcohol dependence and examined its relationship with clinical impulsivity measures.
3-1	118-125	Alcohol	_	
3-2	126-136	dependence	_	
3-3	137-139	is	_	
3-4	140-153	characterized	_	
3-5	154-156	by	_	
3-6	157-170	impulsiveness	_	
3-7	171-177	toward	_	
3-8	178-189	consumption	_	
3-9	190-197	despite	_	
3-10	198-206	negative	_	
3-11	207-219	consequences	_	
3-12	219-220	.	_	
3-13	221-229	Although	_	
3-14	230-242	neuroimaging	_	
3-15	243-250	studies	_	
3-16	251-255	have	_	
3-17	256-266	implicated	_	
3-18	267-271	some	_	
3-19	272-279	regions	_	
3-20	280-290	underlying	_	
3-21	291-295	this	_	
3-22	296-304	disorder	_	
3-23	304-305	,	_	
3-24	306-311	there	_	
3-25	312-314	is	_	
3-26	315-321	little	_	
3-27	322-333	information	_	
3-28	334-343	regarding	_	
3-29	344-347	its	_	
3-30	348-359	large-scale	_	
3-31	360-372	connectivity	_	
3-32	373-380	pattern	_	
3-33	380-381	.	_	
3-34	382-386	This	_	
3-35	387-392	study	_	
3-36	393-405	investigated	_	
3-37	406-409	the	_	
3-38	410-416	within	_	
3-39	416-417	-	_	
3-40	418-421	and	_	
3-41	422-437	between-network	_	
3-42	438-448	functional	_	
3-43	449-461	connectivity	_	
3-44	462-463	(	_	
3-45	463-465	FC	_	
3-46	465-466	)	_	
3-47	467-469	in	_	
3-48	470-477	alcohol	_	
3-49	478-488	dependence	_	
3-50	489-492	and	_	
3-51	493-501	examined	_	
3-52	502-505	its	_	
3-53	506-518	relationship	_	
3-54	519-523	with	_	
3-55	524-532	clinical	_	
3-56	533-544	impulsivity	_	
3-57	545-553	measures	_	
3-58	553-554	.	_	

#Text=Methods
4-1	555-562	Methods	_	

#Text=Using Probabilistic Independent Component Analysis (PICA) on resting-state fMRI (rs-fMRI) data from 25 alcohol dependent (AD) and 26 healthy control (HC) participants, we compared the within- and between-network FC between AD and HC. Then, the relationship between FC and impulsiveness as measured by the Barratt Impulsiveness Scale (BIS-11), the UPPS-P Impulsive Scale and the delay-discounting task (DDT) was explored.
5-1	563-568	Using	_	
5-2	569-582	Probabilistic	_	
5-3	583-594	Independent	_	
5-4	595-604	Component	_	
5-5	605-613	Analysis	_	
5-6	614-615	(	_	
5-7	615-619	PICA	_	
5-8	619-620	)	_	
5-9	621-623	on	_	
5-10	624-637	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[1]	
5-11	638-642	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[1]	
5-12	643-644	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[1]	
5-13	644-651	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[1]	
5-14	651-652	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImagingProtocol[1]	
5-15	653-657	data	_	
5-16	658-662	from	_	
5-17	663-665	25	_	
5-18	666-673	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]	
5-19	674-683	dependent	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]	
5-20	684-685	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]	
5-21	685-687	AD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]	
5-22	687-688	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]	
5-23	689-692	and	_	
5-24	693-695	26	_	
5-25	696-703	healthy	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[3]	
5-26	704-711	control	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[3]	
5-27	712-713	(	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[3]	
5-28	713-715	HC	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[3]	
5-29	715-716	)	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[3]	
5-30	717-729	participants	http://www.ukp.informatik.tu-darmstadt.de/inception/1.0#node1f7tpjks8x1[3]	
5-31	729-730	,	_	
5-32	731-733	we	_	
5-33	734-742	compared	_	
5-34	743-746	the	_	
5-35	747-753	within	_	
5-36	753-754	-	_	
5-37	755-758	and	_	
5-38	759-774	between-network	_	
5-39	775-777	FC	_	
5-40	778-785	between	_	
5-41	786-788	AD	_	
5-42	789-792	and	_	
5-43	793-795	HC	_	
5-44	795-796	.	_	
5-45	797-801	Then	_	
5-46	801-802	,	_	
5-47	803-806	the	_	
5-48	807-819	relationship	_	
5-49	820-827	between	_	
5-50	828-830	FC	_	
5-51	831-834	and	_	
5-52	835-848	impulsiveness	_	
5-53	849-851	as	_	
5-54	852-860	measured	_	
5-55	861-863	by	_	
5-56	864-867	the	_	
5-57	868-875	Barratt	_	
5-58	876-889	Impulsiveness	_	
5-59	890-895	Scale	_	
5-60	896-897	(	_	
5-61	897-900	BIS	_	
5-62	900-901	-	_	
5-63	901-903	11	_	
5-64	903-904	)	_	
5-65	904-905	,	_	
5-66	906-909	the	_	
5-67	910-916	UPPS-P	_	
5-68	917-926	Impulsive	_	
5-69	927-932	Scale	_	
5-70	933-936	and	_	
5-71	937-940	the	_	
5-72	941-958	delay-discounting	_	
5-73	959-963	task	_	
5-74	964-965	(	_	
5-75	965-968	DDT	_	
5-76	968-969	)	_	
5-77	970-973	was	_	
5-78	974-982	explored	_	
5-79	982-983	.	_	

#Text=Results
6-1	984-991	Results	_	

#Text=Compared to HC, AD exhibited increased within-network FC in salience (SN), default-mode (DMN), orbitofrontal cortex (OFCN), left executive control (LECN) and amygdala-striatum (ASN) networks. Increased between-network FC was found among LECN, ASN and SN. Between-network FC correlations were significantly negative between Negative-Urgency and OFCN pairs with RECN, anterior DMN (aDMN), and posterior DMN (pDMN) in AD. DDT was significantly correlated with the between-network FC among the LECN, aDMN and SN in AD.
7-1	992-1000	Compared	_	
7-2	1001-1003	to	_	
7-3	1004-1006	HC	_	
7-4	1006-1007	,	_	
7-5	1008-1010	AD	_	
7-6	1011-1020	exhibited	_	
7-7	1021-1030	increased	_	
7-8	1031-1045	within-network	_	
7-9	1046-1048	FC	_	
7-10	1049-1051	in	_	
7-11	1052-1060	salience	_	
7-12	1061-1062	(	_	
7-13	1062-1064	SN	_	
7-14	1064-1065	)	_	
7-15	1065-1066	,	_	
7-16	1067-1079	default-mode	_	
7-17	1080-1081	(	_	
7-18	1081-1084	DMN	_	
7-19	1084-1085	)	_	
7-20	1085-1086	,	_	
7-21	1087-1100	orbitofrontal	_	
7-22	1101-1107	cortex	_	
7-23	1108-1109	(	_	
7-24	1109-1113	OFCN	_	
7-25	1113-1114	)	_	
7-26	1114-1115	,	_	
7-27	1116-1120	left	_	
7-28	1121-1130	executive	_	
7-29	1131-1138	control	_	
7-30	1139-1140	(	_	
7-31	1140-1144	LECN	_	
7-32	1144-1145	)	_	
7-33	1146-1149	and	_	
7-34	1150-1167	amygdala-striatum	_	
7-35	1168-1169	(	_	
7-36	1169-1172	ASN	_	
7-37	1172-1173	)	_	
7-38	1174-1182	networks	_	
7-39	1182-1183	.	_	
7-40	1184-1193	Increased	_	
7-41	1194-1209	between-network	_	
7-42	1210-1212	FC	_	
7-43	1213-1216	was	_	
7-44	1217-1222	found	_	
7-45	1223-1228	among	_	
7-46	1229-1233	LECN	_	
7-47	1233-1234	,	_	
7-48	1235-1238	ASN	_	
7-49	1239-1242	and	_	
7-50	1243-1245	SN	_	
7-51	1245-1246	.	_	
7-52	1247-1262	Between-network	_	
7-53	1263-1265	FC	_	
7-54	1266-1278	correlations	_	
7-55	1279-1283	were	_	
7-56	1284-1297	significantly	_	
7-57	1298-1306	negative	_	
7-58	1307-1314	between	_	
7-59	1315-1331	Negative-Urgency	_	
7-60	1332-1335	and	_	
7-61	1336-1340	OFCN	_	
7-62	1341-1346	pairs	_	
7-63	1347-1351	with	_	
7-64	1352-1356	RECN	_	
7-65	1356-1357	,	_	
7-66	1358-1366	anterior	_	
7-67	1367-1370	DMN	_	
7-68	1371-1372	(	_	
7-69	1372-1376	aDMN	_	
7-70	1376-1377	)	_	
7-71	1377-1378	,	_	
7-72	1379-1382	and	_	
7-73	1383-1392	posterior	_	
7-74	1393-1396	DMN	_	
7-75	1397-1398	(	_	
7-76	1398-1402	pDMN	_	
7-77	1402-1403	)	_	
7-78	1404-1406	in	_	
7-79	1407-1409	AD	_	
7-80	1409-1410	.	_	
7-81	1411-1414	DDT	_	
7-82	1415-1418	was	_	
7-83	1419-1432	significantly	_	
7-84	1433-1443	correlated	_	
7-85	1444-1448	with	_	
7-86	1449-1452	the	_	
7-87	1453-1468	between-network	_	
7-88	1469-1471	FC	_	
7-89	1472-1477	among	_	
7-90	1478-1481	the	_	
7-91	1482-1486	LECN	_	
7-92	1486-1487	,	_	
7-93	1488-1492	aDMN	_	
7-94	1493-1496	and	_	
7-95	1497-1499	SN	_	
7-96	1500-1502	in	_	
7-97	1503-1505	AD	_	
7-98	1505-1506	.	_	

#Text=Conclusions
8-1	1507-1518	Conclusions	_	

#Text=These findings add evidence to the concept of altered within-network FC and also highlight the role of between-network FC in the pathophysiology of AD. Additionally, this study suggests differential neurobiological bases for different clinical measures of impulsivity that may be used as a systems-level biomarker for alcohol dependence severity and treatment efficacy.
9-1	1519-1524	These	_	
9-2	1525-1533	findings	_	
9-3	1534-1537	add	_	
9-4	1538-1546	evidence	_	
9-5	1547-1549	to	_	
9-6	1550-1553	the	_	
9-7	1554-1561	concept	_	
9-8	1562-1564	of	_	
9-9	1565-1572	altered	_	
9-10	1573-1587	within-network	_	
9-11	1588-1590	FC	_	
9-12	1591-1594	and	_	
9-13	1595-1599	also	_	
9-14	1600-1609	highlight	_	
9-15	1610-1613	the	_	
9-16	1614-1618	role	_	
9-17	1619-1621	of	_	
9-18	1622-1637	between-network	_	
9-19	1638-1640	FC	_	
9-20	1641-1643	in	_	
9-21	1644-1647	the	_	
9-22	1648-1663	pathophysiology	_	
9-23	1664-1666	of	_	
9-24	1667-1669	AD	_	
9-25	1669-1670	.	_	
9-26	1671-1683	Additionally	_	
9-27	1683-1684	,	_	
9-28	1685-1689	this	_	
9-29	1690-1695	study	_	
9-30	1696-1704	suggests	_	
9-31	1705-1717	differential	_	
9-32	1718-1733	neurobiological	_	
9-33	1734-1739	bases	_	
9-34	1740-1743	for	_	
9-35	1744-1753	different	_	
9-36	1754-1762	clinical	_	
9-37	1763-1771	measures	_	
9-38	1772-1774	of	_	
9-39	1775-1786	impulsivity	_	
9-40	1787-1791	that	_	
9-41	1792-1795	may	_	
9-42	1796-1798	be	_	
9-43	1799-1803	used	_	
9-44	1804-1806	as	_	
9-45	1807-1808	a	_	
9-46	1809-1822	systems-level	_	
9-47	1823-1832	biomarker	_	
9-48	1833-1836	for	_	
9-49	1837-1844	alcohol	_	
9-50	1845-1855	dependence	_	
9-51	1856-1864	severity	_	
9-52	1865-1868	and	_	
9-53	1869-1878	treatment	_	
9-54	1879-1887	efficacy	_	
9-55	1887-1888	.	_	

#Text=Introduction
10-1	1889-1901	Introduction	_	

#Text=Alcohol dependence is a mental disorder with an impulsive drive toward alcohol consumption and inability to inhibit its consumption despite negative consequences. Impulsivity is a multidimensional, multifaceted characteristic and construct associated to different aspects of alcohol use, abuse, and dependence. This multidimensional aspect has generated great variability in the usage of impulsivity measures, especially on the personality traits. Despite this variability, personality assessment in addition to neuroimaging data has shown individually to have high predictability for current and future alcohol misuse. The evidence from, not only strengthens the potential of neuroimaging as a tool to generate intermediate endophenotypes in addiction, but also highlights the importance of combining neuroimaging and personality assessments in order to elucidate the biological mechanisms underlying addiction and can lead to the development of improved treatment strategies.
11-1	1902-1909	Alcohol	_	
11-2	1910-1920	dependence	_	
11-3	1921-1923	is	_	
11-4	1924-1925	a	_	
11-5	1926-1932	mental	_	
11-6	1933-1941	disorder	_	
11-7	1942-1946	with	_	
11-8	1947-1949	an	_	
11-9	1950-1959	impulsive	_	
11-10	1960-1965	drive	_	
11-11	1966-1972	toward	_	
11-12	1973-1980	alcohol	_	
11-13	1981-1992	consumption	_	
11-14	1993-1996	and	_	
11-15	1997-2006	inability	_	
11-16	2007-2009	to	_	
11-17	2010-2017	inhibit	_	
11-18	2018-2021	its	_	
11-19	2022-2033	consumption	_	
11-20	2034-2041	despite	_	
11-21	2042-2050	negative	_	
11-22	2051-2063	consequences	_	
11-23	2063-2064	.	_	
11-24	2065-2076	Impulsivity	_	
11-25	2077-2079	is	_	
11-26	2080-2081	a	_	
11-27	2082-2098	multidimensional	_	
11-28	2098-2099	,	_	
11-29	2100-2112	multifaceted	_	
11-30	2113-2127	characteristic	_	
11-31	2128-2131	and	_	
11-32	2132-2141	construct	_	
11-33	2142-2152	associated	_	
11-34	2153-2155	to	_	
11-35	2156-2165	different	_	
11-36	2166-2173	aspects	_	
11-37	2174-2176	of	_	
11-38	2177-2184	alcohol	_	
11-39	2185-2188	use	_	
11-40	2188-2189	,	_	
11-41	2190-2195	abuse	_	
11-42	2195-2196	,	_	
11-43	2197-2200	and	_	
11-44	2201-2211	dependence	_	
11-45	2211-2212	.	_	
11-46	2213-2217	This	_	
11-47	2218-2234	multidimensional	_	
11-48	2235-2241	aspect	_	
11-49	2242-2245	has	_	
11-50	2246-2255	generated	_	
11-51	2256-2261	great	_	
11-52	2262-2273	variability	_	
11-53	2274-2276	in	_	
11-54	2277-2280	the	_	
11-55	2281-2286	usage	_	
11-56	2287-2289	of	_	
11-57	2290-2301	impulsivity	_	
11-58	2302-2310	measures	_	
11-59	2310-2311	,	_	
11-60	2312-2322	especially	_	
11-61	2323-2325	on	_	
11-62	2326-2329	the	_	
11-63	2330-2341	personality	_	
11-64	2342-2348	traits	_	
11-65	2348-2349	.	_	
11-66	2350-2357	Despite	_	
11-67	2358-2362	this	_	
11-68	2363-2374	variability	_	
11-69	2374-2375	,	_	
11-70	2376-2387	personality	_	
11-71	2388-2398	assessment	_	
11-72	2399-2401	in	_	
11-73	2402-2410	addition	_	
11-74	2411-2413	to	_	
11-75	2414-2426	neuroimaging	_	
11-76	2427-2431	data	_	
11-77	2432-2435	has	_	
11-78	2436-2441	shown	_	
11-79	2442-2454	individually	_	
11-80	2455-2457	to	_	
11-81	2458-2462	have	_	
11-82	2463-2467	high	_	
11-83	2468-2482	predictability	_	
11-84	2483-2486	for	_	
11-85	2487-2494	current	_	
11-86	2495-2498	and	_	
11-87	2499-2505	future	_	
11-88	2506-2513	alcohol	_	
11-89	2514-2520	misuse	_	
11-90	2520-2521	.	_	
11-91	2522-2525	The	_	
11-92	2526-2534	evidence	_	
11-93	2535-2539	from	_	
11-94	2539-2540	,	_	
11-95	2541-2544	not	_	
11-96	2545-2549	only	_	
11-97	2550-2561	strengthens	_	
11-98	2562-2565	the	_	
11-99	2566-2575	potential	_	
11-100	2576-2578	of	_	
11-101	2579-2591	neuroimaging	_	
11-102	2592-2594	as	_	
11-103	2595-2596	a	_	
11-104	2597-2601	tool	_	
11-105	2602-2604	to	_	
11-106	2605-2613	generate	_	
11-107	2614-2626	intermediate	_	
11-108	2627-2641	endophenotypes	_	
11-109	2642-2644	in	_	
11-110	2645-2654	addiction	_	
11-111	2654-2655	,	_	
11-112	2656-2659	but	_	
11-113	2660-2664	also	_	
11-114	2665-2675	highlights	_	
11-115	2676-2679	the	_	
11-116	2680-2690	importance	_	
11-117	2691-2693	of	_	
11-118	2694-2703	combining	_	
11-119	2704-2716	neuroimaging	_	
11-120	2717-2720	and	_	
11-121	2721-2732	personality	_	
11-122	2733-2744	assessments	_	
11-123	2745-2747	in	_	
11-124	2748-2753	order	_	
11-125	2754-2756	to	_	
11-126	2757-2766	elucidate	_	
11-127	2767-2770	the	_	
11-128	2771-2781	biological	_	
11-129	2782-2792	mechanisms	_	
11-130	2793-2803	underlying	_	
11-131	2804-2813	addiction	_	
11-132	2814-2817	and	_	
11-133	2818-2821	can	_	
11-134	2822-2826	lead	_	
11-135	2827-2829	to	_	
11-136	2830-2833	the	_	
11-137	2834-2845	development	_	
11-138	2846-2848	of	_	
11-139	2849-2857	improved	_	
11-140	2858-2867	treatment	_	
11-141	2868-2878	strategies	_	
11-142	2878-2879	.	_	

#Text=The neural mechanisms in the addicted brain are complex due to the dynamic changes of different regions and their connectivity. Despite this complexity, a triadic neurocognitive model has been proposed by that the weakened “willpower” that characterizes most addiction behaviors is the results of the altered interaction among three systems: 1) Impulsive system that includes amygdala-striatum regions, and is responsible for automatic cognition and habitual actions. 2) Reflective system, which contains the prefrontal cortex and has been known to be involved in decision-making and impulsive control. 3) Insula cortex, which plays a key role in modulating the dynamics between these two systems. Insula interacts with top-down control networks which hijacks the ability to inhibit alcohol consumption. Thus insula causes a severe imbalance between the impulsive and reflective systems. Although studies have proposed dysfunction in distinct brain regions within these systems in alcohol dependents (AD), there is little information regarding the large-scale patterns of altered functional connectivity (FC) at rest.
12-1	2880-2883	The	_	
12-2	2884-2890	neural	_	
12-3	2891-2901	mechanisms	_	
12-4	2902-2904	in	_	
12-5	2905-2908	the	_	
12-6	2909-2917	addicted	_	
12-7	2918-2923	brain	_	
12-8	2924-2927	are	_	
12-9	2928-2935	complex	_	
12-10	2936-2939	due	_	
12-11	2940-2942	to	_	
12-12	2943-2946	the	_	
12-13	2947-2954	dynamic	_	
12-14	2955-2962	changes	_	
12-15	2963-2965	of	_	
12-16	2966-2975	different	_	
12-17	2976-2983	regions	_	
12-18	2984-2987	and	_	
12-19	2988-2993	their	_	
12-20	2994-3006	connectivity	_	
12-21	3006-3007	.	_	
12-22	3008-3015	Despite	_	
12-23	3016-3020	this	_	
12-24	3021-3031	complexity	_	
12-25	3031-3032	,	_	
12-26	3033-3034	a	_	
12-27	3035-3042	triadic	_	
12-28	3043-3057	neurocognitive	_	
12-29	3058-3063	model	_	
12-30	3064-3067	has	_	
12-31	3068-3072	been	_	
12-32	3073-3081	proposed	_	
12-33	3082-3084	by	_	
12-34	3085-3089	that	_	
12-35	3090-3093	the	_	
12-36	3094-3102	weakened	_	
12-37	3103-3104	“	_	
12-38	3104-3113	willpower	_	
12-39	3113-3114	”	_	
12-40	3115-3119	that	_	
12-41	3120-3133	characterizes	_	
12-42	3134-3138	most	_	
12-43	3139-3148	addiction	_	
12-44	3149-3158	behaviors	_	
12-45	3159-3161	is	_	
12-46	3162-3165	the	_	
12-47	3166-3173	results	_	
12-48	3174-3176	of	_	
12-49	3177-3180	the	_	
12-50	3181-3188	altered	_	
12-51	3189-3200	interaction	_	
12-52	3201-3206	among	_	
12-53	3207-3212	three	_	
12-54	3213-3220	systems	_	
12-55	3220-3221	:	_	
12-56	3222-3223	1	_	
12-57	3223-3224	)	_	
12-58	3225-3234	Impulsive	_	
12-59	3235-3241	system	_	
12-60	3242-3246	that	_	
12-61	3247-3255	includes	_	
12-62	3256-3273	amygdala-striatum	_	
12-63	3274-3281	regions	_	
12-64	3281-3282	,	_	
12-65	3283-3286	and	_	
12-66	3287-3289	is	_	
12-67	3290-3301	responsible	_	
12-68	3302-3305	for	_	
12-69	3306-3315	automatic	_	
12-70	3316-3325	cognition	_	
12-71	3326-3329	and	_	
12-72	3330-3338	habitual	_	
12-73	3339-3346	actions	_	
12-74	3346-3347	.	_	
12-75	3348-3349	2	_	
12-76	3349-3350	)	_	
12-77	3351-3361	Reflective	_	
12-78	3362-3368	system	_	
12-79	3368-3369	,	_	
12-80	3370-3375	which	_	
12-81	3376-3384	contains	_	
12-82	3385-3388	the	_	
12-83	3389-3399	prefrontal	_	
12-84	3400-3406	cortex	_	
12-85	3407-3410	and	_	
12-86	3411-3414	has	_	
12-87	3415-3419	been	_	
12-88	3420-3425	known	_	
12-89	3426-3428	to	_	
12-90	3429-3431	be	_	
12-91	3432-3440	involved	_	
12-92	3441-3443	in	_	
12-93	3444-3459	decision-making	_	
12-94	3460-3463	and	_	
12-95	3464-3473	impulsive	_	
12-96	3474-3481	control	_	
12-97	3481-3482	.	_	
12-98	3483-3484	3	_	
12-99	3484-3485	)	_	
12-100	3486-3492	Insula	_	
12-101	3493-3499	cortex	_	
12-102	3499-3500	,	_	
12-103	3501-3506	which	_	
12-104	3507-3512	plays	_	
12-105	3513-3514	a	_	
12-106	3515-3518	key	_	
12-107	3519-3523	role	_	
12-108	3524-3526	in	_	
12-109	3527-3537	modulating	_	
12-110	3538-3541	the	_	
12-111	3542-3550	dynamics	_	
12-112	3551-3558	between	_	
12-113	3559-3564	these	_	
12-114	3565-3568	two	_	
12-115	3569-3576	systems	_	
12-116	3576-3577	.	_	
12-117	3578-3584	Insula	_	
12-118	3585-3594	interacts	_	
12-119	3595-3599	with	_	
12-120	3600-3608	top-down	_	
12-121	3609-3616	control	_	
12-122	3617-3625	networks	_	
12-123	3626-3631	which	_	
12-124	3632-3639	hijacks	_	
12-125	3640-3643	the	_	
12-126	3644-3651	ability	_	
12-127	3652-3654	to	_	
12-128	3655-3662	inhibit	_	
12-129	3663-3670	alcohol	_	
12-130	3671-3682	consumption	_	
12-131	3682-3683	.	_	
12-132	3684-3688	Thus	_	
12-133	3689-3695	insula	_	
12-134	3696-3702	causes	_	
12-135	3703-3704	a	_	
12-136	3705-3711	severe	_	
12-137	3712-3721	imbalance	_	
12-138	3722-3729	between	_	
12-139	3730-3733	the	_	
12-140	3734-3743	impulsive	_	
12-141	3744-3747	and	_	
12-142	3748-3758	reflective	_	
12-143	3759-3766	systems	_	
12-144	3766-3767	.	_	
12-145	3768-3776	Although	_	
12-146	3777-3784	studies	_	
12-147	3785-3789	have	_	
12-148	3790-3798	proposed	_	
12-149	3799-3810	dysfunction	_	
12-150	3811-3813	in	_	
12-151	3814-3822	distinct	_	
12-152	3823-3828	brain	_	
12-153	3829-3836	regions	_	
12-154	3837-3843	within	_	
12-155	3844-3849	these	_	
12-156	3850-3857	systems	_	
12-157	3858-3860	in	_	
12-158	3861-3868	alcohol	_	
12-159	3869-3879	dependents	_	
12-160	3880-3881	(	_	
12-161	3881-3883	AD	_	
12-162	3883-3884	)	_	
12-163	3884-3885	,	_	
12-164	3886-3891	there	_	
12-165	3892-3894	is	_	
12-166	3895-3901	little	_	
12-167	3902-3913	information	_	
12-168	3914-3923	regarding	_	
12-169	3924-3927	the	_	
12-170	3928-3939	large-scale	_	
12-171	3940-3948	patterns	_	
12-172	3949-3951	of	_	
12-173	3952-3959	altered	_	
12-174	3960-3970	functional	_	
12-175	3971-3983	connectivity	_	
12-176	3984-3985	(	_	
12-177	3985-3987	FC	_	
12-178	3987-3988	)	_	
12-179	3989-3991	at	_	
12-180	3992-3996	rest	_	
12-181	3996-3997	.	_	

#Text=Resting-state fMRI enables the identification of functionally connected brain regions, and data-driven approaches such as independent component analysis (ICA) allow the evaluation of functional synchronous activity between clusters (regions) for the entire RSNs. The regions within a given ICA component are strongly coherent temporally and here referred to as within-network connectivity. In spatial ICA the different components are spatially independent, but temporally dependent with each other and here referred to as between-network connectivity. In this study, the first aim was to identify differences in resting state connectivity within and among the RSNs associated with the triadic model between AD and healthy controls (HC). Besides that, we will also examine the default model network (DMN) which has been used in examining cognitive dysfunction in neurologic and psychiatric brain disorders, and is characterized by dysfunction of introspective mental processes which may be potential sources of interference during goal-directed activity. The second aim was to identify the relationship between RSN connectivity and impulsivity measures. We hypothesize that, 1) AD and HC will show a differential within-network connectivity pattern in the “impulsive”, “reflective”, salience network involving insula, and DMN that will distinguish the two groups; 2) The between-network coupling in these key systems would also be altered in AD; and 3) The changes of network FC would be correlated with key clinical measures of impulsivity.
13-1	3998-4011	Resting-state	_	
13-2	4012-4016	fMRI	_	
13-3	4017-4024	enables	_	
13-4	4025-4028	the	_	
13-5	4029-4043	identification	_	
13-6	4044-4046	of	_	
13-7	4047-4059	functionally	_	
13-8	4060-4069	connected	_	
13-9	4070-4075	brain	_	
13-10	4076-4083	regions	_	
13-11	4083-4084	,	_	
13-12	4085-4088	and	_	
13-13	4089-4100	data-driven	_	
13-14	4101-4111	approaches	_	
13-15	4112-4116	such	_	
13-16	4117-4119	as	_	
13-17	4120-4131	independent	_	
13-18	4132-4141	component	_	
13-19	4142-4150	analysis	_	
13-20	4151-4152	(	_	
13-21	4152-4155	ICA	_	
13-22	4155-4156	)	_	
13-23	4157-4162	allow	_	
13-24	4163-4166	the	_	
13-25	4167-4177	evaluation	_	
13-26	4178-4180	of	_	
13-27	4181-4191	functional	_	
13-28	4192-4203	synchronous	_	
13-29	4204-4212	activity	_	
13-30	4213-4220	between	_	
13-31	4221-4229	clusters	_	
13-32	4230-4231	(	_	
13-33	4231-4238	regions	_	
13-34	4238-4239	)	_	
13-35	4240-4243	for	_	
13-36	4244-4247	the	_	
13-37	4248-4254	entire	_	
13-38	4255-4259	RSNs	_	
13-39	4259-4260	.	_	
13-40	4261-4264	The	_	
13-41	4265-4272	regions	_	
13-42	4273-4279	within	_	
13-43	4280-4281	a	_	
13-44	4282-4287	given	_	
13-45	4288-4291	ICA	_	
13-46	4292-4301	component	_	
13-47	4302-4305	are	_	
13-48	4306-4314	strongly	_	
13-49	4315-4323	coherent	_	
13-50	4324-4334	temporally	_	
13-51	4335-4338	and	_	
13-52	4339-4343	here	_	
13-53	4344-4352	referred	_	
13-54	4353-4355	to	_	
13-55	4356-4358	as	_	
13-56	4359-4373	within-network	_	
13-57	4374-4386	connectivity	_	
13-58	4386-4387	.	_	
13-59	4388-4390	In	_	
13-60	4391-4398	spatial	_	
13-61	4399-4402	ICA	_	
13-62	4403-4406	the	_	
13-63	4407-4416	different	_	
13-64	4417-4427	components	_	
13-65	4428-4431	are	_	
13-66	4432-4441	spatially	_	
13-67	4442-4453	independent	_	
13-68	4453-4454	,	_	
13-69	4455-4458	but	_	
13-70	4459-4469	temporally	_	
13-71	4470-4479	dependent	_	
13-72	4480-4484	with	_	
13-73	4485-4489	each	_	
13-74	4490-4495	other	_	
13-75	4496-4499	and	_	
13-76	4500-4504	here	_	
13-77	4505-4513	referred	_	
13-78	4514-4516	to	_	
13-79	4517-4519	as	_	
13-80	4520-4535	between-network	_	
13-81	4536-4548	connectivity	_	
13-82	4548-4549	.	_	
13-83	4550-4552	In	_	
13-84	4553-4557	this	_	
13-85	4558-4563	study	_	
13-86	4563-4564	,	_	
13-87	4565-4568	the	_	
13-88	4569-4574	first	_	
13-89	4575-4578	aim	_	
13-90	4579-4582	was	_	
13-91	4583-4585	to	_	
13-92	4586-4594	identify	_	
13-93	4595-4606	differences	_	
13-94	4607-4609	in	_	
13-95	4610-4617	resting	_	
13-96	4618-4623	state	_	
13-97	4624-4636	connectivity	_	
13-98	4637-4643	within	_	
13-99	4644-4647	and	_	
13-100	4648-4653	among	_	
13-101	4654-4657	the	_	
13-102	4658-4662	RSNs	_	
13-103	4663-4673	associated	_	
13-104	4674-4678	with	_	
13-105	4679-4682	the	_	
13-106	4683-4690	triadic	_	
13-107	4691-4696	model	_	
13-108	4697-4704	between	_	
13-109	4705-4707	AD	_	
13-110	4708-4711	and	_	
13-111	4712-4719	healthy	_	
13-112	4720-4728	controls	_	
13-113	4729-4730	(	_	
13-114	4730-4732	HC	_	
13-115	4732-4733	)	_	
13-116	4733-4734	.	_	
13-117	4735-4742	Besides	_	
13-118	4743-4747	that	_	
13-119	4747-4748	,	_	
13-120	4749-4751	we	_	
13-121	4752-4756	will	_	
13-122	4757-4761	also	_	
13-123	4762-4769	examine	_	
13-124	4770-4773	the	_	
13-125	4774-4781	default	_	
13-126	4782-4787	model	_	
13-127	4788-4795	network	_	
13-128	4796-4797	(	_	
13-129	4797-4800	DMN	_	
13-130	4800-4801	)	_	
13-131	4802-4807	which	_	
13-132	4808-4811	has	_	
13-133	4812-4816	been	_	
13-134	4817-4821	used	_	
13-135	4822-4824	in	_	
13-136	4825-4834	examining	_	
13-137	4835-4844	cognitive	_	
13-138	4845-4856	dysfunction	_	
13-139	4857-4859	in	_	
13-140	4860-4870	neurologic	_	
13-141	4871-4874	and	_	
13-142	4875-4886	psychiatric	_	
13-143	4887-4892	brain	_	
13-144	4893-4902	disorders	_	
13-145	4902-4903	,	_	
13-146	4904-4907	and	_	
13-147	4908-4910	is	_	
13-148	4911-4924	characterized	_	
13-149	4925-4927	by	_	
13-150	4928-4939	dysfunction	_	
13-151	4940-4942	of	_	
13-152	4943-4956	introspective	_	
13-153	4957-4963	mental	_	
13-154	4964-4973	processes	_	
13-155	4974-4979	which	_	
13-156	4980-4983	may	_	
13-157	4984-4986	be	_	
13-158	4987-4996	potential	_	
13-159	4997-5004	sources	_	
13-160	5005-5007	of	_	
13-161	5008-5020	interference	_	
13-162	5021-5027	during	_	
13-163	5028-5041	goal-directed	_	
13-164	5042-5050	activity	_	
13-165	5050-5051	.	_	
13-166	5052-5055	The	_	
13-167	5056-5062	second	_	
13-168	5063-5066	aim	_	
13-169	5067-5070	was	_	
13-170	5071-5073	to	_	
13-171	5074-5082	identify	_	
13-172	5083-5086	the	_	
13-173	5087-5099	relationship	_	
13-174	5100-5107	between	_	
13-175	5108-5111	RSN	_	
13-176	5112-5124	connectivity	_	
13-177	5125-5128	and	_	
13-178	5129-5140	impulsivity	_	
13-179	5141-5149	measures	_	
13-180	5149-5150	.	_	
13-181	5151-5153	We	_	
13-182	5154-5165	hypothesize	_	
13-183	5166-5170	that	_	
13-184	5170-5171	,	_	
13-185	5172-5173	1	_	
13-186	5173-5174	)	_	
13-187	5175-5177	AD	_	
13-188	5178-5181	and	_	
13-189	5182-5184	HC	_	
13-190	5185-5189	will	_	
13-191	5190-5194	show	_	
13-192	5195-5196	a	_	
13-193	5197-5209	differential	_	
13-194	5210-5224	within-network	_	
13-195	5225-5237	connectivity	_	
13-196	5238-5245	pattern	_	
13-197	5246-5248	in	_	
13-198	5249-5252	the	_	
13-199	5253-5254	“	_	
13-200	5254-5263	impulsive	_	
13-201	5263-5264	”	_	
13-202	5264-5265	,	_	
13-203	5266-5267	“	_	
13-204	5267-5277	reflective	_	
13-205	5277-5278	”	_	
13-206	5278-5279	,	_	
13-207	5280-5288	salience	_	
13-208	5289-5296	network	_	
13-209	5297-5306	involving	_	
13-210	5307-5313	insula	_	
13-211	5313-5314	,	_	
13-212	5315-5318	and	_	
13-213	5319-5322	DMN	_	
13-214	5323-5327	that	_	
13-215	5328-5332	will	_	
13-216	5333-5344	distinguish	_	
13-217	5345-5348	the	_	
13-218	5349-5352	two	_	
13-219	5353-5359	groups	_	
13-220	5359-5360	;	_	
13-221	5361-5362	2	_	
13-222	5362-5363	)	_	
13-223	5364-5367	The	_	
13-224	5368-5383	between-network	_	
13-225	5384-5392	coupling	_	
13-226	5393-5395	in	_	
13-227	5396-5401	these	_	
13-228	5402-5405	key	_	
13-229	5406-5413	systems	_	
13-230	5414-5419	would	_	
13-231	5420-5424	also	_	
13-232	5425-5427	be	_	
13-233	5428-5435	altered	_	
13-234	5436-5438	in	_	
13-235	5439-5441	AD	_	
13-236	5441-5442	;	_	
13-237	5443-5446	and	_	
13-238	5447-5448	3	_	
13-239	5448-5449	)	_	
13-240	5450-5453	The	_	
13-241	5454-5461	changes	_	
13-242	5462-5464	of	_	
13-243	5465-5472	network	_	
13-244	5473-5475	FC	_	
13-245	5476-5481	would	_	
13-246	5482-5484	be	_	
13-247	5485-5495	correlated	_	
13-248	5496-5500	with	_	
13-249	5501-5504	key	_	
13-250	5505-5513	clinical	_	
13-251	5514-5522	measures	_	
13-252	5523-5525	of	_	
13-253	5526-5537	impulsivity	_	
13-254	5537-5538	.	_	

#Text=Methods and Materials
14-1	5539-5546	Methods	_	
14-2	5547-5550	and	_	
14-3	5551-5560	Materials	_	

#Text=2.1 Participants
15-1	5561-5564	2.1	_	
15-2	5565-5577	Participants	_	

#Text=Twenty-five alcohol-dependent (AD) subjects (8 females) with an average age of 31.9 years (range: 21 to 44, std: 7.7) and 26 healthy controls (HC) subjects (15 females) with mean age at examination of 26.3 years (range: 22 to 37, std: 3.9) were examined (Table 1). Healthy controls were recruited through newspaper advertisements and information notices distributed in the Washington, D.C. metropolitan area. Subjects comprising the alcohol-dependent group were recruited from the inpatient alcohol treatment unit at the National Institutes of Health Clinical Research Center in Bethesda, Maryland. Written informed consent to the study was obtained from all of subjects, which was approved by the Institutional Review Board of the National Institute on Alcohol Abuse and Alcoholism.
16-1	5578-5589	Twenty-five	_	
16-2	5590-5607	alcohol-dependent	_	
16-3	5608-5609	(	_	
16-4	5609-5611	AD	_	
16-5	5611-5612	)	_	
16-6	5613-5621	subjects	_	
16-7	5622-5623	(	_	
16-8	5623-5624	8	_	
16-9	5625-5632	females	_	
16-10	5632-5633	)	_	
16-11	5634-5638	with	_	
16-12	5639-5641	an	_	
16-13	5642-5649	average	_	
16-14	5650-5653	age	_	
16-15	5654-5656	of	_	
16-16	5657-5661	31.9	_	
16-17	5662-5667	years	_	
16-18	5668-5669	(	_	
16-19	5669-5674	range	_	
16-20	5674-5675	:	_	
16-21	5676-5678	21	_	
16-22	5679-5681	to	_	
16-23	5682-5684	44	_	
16-24	5684-5685	,	_	
16-25	5686-5689	std	_	
16-26	5689-5690	:	_	
16-27	5691-5694	7.7	_	
16-28	5694-5695	)	_	
16-29	5696-5699	and	_	
16-30	5700-5702	26	_	
16-31	5703-5710	healthy	_	
16-32	5711-5719	controls	_	
16-33	5720-5721	(	_	
16-34	5721-5723	HC	_	
16-35	5723-5724	)	_	
16-36	5725-5733	subjects	_	
16-37	5734-5735	(	_	
16-38	5735-5737	15	_	
16-39	5738-5745	females	_	
16-40	5745-5746	)	_	
16-41	5747-5751	with	_	
16-42	5752-5756	mean	_	
16-43	5757-5760	age	_	
16-44	5761-5763	at	_	
16-45	5764-5775	examination	_	
16-46	5776-5778	of	_	
16-47	5779-5783	26.3	_	
16-48	5784-5789	years	_	
16-49	5790-5791	(	_	
16-50	5791-5796	range	_	
16-51	5796-5797	:	_	
16-52	5798-5800	22	_	
16-53	5801-5803	to	_	
16-54	5804-5806	37	_	
16-55	5806-5807	,	_	
16-56	5808-5811	std	_	
16-57	5811-5812	:	_	
16-58	5813-5816	3.9	_	
16-59	5816-5817	)	_	
16-60	5818-5822	were	_	
16-61	5823-5831	examined	_	
16-62	5832-5833	(	_	
16-63	5833-5838	Table	_	
16-64	5839-5840	1	_	
16-65	5840-5841	)	_	
16-66	5841-5842	.	_	
16-67	5843-5850	Healthy	_	
16-68	5851-5859	controls	_	
16-69	5860-5864	were	_	
16-70	5865-5874	recruited	_	
16-71	5875-5882	through	_	
16-72	5883-5892	newspaper	_	
16-73	5893-5907	advertisements	_	
16-74	5908-5911	and	_	
16-75	5912-5923	information	_	
16-76	5924-5931	notices	_	
16-77	5932-5943	distributed	_	
16-78	5944-5946	in	_	
16-79	5947-5950	the	_	
16-80	5951-5961	Washington	_	
16-81	5961-5962	,	_	
16-82	5963-5966	D.C	_	
16-83	5966-5967	.	_	
16-84	5968-5980	metropolitan	_	
16-85	5981-5985	area	_	
16-86	5985-5986	.	_	
16-87	5987-5995	Subjects	_	
16-88	5996-6006	comprising	_	
16-89	6007-6010	the	_	
16-90	6011-6028	alcohol-dependent	_	
16-91	6029-6034	group	_	
16-92	6035-6039	were	_	
16-93	6040-6049	recruited	_	
16-94	6050-6054	from	_	
16-95	6055-6058	the	_	
16-96	6059-6068	inpatient	_	
16-97	6069-6076	alcohol	_	
16-98	6077-6086	treatment	_	
16-99	6087-6091	unit	_	
16-100	6092-6094	at	_	
16-101	6095-6098	the	_	
16-102	6099-6107	National	_	
16-103	6108-6118	Institutes	_	
16-104	6119-6121	of	_	
16-105	6122-6128	Health	_	
16-106	6129-6137	Clinical	_	
16-107	6138-6146	Research	_	
16-108	6147-6153	Center	_	
16-109	6154-6156	in	_	
16-110	6157-6165	Bethesda	_	
16-111	6165-6166	,	_	
16-112	6167-6175	Maryland	_	
16-113	6175-6176	.	_	
16-114	6177-6184	Written	_	
16-115	6185-6193	informed	_	
16-116	6194-6201	consent	_	
16-117	6202-6204	to	_	
16-118	6205-6208	the	_	
16-119	6209-6214	study	_	
16-120	6215-6218	was	_	
16-121	6219-6227	obtained	_	
16-122	6228-6232	from	_	
16-123	6233-6236	all	_	
16-124	6237-6239	of	_	
16-125	6240-6248	subjects	_	
16-126	6248-6249	,	_	
16-127	6250-6255	which	_	
16-128	6256-6259	was	_	
16-129	6260-6268	approved	_	
16-130	6269-6271	by	_	
16-131	6272-6275	the	_	
16-132	6276-6289	Institutional	_	
16-133	6290-6296	Review	_	
16-134	6297-6302	Board	_	
16-135	6303-6305	of	_	
16-136	6306-6309	the	_	
16-137	6310-6318	National	_	
16-138	6319-6328	Institute	_	
16-139	6329-6331	on	_	
16-140	6332-6339	Alcohol	_	
16-141	6340-6345	Abuse	_	
16-142	6346-6349	and	_	
16-143	6350-6360	Alcoholism	_	
16-144	6360-6361	.	_	

#Text=2.2 Assessments
17-1	6362-6365	2.2	_	
17-2	6366-6377	Assessments	_	

#Text=The Structured Clinical Interview for DSM-IV-TR (SCID) was administered to all participants to determine diagnoses of alcohol dependence as well as other substance use and psychiatric disorders. The Wechsler Adult Intelligence Scale (WAIS-III) was administered to determine the intelligence quotient (IQ) of all participants. A 90 day Timeline Followback (TLFB) calendar was used to measure the frequency and amount of drinking for all subjects. The first dimension of impulsivity, trait-impulsivity, was measured by the Barratt Impulsiveness Scale (BIS-11), which is one of the most widely-used self-report measures of trait-impulsivity, refers to aspects of inattention, spontaneous actions, and lack of forethought. Another one is the UPPS-P Impulsive Behavior Scale (UPPS). This scale measures impulsivity across the Five-Factor Model of personality, measuring in this way distinct personality traits that lead to impulsive behavior. It includes Urgency (negative) (UPPS (−)), Premeditation (lack of), Perseverance (lack of), Sensation-seeking, and Positive-urgency (UPPS (+)). Second dimension of impulsivity is choice impulsivity. This deficiency was measured by delay discounting task (DDT). The DDT measures impulsivity by presenting the subject with an option between receiving a smaller immediate monetary reward or a potentially greater delayed reward. Participants were presented with a choice between an immediate reward and a fixed larger ($100) but delayed (zero to 30 days) rewards. Accordingly, a discounting factor k represents the rate of discounting of the delayed outcome. As k values are not normally distributed, a natural log-transformation is usually applied and the ln(k) is used for the analyses. Higher ln(k) values mean greater preference for immediate rewards. A smoking questionnaire helped to determine the amount and frequency of a participant’s cigarette use.
18-1	6378-6381	The	_	
18-2	6382-6392	Structured	_	
18-3	6393-6401	Clinical	_	
18-4	6402-6411	Interview	_	
18-5	6412-6415	for	_	
18-6	6416-6425	DSM-IV-TR	_	
18-7	6426-6427	(	_	
18-8	6427-6431	SCID	_	
18-9	6431-6432	)	_	
18-10	6433-6436	was	_	
18-11	6437-6449	administered	_	
18-12	6450-6452	to	_	
18-13	6453-6456	all	_	
18-14	6457-6469	participants	_	
18-15	6470-6472	to	_	
18-16	6473-6482	determine	_	
18-17	6483-6492	diagnoses	_	
18-18	6493-6495	of	_	
18-19	6496-6503	alcohol	_	
18-20	6504-6514	dependence	_	
18-21	6515-6517	as	_	
18-22	6518-6522	well	_	
18-23	6523-6525	as	_	
18-24	6526-6531	other	_	
18-25	6532-6541	substance	_	
18-26	6542-6545	use	_	
18-27	6546-6549	and	_	
18-28	6550-6561	psychiatric	_	
18-29	6562-6571	disorders	_	
18-30	6571-6572	.	_	
18-31	6573-6576	The	_	
18-32	6577-6585	Wechsler	_	
18-33	6586-6591	Adult	_	
18-34	6592-6604	Intelligence	_	
18-35	6605-6610	Scale	_	
18-36	6611-6612	(	_	
18-37	6612-6620	WAIS-III	_	
18-38	6620-6621	)	_	
18-39	6622-6625	was	_	
18-40	6626-6638	administered	_	
18-41	6639-6641	to	_	
18-42	6642-6651	determine	_	
18-43	6652-6655	the	_	
18-44	6656-6668	intelligence	_	
18-45	6669-6677	quotient	_	
18-46	6678-6679	(	_	
18-47	6679-6681	IQ	_	
18-48	6681-6682	)	_	
18-49	6683-6685	of	_	
18-50	6686-6689	all	_	
18-51	6690-6702	participants	_	
18-52	6702-6703	.	_	
18-53	6704-6705	A	_	
18-54	6706-6708	90	_	
18-55	6709-6712	day	_	
18-56	6713-6721	Timeline	_	
18-57	6722-6732	Followback	_	
18-58	6733-6734	(	_	
18-59	6734-6738	TLFB	_	
18-60	6738-6739	)	_	
18-61	6740-6748	calendar	_	
18-62	6749-6752	was	_	
18-63	6753-6757	used	_	
18-64	6758-6760	to	_	
18-65	6761-6768	measure	_	
18-66	6769-6772	the	_	
18-67	6773-6782	frequency	_	
18-68	6783-6786	and	_	
18-69	6787-6793	amount	_	
18-70	6794-6796	of	_	
18-71	6797-6805	drinking	_	
18-72	6806-6809	for	_	
18-73	6810-6813	all	_	
18-74	6814-6822	subjects	_	
18-75	6822-6823	.	_	
18-76	6824-6827	The	_	
18-77	6828-6833	first	_	
18-78	6834-6843	dimension	_	
18-79	6844-6846	of	_	
18-80	6847-6858	impulsivity	_	
18-81	6858-6859	,	_	
18-82	6860-6877	trait-impulsivity	_	
18-83	6877-6878	,	_	
18-84	6879-6882	was	_	
18-85	6883-6891	measured	_	
18-86	6892-6894	by	_	
18-87	6895-6898	the	_	
18-88	6899-6906	Barratt	_	
18-89	6907-6920	Impulsiveness	_	
18-90	6921-6926	Scale	_	
18-91	6927-6928	(	_	
18-92	6928-6931	BIS	_	
18-93	6931-6932	-	_	
18-94	6932-6934	11	_	
18-95	6934-6935	)	_	
18-96	6935-6936	,	_	
18-97	6937-6942	which	_	
18-98	6943-6945	is	_	
18-99	6946-6949	one	_	
18-100	6950-6952	of	_	
18-101	6953-6956	the	_	
18-102	6957-6961	most	_	
18-103	6962-6973	widely-used	_	
18-104	6974-6985	self-report	_	
18-105	6986-6994	measures	_	
18-106	6995-6997	of	_	
18-107	6998-7015	trait-impulsivity	_	
18-108	7015-7016	,	_	
18-109	7017-7023	refers	_	
18-110	7024-7026	to	_	
18-111	7027-7034	aspects	_	
18-112	7035-7037	of	_	
18-113	7038-7049	inattention	_	
18-114	7049-7050	,	_	
18-115	7051-7062	spontaneous	_	
18-116	7063-7070	actions	_	
18-117	7070-7071	,	_	
18-118	7072-7075	and	_	
18-119	7076-7080	lack	_	
18-120	7081-7083	of	_	
18-121	7084-7095	forethought	_	
18-122	7095-7096	.	_	
18-123	7097-7104	Another	_	
18-124	7105-7108	one	_	
18-125	7109-7111	is	_	
18-126	7112-7115	the	_	
18-127	7116-7122	UPPS-P	_	
18-128	7123-7132	Impulsive	_	
18-129	7133-7141	Behavior	_	
18-130	7142-7147	Scale	_	
18-131	7148-7149	(	_	
18-132	7149-7153	UPPS	_	
18-133	7153-7154	)	_	
18-134	7154-7155	.	_	
18-135	7156-7160	This	_	
18-136	7161-7166	scale	_	
18-137	7167-7175	measures	_	
18-138	7176-7187	impulsivity	_	
18-139	7188-7194	across	_	
18-140	7195-7198	the	_	
18-141	7199-7210	Five-Factor	_	
18-142	7211-7216	Model	_	
18-143	7217-7219	of	_	
18-144	7220-7231	personality	_	
18-145	7231-7232	,	_	
18-146	7233-7242	measuring	_	
18-147	7243-7245	in	_	
18-148	7246-7250	this	_	
18-149	7251-7254	way	_	
18-150	7255-7263	distinct	_	
18-151	7264-7275	personality	_	
18-152	7276-7282	traits	_	
18-153	7283-7287	that	_	
18-154	7288-7292	lead	_	
18-155	7293-7295	to	_	
18-156	7296-7305	impulsive	_	
18-157	7306-7314	behavior	_	
18-158	7314-7315	.	_	
18-159	7316-7318	It	_	
18-160	7319-7327	includes	_	
18-161	7328-7335	Urgency	_	
18-162	7336-7337	(	_	
18-163	7337-7345	negative	_	
18-164	7345-7346	)	_	
18-165	7347-7348	(	_	
18-166	7348-7352	UPPS	_	
18-167	7353-7354	(	_	
18-168	7354-7355	−	_	
18-169	7355-7356	)	_	
18-170	7356-7357	)	_	
18-171	7357-7358	,	_	
18-172	7359-7372	Premeditation	_	
18-173	7373-7374	(	_	
18-174	7374-7378	lack	_	
18-175	7379-7381	of	_	
18-176	7381-7382	)	_	
18-177	7382-7383	,	_	
18-178	7384-7396	Perseverance	_	
18-179	7397-7398	(	_	
18-180	7398-7402	lack	_	
18-181	7403-7405	of	_	
18-182	7405-7406	)	_	
18-183	7406-7407	,	_	
18-184	7408-7425	Sensation-seeking	_	
18-185	7425-7426	,	_	
18-186	7427-7430	and	_	
18-187	7431-7447	Positive-urgency	_	
18-188	7448-7449	(	_	
18-189	7449-7453	UPPS	_	
18-190	7454-7455	(	_	
18-191	7455-7456	+	_	
18-192	7456-7457	)	_	
18-193	7457-7458	)	_	
18-194	7458-7459	.	_	
18-195	7460-7466	Second	_	
18-196	7467-7476	dimension	_	
18-197	7477-7479	of	_	
18-198	7480-7491	impulsivity	_	
18-199	7492-7494	is	_	
18-200	7495-7501	choice	_	
18-201	7502-7513	impulsivity	_	
18-202	7513-7514	.	_	
18-203	7515-7519	This	_	
18-204	7520-7530	deficiency	_	
18-205	7531-7534	was	_	
18-206	7535-7543	measured	_	
18-207	7544-7546	by	_	
18-208	7547-7552	delay	_	
18-209	7553-7564	discounting	_	
18-210	7565-7569	task	_	
18-211	7570-7571	(	_	
18-212	7571-7574	DDT	_	
18-213	7574-7575	)	_	
18-214	7575-7576	.	_	
18-215	7577-7580	The	_	
18-216	7581-7584	DDT	_	
18-217	7585-7593	measures	_	
18-218	7594-7605	impulsivity	_	
18-219	7606-7608	by	_	
18-220	7609-7619	presenting	_	
18-221	7620-7623	the	_	
18-222	7624-7631	subject	_	
18-223	7632-7636	with	_	
18-224	7637-7639	an	_	
18-225	7640-7646	option	_	
18-226	7647-7654	between	_	
18-227	7655-7664	receiving	_	
18-228	7665-7666	a	_	
18-229	7667-7674	smaller	_	
18-230	7675-7684	immediate	_	
18-231	7685-7693	monetary	_	
18-232	7694-7700	reward	_	
18-233	7701-7703	or	_	
18-234	7704-7705	a	_	
18-235	7706-7717	potentially	_	
18-236	7718-7725	greater	_	
18-237	7726-7733	delayed	_	
18-238	7734-7740	reward	_	
18-239	7740-7741	.	_	
18-240	7742-7754	Participants	_	
18-241	7755-7759	were	_	
18-242	7760-7769	presented	_	
18-243	7770-7774	with	_	
18-244	7775-7776	a	_	
18-245	7777-7783	choice	_	
18-246	7784-7791	between	_	
18-247	7792-7794	an	_	
18-248	7795-7804	immediate	_	
18-249	7805-7811	reward	_	
18-250	7812-7815	and	_	
18-251	7816-7817	a	_	
18-252	7818-7823	fixed	_	
18-253	7824-7830	larger	_	
18-254	7831-7832	(	_	
18-255	7832-7836	$100	_	
18-256	7836-7837	)	_	
18-257	7838-7841	but	_	
18-258	7842-7849	delayed	_	
18-259	7850-7851	(	_	
18-260	7851-7855	zero	_	
18-261	7856-7858	to	_	
18-262	7859-7861	30	_	
18-263	7862-7866	days	_	
18-264	7866-7867	)	_	
18-265	7868-7875	rewards	_	
18-266	7875-7876	.	_	
18-267	7877-7888	Accordingly	_	
18-268	7888-7889	,	_	
18-269	7890-7891	a	_	
18-270	7892-7903	discounting	_	
18-271	7904-7910	factor	_	
18-272	7911-7912	k	_	
18-273	7913-7923	represents	_	
18-274	7924-7927	the	_	
18-275	7928-7932	rate	_	
18-276	7933-7935	of	_	
18-277	7936-7947	discounting	_	
18-278	7948-7950	of	_	
18-279	7951-7954	the	_	
18-280	7955-7962	delayed	_	
18-281	7963-7970	outcome	_	
18-282	7970-7971	.	_	
18-283	7972-7974	As	_	
18-284	7975-7976	k	_	
18-285	7977-7983	values	_	
18-286	7984-7987	are	_	
18-287	7988-7991	not	_	
18-288	7992-8000	normally	_	
18-289	8001-8012	distributed	_	
18-290	8012-8013	,	_	
18-291	8014-8015	a	_	
18-292	8016-8023	natural	_	
18-293	8024-8042	log-transformation	_	
18-294	8043-8045	is	_	
18-295	8046-8053	usually	_	
18-296	8054-8061	applied	_	
18-297	8062-8065	and	_	
18-298	8066-8069	the	_	
18-299	8070-8072	ln	_	
18-300	8072-8073	(	_	
18-301	8073-8074	k	_	
18-302	8074-8075	)	_	
18-303	8076-8078	is	_	
18-304	8079-8083	used	_	
18-305	8084-8087	for	_	
18-306	8088-8091	the	_	
18-307	8092-8100	analyses	_	
18-308	8100-8101	.	_	
18-309	8102-8108	Higher	_	
18-310	8109-8111	ln	_	
18-311	8111-8112	(	_	
18-312	8112-8113	k	_	
18-313	8113-8114	)	_	
18-314	8115-8121	values	_	
18-315	8122-8126	mean	_	
18-316	8127-8134	greater	_	
18-317	8135-8145	preference	_	
18-318	8146-8149	for	_	
18-319	8150-8159	immediate	_	
18-320	8160-8167	rewards	_	
18-321	8167-8168	.	_	
18-322	8169-8170	A	_	
18-323	8171-8178	smoking	_	
18-324	8179-8192	questionnaire	_	
18-325	8193-8199	helped	_	
18-326	8200-8202	to	_	
18-327	8203-8212	determine	_	
18-328	8213-8216	the	_	
18-329	8217-8223	amount	_	
18-330	8224-8227	and	_	
18-331	8228-8237	frequency	_	
18-332	8238-8240	of	_	
18-333	8241-8242	a	_	
18-334	8243-8254	participant	_	
18-335	8254-8255	’	_	
18-336	8255-8256	s	_	
18-337	8257-8266	cigarette	_	
18-338	8267-8270	use	_	
18-339	8270-8271	.	_	

#Text=2.3 Exclusionary criteria
19-1	8272-8275	2.3	_	
19-2	8276-8288	Exclusionary	_	
19-3	8289-8297	criteria	_	

#Text=Exclusionary criteria included pregnancy, claustrophobia, significant neurological, or medical diagnoses. Participants were instructed not to consume any alcohol for 24 hours and no more than half a cup of caffeinated beverages 12 hours prior to each scanning visit. Participants could not participate if they had a positive alcohol breathalyzer or urine drug screen on the day of the scan. HC were excluded if they met criteria for any current or past alcohol use disorder. All subjects were required to be right handed and deemed physically healthy by a clinician. Subjects were excluded if they had a positive HIV test, active suicidal or homicidal ideations, or were currently taking psychotropic medication. Since the subjects were primarily recruited for fMRI tasks a failed neuromotor examination, which evaluated motor strength, deep tendon reflexes, extraocular movements, gait, and a cerebellar assessment, was also exclusionary. This allowed the researchers to exclude subjects who may possess neurological deficiencies that could potentially compromise task driven fMRI data. AD participants could not have severe symptoms of alcohol withdrawal as determined by a Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA) score of greater than 8.
20-1	8298-8310	Exclusionary	_	
20-2	8311-8319	criteria	_	
20-3	8320-8328	included	_	
20-4	8329-8338	pregnancy	_	
20-5	8338-8339	,	_	
20-6	8340-8354	claustrophobia	_	
20-7	8354-8355	,	_	
20-8	8356-8367	significant	_	
20-9	8368-8380	neurological	_	
20-10	8380-8381	,	_	
20-11	8382-8384	or	_	
20-12	8385-8392	medical	_	
20-13	8393-8402	diagnoses	_	
20-14	8402-8403	.	_	
20-15	8404-8416	Participants	_	
20-16	8417-8421	were	_	
20-17	8422-8432	instructed	_	
20-18	8433-8436	not	_	
20-19	8437-8439	to	_	
20-20	8440-8447	consume	_	
20-21	8448-8451	any	_	
20-22	8452-8459	alcohol	_	
20-23	8460-8463	for	_	
20-24	8464-8466	24	_	
20-25	8467-8472	hours	_	
20-26	8473-8476	and	_	
20-27	8477-8479	no	_	
20-28	8480-8484	more	_	
20-29	8485-8489	than	_	
20-30	8490-8494	half	_	
20-31	8495-8496	a	_	
20-32	8497-8500	cup	_	
20-33	8501-8503	of	_	
20-34	8504-8515	caffeinated	_	
20-35	8516-8525	beverages	_	
20-36	8526-8528	12	_	
20-37	8529-8534	hours	_	
20-38	8535-8540	prior	_	
20-39	8541-8543	to	_	
20-40	8544-8548	each	_	
20-41	8549-8557	scanning	_	
20-42	8558-8563	visit	_	
20-43	8563-8564	.	_	
20-44	8565-8577	Participants	_	
20-45	8578-8583	could	_	
20-46	8584-8587	not	_	
20-47	8588-8599	participate	_	
20-48	8600-8602	if	_	
20-49	8603-8607	they	_	
20-50	8608-8611	had	_	
20-51	8612-8613	a	_	
20-52	8614-8622	positive	_	
20-53	8623-8630	alcohol	_	
20-54	8631-8643	breathalyzer	_	
20-55	8644-8646	or	_	
20-56	8647-8652	urine	_	
20-57	8653-8657	drug	_	
20-58	8658-8664	screen	_	
20-59	8665-8667	on	_	
20-60	8668-8671	the	_	
20-61	8672-8675	day	_	
20-62	8676-8678	of	_	
20-63	8679-8682	the	_	
20-64	8683-8687	scan	_	
20-65	8687-8688	.	_	
20-66	8689-8691	HC	_	
20-67	8692-8696	were	_	
20-68	8697-8705	excluded	_	
20-69	8706-8708	if	_	
20-70	8709-8713	they	_	
20-71	8714-8717	met	_	
20-72	8718-8726	criteria	_	
20-73	8727-8730	for	_	
20-74	8731-8734	any	_	
20-75	8735-8742	current	_	
20-76	8743-8745	or	_	
20-77	8746-8750	past	_	
20-78	8751-8758	alcohol	_	
20-79	8759-8762	use	_	
20-80	8763-8771	disorder	_	
20-81	8771-8772	.	_	
20-82	8773-8776	All	_	
20-83	8777-8785	subjects	_	
20-84	8786-8790	were	_	
20-85	8791-8799	required	_	
20-86	8800-8802	to	_	
20-87	8803-8805	be	_	
20-88	8806-8811	right	_	
20-89	8812-8818	handed	_	
20-90	8819-8822	and	_	
20-91	8823-8829	deemed	_	
20-92	8830-8840	physically	_	
20-93	8841-8848	healthy	_	
20-94	8849-8851	by	_	
20-95	8852-8853	a	_	
20-96	8854-8863	clinician	_	
20-97	8863-8864	.	_	
20-98	8865-8873	Subjects	_	
20-99	8874-8878	were	_	
20-100	8879-8887	excluded	_	
20-101	8888-8890	if	_	
20-102	8891-8895	they	_	
20-103	8896-8899	had	_	
20-104	8900-8901	a	_	
20-105	8902-8910	positive	_	
20-106	8911-8914	HIV	_	
20-107	8915-8919	test	_	
20-108	8919-8920	,	_	
20-109	8921-8927	active	_	
20-110	8928-8936	suicidal	_	
20-111	8937-8939	or	_	
20-112	8940-8949	homicidal	_	
20-113	8950-8959	ideations	_	
20-114	8959-8960	,	_	
20-115	8961-8963	or	_	
20-116	8964-8968	were	_	
20-117	8969-8978	currently	_	
20-118	8979-8985	taking	_	
20-119	8986-8998	psychotropic	_	
20-120	8999-9009	medication	_	
20-121	9009-9010	.	_	
20-122	9011-9016	Since	_	
20-123	9017-9020	the	_	
20-124	9021-9029	subjects	_	
20-125	9030-9034	were	_	
20-126	9035-9044	primarily	_	
20-127	9045-9054	recruited	_	
20-128	9055-9058	for	_	
20-129	9059-9063	fMRI	_	
20-130	9064-9069	tasks	_	
20-131	9070-9071	a	_	
20-132	9072-9078	failed	_	
20-133	9079-9089	neuromotor	_	
20-134	9090-9101	examination	_	
20-135	9101-9102	,	_	
20-136	9103-9108	which	_	
20-137	9109-9118	evaluated	_	
20-138	9119-9124	motor	_	
20-139	9125-9133	strength	_	
20-140	9133-9134	,	_	
20-141	9135-9139	deep	_	
20-142	9140-9146	tendon	_	
20-143	9147-9155	reflexes	_	
20-144	9155-9156	,	_	
20-145	9157-9168	extraocular	_	
20-146	9169-9178	movements	_	
20-147	9178-9179	,	_	
20-148	9180-9184	gait	_	
20-149	9184-9185	,	_	
20-150	9186-9189	and	_	
20-151	9190-9191	a	_	
20-152	9192-9202	cerebellar	_	
20-153	9203-9213	assessment	_	
20-154	9213-9214	,	_	
20-155	9215-9218	was	_	
20-156	9219-9223	also	_	
20-157	9224-9236	exclusionary	_	
20-158	9236-9237	.	_	
20-159	9238-9242	This	_	
20-160	9243-9250	allowed	_	
20-161	9251-9254	the	_	
20-162	9255-9266	researchers	_	
20-163	9267-9269	to	_	
20-164	9270-9277	exclude	_	
20-165	9278-9286	subjects	_	
20-166	9287-9290	who	_	
20-167	9291-9294	may	_	
20-168	9295-9302	possess	_	
20-169	9303-9315	neurological	_	
20-170	9316-9328	deficiencies	_	
20-171	9329-9333	that	_	
20-172	9334-9339	could	_	
20-173	9340-9351	potentially	_	
20-174	9352-9362	compromise	_	
20-175	9363-9367	task	_	
20-176	9368-9374	driven	_	
20-177	9375-9379	fMRI	_	
20-178	9380-9384	data	_	
20-179	9384-9385	.	_	
20-180	9386-9388	AD	_	
20-181	9389-9401	participants	_	
20-182	9402-9407	could	_	
20-183	9408-9411	not	_	
20-184	9412-9416	have	_	
20-185	9417-9423	severe	_	
20-186	9424-9432	symptoms	_	
20-187	9433-9435	of	_	
20-188	9436-9443	alcohol	_	
20-189	9444-9454	withdrawal	_	
20-190	9455-9457	as	_	
20-191	9458-9468	determined	_	
20-192	9469-9471	by	_	
20-193	9472-9473	a	_	
20-194	9474-9482	Clinical	_	
20-195	9483-9492	Institute	_	
20-196	9493-9503	Withdrawal	_	
20-197	9504-9514	Assessment	_	
20-198	9515-9517	of	_	
20-199	9518-9525	Alcohol	_	
20-200	9526-9531	Scale	_	
20-201	9532-9533	(	_	
20-202	9533-9537	CIWA	_	
20-203	9537-9538	)	_	
20-204	9539-9544	score	_	
20-205	9545-9547	of	_	
20-206	9548-9555	greater	_	
20-207	9556-9560	than	_	
20-208	9561-9562	8	_	
20-209	9562-9563	.	_	

#Text=2.4 MRI Data acquisition
21-1	9564-9567	2.4	_	
21-2	9568-9571	MRI	_	
21-3	9572-9576	Data	_	
21-4	9577-9588	acquisition	_	

#Text=Whole brain Anatomical images and five minutes of closed-eyes rs-fMRI were collected at the beginning of the scan session using a 3T General Electric MRI scanner (General Electric, Milwaukee, WI) after a short 3D brain localization. High-resolution T1-weighted 3-D structural scans were acquired for each subject using an MPRAGE sequence (128 axial slices, TR = 1200ms TE =30ms, 256 × 256 matrix). Resting state fMRI datasets were collected using a single-shot gradient echo planar imaging pulse sequence with thirty-four 5mm-thick axial slices acquired parallel to the anterior/posterior commissural line (TR = 2000ms, TE = 30ms, flip angle=90o, 3.75 mm × 3.75 mm × 5.0 mm voxels). Therefore, for each subject a total of 150 resting state frames (volumes) were acquired.
22-1	9589-9594	Whole	_	
22-2	9595-9600	brain	_	
22-3	9601-9611	Anatomical	_	
22-4	9612-9618	images	_	
22-5	9619-9622	and	_	
22-6	9623-9627	five	_	
22-7	9628-9635	minutes	_	
22-8	9636-9638	of	_	
22-9	9639-9650	closed-eyes	_	
22-10	9651-9658	rs-fMRI	_	
22-11	9659-9663	were	_	
22-12	9664-9673	collected	_	
22-13	9674-9676	at	_	
22-14	9677-9680	the	_	
22-15	9681-9690	beginning	_	
22-16	9691-9693	of	_	
22-17	9694-9697	the	_	
22-18	9698-9702	scan	_	
22-19	9703-9710	session	_	
22-20	9711-9716	using	_	
22-21	9717-9718	a	_	
22-22	9719-9721	3T	_	
22-23	9722-9729	General	_	
22-24	9730-9738	Electric	_	
22-25	9739-9742	MRI	_	
22-26	9743-9750	scanner	_	
22-27	9751-9752	(	_	
22-28	9752-9759	General	_	
22-29	9760-9768	Electric	_	
22-30	9768-9769	,	_	
22-31	9770-9779	Milwaukee	_	
22-32	9779-9780	,	_	
22-33	9781-9783	WI	_	
22-34	9783-9784	)	_	
22-35	9785-9790	after	_	
22-36	9791-9792	a	_	
22-37	9793-9798	short	_	
22-38	9799-9801	3D	_	
22-39	9802-9807	brain	_	
22-40	9808-9820	localization	_	
22-41	9820-9821	.	_	
22-42	9822-9837	High-resolution	_	
22-43	9838-9840	T1	_	
22-44	9840-9841	-	_	
22-45	9841-9849	weighted	_	
22-46	9850-9851	3	_	
22-47	9851-9852	-	_	
22-48	9852-9853	D	_	
22-49	9854-9864	structural	_	
22-50	9865-9870	scans	_	
22-51	9871-9875	were	_	
22-52	9876-9884	acquired	_	
22-53	9885-9888	for	_	
22-54	9889-9893	each	_	
22-55	9894-9901	subject	_	
22-56	9902-9907	using	_	
22-57	9908-9910	an	_	
22-58	9911-9917	MPRAGE	_	
22-59	9918-9926	sequence	_	
22-60	9927-9928	(	_	
22-61	9928-9931	128	_	
22-62	9932-9937	axial	_	
22-63	9938-9944	slices	_	
22-64	9944-9945	,	_	
22-65	9946-9948	TR	_	
22-66	9949-9950	=	_	
22-67	9951-9957	1200ms	_	
22-68	9958-9960	TE	_	
22-69	9961-9962	=	_	
22-70	9962-9966	30ms	_	
22-71	9966-9967	,	_	
22-72	9968-9971	256	_	
22-73	9972-9973	×	_	
22-74	9974-9977	256	_	
22-75	9978-9984	matrix	_	
22-76	9984-9985	)	_	
22-77	9985-9986	.	_	
22-78	9987-9994	Resting	_	
22-79	9995-10000	state	_	
22-80	10001-10005	fMRI	_	
22-81	10006-10014	datasets	_	
22-82	10015-10019	were	_	
22-83	10020-10029	collected	_	
22-84	10030-10035	using	_	
22-85	10036-10037	a	_	
22-86	10038-10049	single-shot	_	
22-87	10050-10058	gradient	_	
22-88	10059-10063	echo	_	
22-89	10064-10070	planar	_	
22-90	10071-10078	imaging	_	
22-91	10079-10084	pulse	_	
22-92	10085-10093	sequence	_	
22-93	10094-10098	with	_	
22-94	10099-10110	thirty-four	_	
22-95	10111-10120	5mm-thick	_	
22-96	10121-10126	axial	_	
22-97	10127-10133	slices	_	
22-98	10134-10142	acquired	_	
22-99	10143-10151	parallel	_	
22-100	10152-10154	to	_	
22-101	10155-10158	the	_	
22-102	10159-10167	anterior	_	
22-103	10167-10168	/	_	
22-104	10168-10177	posterior	_	
22-105	10178-10189	commissural	_	
22-106	10190-10194	line	_	
22-107	10195-10196	(	_	
22-108	10196-10198	TR	_	
22-109	10199-10200	=	_	
22-110	10201-10207	2000ms	_	
22-111	10207-10208	,	_	
22-112	10209-10211	TE	_	
22-113	10212-10213	=	_	
22-114	10214-10218	30ms	_	
22-115	10218-10219	,	_	
22-116	10220-10224	flip	_	
22-117	10225-10230	angle	_	
22-118	10230-10231	=	_	
22-119	10231-10234	90o	_	
22-120	10234-10235	,	_	
22-121	10236-10240	3.75	_	
22-122	10241-10243	mm	_	
22-123	10244-10245	×	_	
22-124	10246-10250	3.75	_	
22-125	10251-10253	mm	_	
22-126	10254-10255	×	_	
22-127	10256-10259	5.0	_	
22-128	10260-10262	mm	_	
22-129	10263-10269	voxels	_	
22-130	10269-10270	)	_	
22-131	10270-10271	.	_	
22-132	10272-10281	Therefore	_	
22-133	10281-10282	,	_	
22-134	10283-10286	for	_	
22-135	10287-10291	each	_	
22-136	10292-10299	subject	_	
22-137	10300-10301	a	_	
22-138	10302-10307	total	_	
22-139	10308-10310	of	_	
22-140	10311-10314	150	_	
22-141	10315-10322	resting	_	
22-142	10323-10328	state	_	
22-143	10329-10335	frames	_	
22-144	10336-10337	(	_	
22-145	10337-10344	volumes	_	
22-146	10344-10345	)	_	
22-147	10346-10350	were	_	
22-148	10351-10359	acquired	_	
22-149	10359-10360	.	_	

#Text=2.5 rs-fMRI data pre-processing
23-1	10361-10364	2.5	_	
23-2	10365-10372	rs-fMRI	_	
23-3	10373-10377	data	_	
23-4	10378-10392	pre-processing	_	

#Text=Using Functional MRI of the Brain (FMRIB)'s Software Library (www.fmrib.ox.ac.uk/fsl) we applied; 1) slice timing correction for interleaved acquisitions using Sinc interpolation with a Hanning windowing kernel; 2) motion correction; 3) non-brain removal; 4) spatial smoothing using a Gaussian kernel of full width at half maximum 5mm; 5) grand-mean intensity normalization of the entire 4D dataset by a single multiplicative factor, the size of the voxels is 4×4×4 mm3; 6) high-pass temporal filtering (Gaussian-weighted least-squares straight line fitting, with sigma=50s); and 7) registration to high resolution structural MNI standard space images. We used a stringent threshold for head motion in pre-processing step. Subjects with head motion greater than 0.3 mm for translation and 0.3° for rotation between consecutive TRs were removed from the study.
24-1	10393-10398	Using	_	
24-2	10399-10409	Functional	_	
24-3	10410-10413	MRI	_	
24-4	10414-10416	of	_	
24-5	10417-10420	the	_	
24-6	10421-10426	Brain	_	
24-7	10427-10428	(	_	
24-8	10428-10433	FMRIB	_	
24-9	10433-10434	)	_	
24-10	10434-10435	'	_	
24-11	10435-10436	s	_	
24-12	10437-10445	Software	_	
24-13	10446-10453	Library	_	
24-14	10454-10455	(	_	
24-15	10455-10473	www.fmrib.ox.ac.uk	_	
24-16	10473-10474	/	_	
24-17	10474-10477	fsl	_	
24-18	10477-10478	)	_	
24-19	10479-10481	we	_	
24-20	10482-10489	applied	_	
24-21	10489-10490	;	_	
24-22	10491-10492	1	_	
24-23	10492-10493	)	_	
24-24	10494-10499	slice	_	
24-25	10500-10506	timing	_	
24-26	10507-10517	correction	_	
24-27	10518-10521	for	_	
24-28	10522-10533	interleaved	_	
24-29	10534-10546	acquisitions	_	
24-30	10547-10552	using	_	
24-31	10553-10557	Sinc	_	
24-32	10558-10571	interpolation	_	
24-33	10572-10576	with	_	
24-34	10577-10578	a	_	
24-35	10579-10586	Hanning	_	
24-36	10587-10596	windowing	_	
24-37	10597-10603	kernel	_	
24-38	10603-10604	;	_	
24-39	10605-10606	2	_	
24-40	10606-10607	)	_	
24-41	10608-10614	motion	_	
24-42	10615-10625	correction	_	
24-43	10625-10626	;	_	
24-44	10627-10628	3	_	
24-45	10628-10629	)	_	
24-46	10630-10639	non-brain	_	
24-47	10640-10647	removal	_	
24-48	10647-10648	;	_	
24-49	10649-10650	4	_	
24-50	10650-10651	)	_	
24-51	10652-10659	spatial	_	
24-52	10660-10669	smoothing	_	
24-53	10670-10675	using	_	
24-54	10676-10677	a	_	
24-55	10678-10686	Gaussian	_	
24-56	10687-10693	kernel	_	
24-57	10694-10696	of	_	
24-58	10697-10701	full	_	
24-59	10702-10707	width	_	
24-60	10708-10710	at	_	
24-61	10711-10715	half	_	
24-62	10716-10723	maximum	_	
24-63	10724-10727	5mm	_	
24-64	10727-10728	;	_	
24-65	10729-10730	5	_	
24-66	10730-10731	)	_	
24-67	10732-10742	grand-mean	_	
24-68	10743-10752	intensity	_	
24-69	10753-10766	normalization	_	
24-70	10767-10769	of	_	
24-71	10770-10773	the	_	
24-72	10774-10780	entire	_	
24-73	10781-10783	4D	_	
24-74	10784-10791	dataset	_	
24-75	10792-10794	by	_	
24-76	10795-10796	a	_	
24-77	10797-10803	single	_	
24-78	10804-10818	multiplicative	_	
24-79	10819-10825	factor	_	
24-80	10825-10826	,	_	
24-81	10827-10830	the	_	
24-82	10831-10835	size	_	
24-83	10836-10838	of	_	
24-84	10839-10842	the	_	
24-85	10843-10849	voxels	_	
24-86	10850-10852	is	_	
24-87	10853-10854	4	_	
24-88	10854-10855	×	_	
24-89	10855-10856	4	_	
24-90	10856-10857	×	_	
24-91	10857-10858	4	_	
24-92	10859-10862	mm3	_	
24-93	10862-10863	;	_	
24-94	10864-10865	6	_	
24-95	10865-10866	)	_	
24-96	10867-10876	high-pass	_	
24-97	10877-10885	temporal	_	
24-98	10886-10895	filtering	_	
24-99	10896-10897	(	_	
24-100	10897-10914	Gaussian-weighted	_	
24-101	10915-10928	least-squares	_	
24-102	10929-10937	straight	_	
24-103	10938-10942	line	_	
24-104	10943-10950	fitting	_	
24-105	10950-10951	,	_	
24-106	10952-10956	with	_	
24-107	10957-10962	sigma	_	
24-108	10962-10963	=	_	
24-109	10963-10966	50s	_	
24-110	10966-10967	)	_	
24-111	10967-10968	;	_	
24-112	10969-10972	and	_	
24-113	10973-10974	7	_	
24-114	10974-10975	)	_	
24-115	10976-10988	registration	_	
24-116	10989-10991	to	_	
24-117	10992-10996	high	_	
24-118	10997-11007	resolution	_	
24-119	11008-11018	structural	_	
24-120	11019-11022	MNI	_	
24-121	11023-11031	standard	_	
24-122	11032-11037	space	_	
24-123	11038-11044	images	_	
24-124	11044-11045	.	_	
24-125	11046-11048	We	_	
24-126	11049-11053	used	_	
24-127	11054-11055	a	_	
24-128	11056-11065	stringent	_	
24-129	11066-11075	threshold	_	
24-130	11076-11079	for	_	
24-131	11080-11084	head	_	
24-132	11085-11091	motion	_	
24-133	11092-11094	in	_	
24-134	11095-11109	pre-processing	_	
24-135	11110-11114	step	_	
24-136	11114-11115	.	_	
24-137	11116-11124	Subjects	_	
24-138	11125-11129	with	_	
24-139	11130-11134	head	_	
24-140	11135-11141	motion	_	
24-141	11142-11149	greater	_	
24-142	11150-11154	than	_	
24-143	11155-11158	0.3	_	
24-144	11159-11161	mm	_	
24-145	11162-11165	for	_	
24-146	11166-11177	translation	_	
24-147	11178-11181	and	_	
24-148	11182-11185	0.3	_	
24-149	11185-11186	°	_	
24-150	11187-11190	for	_	
24-151	11191-11199	rotation	_	
24-152	11200-11207	between	_	
24-153	11208-11219	consecutive	_	
24-154	11220-11223	TRs	_	
24-155	11224-11228	were	_	
24-156	11229-11236	removed	_	
24-157	11237-11241	from	_	
24-158	11242-11245	the	_	
24-159	11246-11251	study	_	
24-160	11251-11252	.	_	

#Text=2.6 rs-fMRI connectivity analysis
25-1	11253-11256	2.6	_	
25-2	11257-11264	rs-fMRI	_	
25-3	11265-11277	connectivity	_	
25-4	11278-11286	analysis	_	

#Text=We applied Probabilistic Independent Component Analysis (PICA) by using the Multivariate Exploratory Linear Decomposition into Independent Components (MELODIC) toolbox of the FMRIB Software library (FSL) package (www.fmrib.ox.ac.uk/fsl). A temporal concatenation tool in MELODIC was used to derive group level components across all subjects. Pre-processed data were whitened and projected into a 35-dimensional subspace using PICA where the number of dimensions was estimated using the Laplace approximation to the Bayesian evidence of the model order. The whitened observations were decomposed into sets of vectors that describe signal variation across the temporal domain (time-courses) and across the spatial domain (maps) by optimizing for non-Gaussian spatial source distributions using a fixed-point iteration technique. These FC components maps were standardized into z statistic images via a normalized mixture model fit, thresholded at z > 5.
26-1	11287-11289	We	_	
26-2	11290-11297	applied	_	
26-3	11298-11311	Probabilistic	_	
26-4	11312-11323	Independent	_	
26-5	11324-11333	Component	_	
26-6	11334-11342	Analysis	_	
26-7	11343-11344	(	_	
26-8	11344-11348	PICA	_	
26-9	11348-11349	)	_	
26-10	11350-11352	by	_	
26-11	11353-11358	using	_	
26-12	11359-11362	the	_	
26-13	11363-11375	Multivariate	_	
26-14	11376-11387	Exploratory	_	
26-15	11388-11394	Linear	_	
26-16	11395-11408	Decomposition	_	
26-17	11409-11413	into	_	
26-18	11414-11425	Independent	_	
26-19	11426-11436	Components	_	
26-20	11437-11438	(	_	
26-21	11438-11445	MELODIC	_	
26-22	11445-11446	)	_	
26-23	11447-11454	toolbox	_	
26-24	11455-11457	of	_	
26-25	11458-11461	the	_	
26-26	11462-11467	FMRIB	_	
26-27	11468-11476	Software	_	
26-28	11477-11484	library	_	
26-29	11485-11486	(	_	
26-30	11486-11489	FSL	_	
26-31	11489-11490	)	_	
26-32	11491-11498	package	_	
26-33	11499-11500	(	_	
26-34	11500-11518	www.fmrib.ox.ac.uk	_	
26-35	11518-11519	/	_	
26-36	11519-11522	fsl	_	
26-37	11522-11523	)	_	
26-38	11523-11524	.	_	
26-39	11525-11526	A	_	
26-40	11527-11535	temporal	_	
26-41	11536-11549	concatenation	_	
26-42	11550-11554	tool	_	
26-43	11555-11557	in	_	
26-44	11558-11565	MELODIC	_	
26-45	11566-11569	was	_	
26-46	11570-11574	used	_	
26-47	11575-11577	to	_	
26-48	11578-11584	derive	_	
26-49	11585-11590	group	_	
26-50	11591-11596	level	_	
26-51	11597-11607	components	_	
26-52	11608-11614	across	_	
26-53	11615-11618	all	_	
26-54	11619-11627	subjects	_	
26-55	11627-11628	.	_	
26-56	11629-11642	Pre-processed	_	
26-57	11643-11647	data	_	
26-58	11648-11652	were	_	
26-59	11653-11661	whitened	_	
26-60	11662-11665	and	_	
26-61	11666-11675	projected	_	
26-62	11676-11680	into	_	
26-63	11681-11682	a	_	
26-64	11683-11685	35	_	
26-65	11685-11686	-	_	
26-66	11686-11697	dimensional	_	
26-67	11698-11706	subspace	_	
26-68	11707-11712	using	_	
26-69	11713-11717	PICA	_	
26-70	11718-11723	where	_	
26-71	11724-11727	the	_	
26-72	11728-11734	number	_	
26-73	11735-11737	of	_	
26-74	11738-11748	dimensions	_	
26-75	11749-11752	was	_	
26-76	11753-11762	estimated	_	
26-77	11763-11768	using	_	
26-78	11769-11772	the	_	
26-79	11773-11780	Laplace	_	
26-80	11781-11794	approximation	_	
26-81	11795-11797	to	_	
26-82	11798-11801	the	_	
26-83	11802-11810	Bayesian	_	
26-84	11811-11819	evidence	_	
26-85	11820-11822	of	_	
26-86	11823-11826	the	_	
26-87	11827-11832	model	_	
26-88	11833-11838	order	_	
26-89	11838-11839	.	_	
26-90	11840-11843	The	_	
26-91	11844-11852	whitened	_	
26-92	11853-11865	observations	_	
26-93	11866-11870	were	_	
26-94	11871-11881	decomposed	_	
26-95	11882-11886	into	_	
26-96	11887-11891	sets	_	
26-97	11892-11894	of	_	
26-98	11895-11902	vectors	_	
26-99	11903-11907	that	_	
26-100	11908-11916	describe	_	
26-101	11917-11923	signal	_	
26-102	11924-11933	variation	_	
26-103	11934-11940	across	_	
26-104	11941-11944	the	_	
26-105	11945-11953	temporal	_	
26-106	11954-11960	domain	_	
26-107	11961-11962	(	_	
26-108	11962-11974	time-courses	_	
26-109	11974-11975	)	_	
26-110	11976-11979	and	_	
26-111	11980-11986	across	_	
26-112	11987-11990	the	_	
26-113	11991-11998	spatial	_	
26-114	11999-12005	domain	_	
26-115	12006-12007	(	_	
26-116	12007-12011	maps	_	
26-117	12011-12012	)	_	
26-118	12013-12015	by	_	
26-119	12016-12026	optimizing	_	
26-120	12027-12030	for	_	
26-121	12031-12043	non-Gaussian	_	
26-122	12044-12051	spatial	_	
26-123	12052-12058	source	_	
26-124	12059-12072	distributions	_	
26-125	12073-12078	using	_	
26-126	12079-12080	a	_	
26-127	12081-12092	fixed-point	_	
26-128	12093-12102	iteration	_	
26-129	12103-12112	technique	_	
26-130	12112-12113	.	_	
26-131	12114-12119	These	_	
26-132	12120-12122	FC	_	
26-133	12123-12133	components	_	
26-134	12134-12138	maps	_	
26-135	12139-12143	were	_	
26-136	12144-12156	standardized	_	
26-137	12157-12161	into	_	
26-138	12162-12163	z	_	
26-139	12164-12173	statistic	_	
26-140	12174-12180	images	_	
26-141	12181-12184	via	_	
26-142	12185-12186	a	_	
26-143	12187-12197	normalized	_	
26-144	12198-12205	mixture	_	
26-145	12206-12211	model	_	
26-146	12212-12215	fit	_	
26-147	12215-12216	,	_	
26-148	12217-12228	thresholded	_	
26-149	12229-12231	at	_	
26-150	12232-12233	z	_	
26-151	12234-12235	>	_	
26-152	12236-12237	5	_	
26-153	12237-12238	.	_	

#Text=Two criteria were used to remove biologically irrelevant components: (1) those representing known artifacts such as motion, and high-frequency noise; and (2) those with connectivity patterns not located mainly in gray matter. Networks of interest were identified as anatomically and functionally classical RSNs upon visual inspection. The between-subject analysis was carried out using dual regression, a regression technique that back-reconstructs each group level component map at the individual subject level. This technique allows for voxel-wise comparisons of resting state FC by carrying out the following steps: First, regresses the group level spatial maps into each individual’s 4D dataset to obtain a set of time series. Then, regresses those individual level time series into the same 4D dataset to obtain a subject-specific set of spatial maps. Statistic inferences were then tested using FSL’s randomize permutation-testing tool. In cases such as fMRI data, when the null distribution is not known, permutation testing is used for inference on statistical maps. Voxel-wise two-sample t-test was carried out to assess statistically significant differences in FC between the groups using a 5000 non-parametric permutation testing. We utilized a threshold-free cluster enhanced (TFCE) technique to control for multiple comparisons. This method allows detecting significant clusters without having to define cluster size or the number of clusters prior to analysis. Finally, the resulting statistical maps were threshold at p < 0.05 FWE-corrected for multiple comparisons for the main group effect. This step generated the probabilistic maps which represent the probability of FC between AD and HC: AD maps subtracted from HC one and vice versa for all RSNs of interest. The Harvard-Oxford cortical and subcortical atlases incorporated in FSL were used to identify the anatomical regions of the resulting PICA maps.
27-1	12239-12242	Two	_	
27-2	12243-12251	criteria	_	
27-3	12252-12256	were	_	
27-4	12257-12261	used	_	
27-5	12262-12264	to	_	
27-6	12265-12271	remove	_	
27-7	12272-12284	biologically	_	
27-8	12285-12295	irrelevant	_	
27-9	12296-12306	components	_	
27-10	12306-12307	:	_	
27-11	12308-12309	(	_	
27-12	12309-12310	1	_	
27-13	12310-12311	)	_	
27-14	12312-12317	those	_	
27-15	12318-12330	representing	_	
27-16	12331-12336	known	_	
27-17	12337-12346	artifacts	_	
27-18	12347-12351	such	_	
27-19	12352-12354	as	_	
27-20	12355-12361	motion	_	
27-21	12361-12362	,	_	
27-22	12363-12366	and	_	
27-23	12367-12381	high-frequency	_	
27-24	12382-12387	noise	_	
27-25	12387-12388	;	_	
27-26	12389-12392	and	_	
27-27	12393-12394	(	_	
27-28	12394-12395	2	_	
27-29	12395-12396	)	_	
27-30	12397-12402	those	_	
27-31	12403-12407	with	_	
27-32	12408-12420	connectivity	_	
27-33	12421-12429	patterns	_	
27-34	12430-12433	not	_	
27-35	12434-12441	located	_	
27-36	12442-12448	mainly	_	
27-37	12449-12451	in	_	
27-38	12452-12456	gray	_	
27-39	12457-12463	matter	_	
27-40	12463-12464	.	_	
27-41	12465-12473	Networks	_	
27-42	12474-12476	of	_	
27-43	12477-12485	interest	_	
27-44	12486-12490	were	_	
27-45	12491-12501	identified	_	
27-46	12502-12504	as	_	
27-47	12505-12517	anatomically	_	
27-48	12518-12521	and	_	
27-49	12522-12534	functionally	_	
27-50	12535-12544	classical	_	
27-51	12545-12549	RSNs	_	
27-52	12550-12554	upon	_	
27-53	12555-12561	visual	_	
27-54	12562-12572	inspection	_	
27-55	12572-12573	.	_	
27-56	12574-12577	The	_	
27-57	12578-12593	between-subject	_	
27-58	12594-12602	analysis	_	
27-59	12603-12606	was	_	
27-60	12607-12614	carried	_	
27-61	12615-12618	out	_	
27-62	12619-12624	using	_	
27-63	12625-12629	dual	_	
27-64	12630-12640	regression	_	
27-65	12640-12641	,	_	
27-66	12642-12643	a	_	
27-67	12644-12654	regression	_	
27-68	12655-12664	technique	_	
27-69	12665-12669	that	_	
27-70	12670-12687	back-reconstructs	_	
27-71	12688-12692	each	_	
27-72	12693-12698	group	_	
27-73	12699-12704	level	_	
27-74	12705-12714	component	_	
27-75	12715-12718	map	_	
27-76	12719-12721	at	_	
27-77	12722-12725	the	_	
27-78	12726-12736	individual	_	
27-79	12737-12744	subject	_	
27-80	12745-12750	level	_	
27-81	12750-12751	.	_	
27-82	12752-12756	This	_	
27-83	12757-12766	technique	_	
27-84	12767-12773	allows	_	
27-85	12774-12777	for	_	
27-86	12778-12788	voxel-wise	_	
27-87	12789-12800	comparisons	_	
27-88	12801-12803	of	_	
27-89	12804-12811	resting	_	
27-90	12812-12817	state	_	
27-91	12818-12820	FC	_	
27-92	12821-12823	by	_	
27-93	12824-12832	carrying	_	
27-94	12833-12836	out	_	
27-95	12837-12840	the	_	
27-96	12841-12850	following	_	
27-97	12851-12856	steps	_	
27-98	12856-12857	:	_	
27-99	12858-12863	First	_	
27-100	12863-12864	,	_	
27-101	12865-12874	regresses	_	
27-102	12875-12878	the	_	
27-103	12879-12884	group	_	
27-104	12885-12890	level	_	
27-105	12891-12898	spatial	_	
27-106	12899-12903	maps	_	
27-107	12904-12908	into	_	
27-108	12909-12913	each	_	
27-109	12914-12924	individual	_	
27-110	12924-12925	’	_	
27-111	12925-12926	s	_	
27-112	12927-12929	4D	_	
27-113	12930-12937	dataset	_	
27-114	12938-12940	to	_	
27-115	12941-12947	obtain	_	
27-116	12948-12949	a	_	
27-117	12950-12953	set	_	
27-118	12954-12956	of	_	
27-119	12957-12961	time	_	
27-120	12962-12968	series	_	
27-121	12968-12969	.	_	
27-122	12970-12974	Then	_	
27-123	12974-12975	,	_	
27-124	12976-12985	regresses	_	
27-125	12986-12991	those	_	
27-126	12992-13002	individual	_	
27-127	13003-13008	level	_	
27-128	13009-13013	time	_	
27-129	13014-13020	series	_	
27-130	13021-13025	into	_	
27-131	13026-13029	the	_	
27-132	13030-13034	same	_	
27-133	13035-13037	4D	_	
27-134	13038-13045	dataset	_	
27-135	13046-13048	to	_	
27-136	13049-13055	obtain	_	
27-137	13056-13057	a	_	
27-138	13058-13074	subject-specific	_	
27-139	13075-13078	set	_	
27-140	13079-13081	of	_	
27-141	13082-13089	spatial	_	
27-142	13090-13094	maps	_	
27-143	13094-13095	.	_	
27-144	13096-13105	Statistic	_	
27-145	13106-13116	inferences	_	
27-146	13117-13121	were	_	
27-147	13122-13126	then	_	
27-148	13127-13133	tested	_	
27-149	13134-13139	using	_	
27-150	13140-13143	FSL	_	
27-151	13143-13144	’	_	
27-152	13144-13145	s	_	
27-153	13146-13155	randomize	_	
27-154	13156-13175	permutation-testing	_	
27-155	13176-13180	tool	_	
27-156	13180-13181	.	_	
27-157	13182-13184	In	_	
27-158	13185-13190	cases	_	
27-159	13191-13195	such	_	
27-160	13196-13198	as	_	
27-161	13199-13203	fMRI	_	
27-162	13204-13208	data	_	
27-163	13208-13209	,	_	
27-164	13210-13214	when	_	
27-165	13215-13218	the	_	
27-166	13219-13223	null	_	
27-167	13224-13236	distribution	_	
27-168	13237-13239	is	_	
27-169	13240-13243	not	_	
27-170	13244-13249	known	_	
27-171	13249-13250	,	_	
27-172	13251-13262	permutation	_	
27-173	13263-13270	testing	_	
27-174	13271-13273	is	_	
27-175	13274-13278	used	_	
27-176	13279-13282	for	_	
27-177	13283-13292	inference	_	
27-178	13293-13295	on	_	
27-179	13296-13307	statistical	_	
27-180	13308-13312	maps	_	
27-181	13312-13313	.	_	
27-182	13314-13324	Voxel-wise	_	
27-183	13325-13335	two-sample	_	
27-184	13336-13342	t-test	_	
27-185	13343-13346	was	_	
27-186	13347-13354	carried	_	
27-187	13355-13358	out	_	
27-188	13359-13361	to	_	
27-189	13362-13368	assess	_	
27-190	13369-13382	statistically	_	
27-191	13383-13394	significant	_	
27-192	13395-13406	differences	_	
27-193	13407-13409	in	_	
27-194	13410-13412	FC	_	
27-195	13413-13420	between	_	
27-196	13421-13424	the	_	
27-197	13425-13431	groups	_	
27-198	13432-13437	using	_	
27-199	13438-13439	a	_	
27-200	13440-13444	5000	_	
27-201	13445-13459	non-parametric	_	
27-202	13460-13471	permutation	_	
27-203	13472-13479	testing	_	
27-204	13479-13480	.	_	
27-205	13481-13483	We	_	
27-206	13484-13492	utilized	_	
27-207	13493-13494	a	_	
27-208	13495-13509	threshold-free	_	
27-209	13510-13517	cluster	_	
27-210	13518-13526	enhanced	_	
27-211	13527-13528	(	_	
27-212	13528-13532	TFCE	_	
27-213	13532-13533	)	_	
27-214	13534-13543	technique	_	
27-215	13544-13546	to	_	
27-216	13547-13554	control	_	
27-217	13555-13558	for	_	
27-218	13559-13567	multiple	_	
27-219	13568-13579	comparisons	_	
27-220	13579-13580	.	_	
27-221	13581-13585	This	_	
27-222	13586-13592	method	_	
27-223	13593-13599	allows	_	
27-224	13600-13609	detecting	_	
27-225	13610-13621	significant	_	
27-226	13622-13630	clusters	_	
27-227	13631-13638	without	_	
27-228	13639-13645	having	_	
27-229	13646-13648	to	_	
27-230	13649-13655	define	_	
27-231	13656-13663	cluster	_	
27-232	13664-13668	size	_	
27-233	13669-13671	or	_	
27-234	13672-13675	the	_	
27-235	13676-13682	number	_	
27-236	13683-13685	of	_	
27-237	13686-13694	clusters	_	
27-238	13695-13700	prior	_	
27-239	13701-13703	to	_	
27-240	13704-13712	analysis	_	
27-241	13712-13713	.	_	
27-242	13714-13721	Finally	_	
27-243	13721-13722	,	_	
27-244	13723-13726	the	_	
27-245	13727-13736	resulting	_	
27-246	13737-13748	statistical	_	
27-247	13749-13753	maps	_	
27-248	13754-13758	were	_	
27-249	13759-13768	threshold	_	
27-250	13769-13771	at	_	
27-251	13772-13773	p	_	
27-252	13774-13775	<	_	
27-253	13776-13780	0.05	_	
27-254	13781-13794	FWE-corrected	_	
27-255	13795-13798	for	_	
27-256	13799-13807	multiple	_	
27-257	13808-13819	comparisons	_	
27-258	13820-13823	for	_	
27-259	13824-13827	the	_	
27-260	13828-13832	main	_	
27-261	13833-13838	group	_	
27-262	13839-13845	effect	_	
27-263	13845-13846	.	_	
27-264	13847-13851	This	_	
27-265	13852-13856	step	_	
27-266	13857-13866	generated	_	
27-267	13867-13870	the	_	
27-268	13871-13884	probabilistic	_	
27-269	13885-13889	maps	_	
27-270	13890-13895	which	_	
27-271	13896-13905	represent	_	
27-272	13906-13909	the	_	
27-273	13910-13921	probability	_	
27-274	13922-13924	of	_	
27-275	13925-13927	FC	_	
27-276	13928-13935	between	_	
27-277	13936-13938	AD	_	
27-278	13939-13942	and	_	
27-279	13943-13945	HC	_	
27-280	13945-13946	:	_	
27-281	13947-13949	AD	_	
27-282	13950-13954	maps	_	
27-283	13955-13965	subtracted	_	
27-284	13966-13970	from	_	
27-285	13971-13973	HC	_	
27-286	13974-13977	one	_	
27-287	13978-13981	and	_	
27-288	13982-13986	vice	_	
27-289	13987-13992	versa	_	
27-290	13993-13996	for	_	
27-291	13997-14000	all	_	
27-292	14001-14005	RSNs	_	
27-293	14006-14008	of	_	
27-294	14009-14017	interest	_	
27-295	14017-14018	.	_	
27-296	14019-14022	The	_	
27-297	14023-14037	Harvard-Oxford	_	
27-298	14038-14046	cortical	_	
27-299	14047-14050	and	_	
27-300	14051-14062	subcortical	_	
27-301	14063-14070	atlases	_	
27-302	14071-14083	incorporated	_	
27-303	14084-14086	in	_	
27-304	14087-14090	FSL	_	
27-305	14091-14095	were	_	
27-306	14096-14100	used	_	
27-307	14101-14103	to	_	
27-308	14104-14112	identify	_	
27-309	14113-14116	the	_	
27-310	14117-14127	anatomical	_	
27-311	14128-14135	regions	_	
27-312	14136-14138	of	_	
27-313	14139-14142	the	_	
27-314	14143-14152	resulting	_	
27-315	14153-14157	PICA	_	
27-316	14158-14162	maps	_	
27-317	14162-14163	.	_	

#Text=2.7 Correlation Analysis
28-1	14164-14167	2.7	_	
28-2	14168-14179	Correlation	_	
28-3	14180-14188	Analysis	_	

#Text=Within-network connectivity correlation with impulsivity measures: Using Statistical Parametric Mapping 8 (SPM8) (http://www.fil.ion.ucl.ac.uk/spm), for each group, individual subject maps for the independent components for the impulsive system (ASN), reflective system (OFCN, left ECN, right ECN), insula cortex (SN) and DMN (a-DMN and p-DMN), were entered as second-level regression analysis versus the impulsivity measures (BIS-11, DDT, UPPS-P) as covariate with its own IC map as mask. All within-RSN correlational analyses were done with the cluster-level Family-wise error (FWE) corrected threshold of 0.05.
29-1	14189-14203	Within-network	_	
29-2	14204-14216	connectivity	_	
29-3	14217-14228	correlation	_	
29-4	14229-14233	with	_	
29-5	14234-14245	impulsivity	_	
29-6	14246-14254	measures	_	
29-7	14254-14255	:	_	
29-8	14256-14261	Using	_	
29-9	14262-14273	Statistical	_	
29-10	14274-14284	Parametric	_	
29-11	14285-14292	Mapping	_	
29-12	14293-14294	8	_	
29-13	14295-14296	(	_	
29-14	14296-14300	SPM8	_	
29-15	14300-14301	)	_	
29-16	14302-14303	(	_	
29-17	14303-14307	http	_	
29-18	14307-14308	:	_	
29-19	14308-14309	/	_	
29-20	14309-14310	/	_	
29-21	14310-14331	www.fil.ion.ucl.ac.uk	_	
29-22	14331-14332	/	_	
29-23	14332-14335	spm	_	
29-24	14335-14336	)	_	
29-25	14336-14337	,	_	
29-26	14338-14341	for	_	
29-27	14342-14346	each	_	
29-28	14347-14352	group	_	
29-29	14352-14353	,	_	
29-30	14354-14364	individual	_	
29-31	14365-14372	subject	_	
29-32	14373-14377	maps	_	
29-33	14378-14381	for	_	
29-34	14382-14385	the	_	
29-35	14386-14397	independent	_	
29-36	14398-14408	components	_	
29-37	14409-14412	for	_	
29-38	14413-14416	the	_	
29-39	14417-14426	impulsive	_	
29-40	14427-14433	system	_	
29-41	14434-14435	(	_	
29-42	14435-14438	ASN	_	
29-43	14438-14439	)	_	
29-44	14439-14440	,	_	
29-45	14441-14451	reflective	_	
29-46	14452-14458	system	_	
29-47	14459-14460	(	_	
29-48	14460-14464	OFCN	_	
29-49	14464-14465	,	_	
29-50	14466-14470	left	_	
29-51	14471-14474	ECN	_	
29-52	14474-14475	,	_	
29-53	14476-14481	right	_	
29-54	14482-14485	ECN	_	
29-55	14485-14486	)	_	
29-56	14486-14487	,	_	
29-57	14488-14494	insula	_	
29-58	14495-14501	cortex	_	
29-59	14502-14503	(	_	
29-60	14503-14505	SN	_	
29-61	14505-14506	)	_	
29-62	14507-14510	and	_	
29-63	14511-14514	DMN	_	
29-64	14515-14516	(	_	
29-65	14516-14521	a-DMN	_	
29-66	14522-14525	and	_	
29-67	14526-14531	p-DMN	_	
29-68	14531-14532	)	_	
29-69	14532-14533	,	_	
29-70	14534-14538	were	_	
29-71	14539-14546	entered	_	
29-72	14547-14549	as	_	
29-73	14550-14562	second-level	_	
29-74	14563-14573	regression	_	
29-75	14574-14582	analysis	_	
29-76	14583-14589	versus	_	
29-77	14590-14593	the	_	
29-78	14594-14605	impulsivity	_	
29-79	14606-14614	measures	_	
29-80	14615-14616	(	_	
29-81	14616-14619	BIS	_	
29-82	14619-14620	-	_	
29-83	14620-14622	11	_	
29-84	14622-14623	,	_	
29-85	14624-14627	DDT	_	
29-86	14627-14628	,	_	
29-87	14629-14635	UPPS-P	_	
29-88	14635-14636	)	_	
29-89	14637-14639	as	_	
29-90	14640-14649	covariate	_	
29-91	14650-14654	with	_	
29-92	14655-14658	its	_	
29-93	14659-14662	own	_	
29-94	14663-14665	IC	_	
29-95	14666-14669	map	_	
29-96	14670-14672	as	_	
29-97	14673-14677	mask	_	
29-98	14677-14678	.	_	
29-99	14679-14682	All	_	
29-100	14683-14693	within-RSN	_	
29-101	14694-14707	correlational	_	
29-102	14708-14716	analyses	_	
29-103	14717-14721	were	_	
29-104	14722-14726	done	_	
29-105	14727-14731	with	_	
29-106	14732-14735	the	_	
29-107	14736-14749	cluster-level	_	
29-108	14750-14761	Family-wise	_	
29-109	14762-14767	error	_	
29-110	14768-14769	(	_	
29-111	14769-14772	FWE	_	
29-112	14772-14773	)	_	
29-113	14774-14783	corrected	_	
29-114	14784-14793	threshold	_	
29-115	14794-14796	of	_	
29-116	14797-14801	0.05	_	
29-117	14801-14802	.	_	

#Text=Between-network connectivity correlation with clinical measures: Even though all component maps are spatially independent, time series of the components may still have significant temporal correlations. Network interaction comparisons (Correlation coefficients, Pearson’s r) between AD and HC were computed between each subject time series for the RSNs of interest that were obtained by the first stage of the dual regression procedure. These correlation coefficients were Fisher z-transformed and unpaired t-tests were conducted to compare between network connectivity in AD and HC using Statistical Analysis System (SAS software, Copyright, SAS Institute Inc. SAS and all other SAS Institute Inc.). Finally, the results were threshold at p < 0.05 bonferroni-corrected for multiple comparisons.
30-1	14803-14818	Between-network	_	
30-2	14819-14831	connectivity	_	
30-3	14832-14843	correlation	_	
30-4	14844-14848	with	_	
30-5	14849-14857	clinical	_	
30-6	14858-14866	measures	_	
30-7	14866-14867	:	_	
30-8	14868-14872	Even	_	
30-9	14873-14879	though	_	
30-10	14880-14883	all	_	
30-11	14884-14893	component	_	
30-12	14894-14898	maps	_	
30-13	14899-14902	are	_	
30-14	14903-14912	spatially	_	
30-15	14913-14924	independent	_	
30-16	14924-14925	,	_	
30-17	14926-14930	time	_	
30-18	14931-14937	series	_	
30-19	14938-14940	of	_	
30-20	14941-14944	the	_	
30-21	14945-14955	components	_	
30-22	14956-14959	may	_	
30-23	14960-14965	still	_	
30-24	14966-14970	have	_	
30-25	14971-14982	significant	_	
30-26	14983-14991	temporal	_	
30-27	14992-15004	correlations	_	
30-28	15004-15005	.	_	
30-29	15006-15013	Network	_	
30-30	15014-15025	interaction	_	
30-31	15026-15037	comparisons	_	
30-32	15038-15039	(	_	
30-33	15039-15050	Correlation	_	
30-34	15051-15063	coefficients	_	
30-35	15063-15064	,	_	
30-36	15065-15072	Pearson	_	
30-37	15072-15073	’	_	
30-38	15073-15074	s	_	
30-39	15075-15076	r	_	
30-40	15076-15077	)	_	
30-41	15078-15085	between	_	
30-42	15086-15088	AD	_	
30-43	15089-15092	and	_	
30-44	15093-15095	HC	_	
30-45	15096-15100	were	_	
30-46	15101-15109	computed	_	
30-47	15110-15117	between	_	
30-48	15118-15122	each	_	
30-49	15123-15130	subject	_	
30-50	15131-15135	time	_	
30-51	15136-15142	series	_	
30-52	15143-15146	for	_	
30-53	15147-15150	the	_	
30-54	15151-15155	RSNs	_	
30-55	15156-15158	of	_	
30-56	15159-15167	interest	_	
30-57	15168-15172	that	_	
30-58	15173-15177	were	_	
30-59	15178-15186	obtained	_	
30-60	15187-15189	by	_	
30-61	15190-15193	the	_	
30-62	15194-15199	first	_	
30-63	15200-15205	stage	_	
30-64	15206-15208	of	_	
30-65	15209-15212	the	_	
30-66	15213-15217	dual	_	
30-67	15218-15228	regression	_	
30-68	15229-15238	procedure	_	
30-69	15238-15239	.	_	
30-70	15240-15245	These	_	
30-71	15246-15257	correlation	_	
30-72	15258-15270	coefficients	_	
30-73	15271-15275	were	_	
30-74	15276-15282	Fisher	_	
30-75	15283-15296	z-transformed	_	
30-76	15297-15300	and	_	
30-77	15301-15309	unpaired	_	
30-78	15310-15317	t-tests	_	
30-79	15318-15322	were	_	
30-80	15323-15332	conducted	_	
30-81	15333-15335	to	_	
30-82	15336-15343	compare	_	
30-83	15344-15351	between	_	
30-84	15352-15359	network	_	
30-85	15360-15372	connectivity	_	
30-86	15373-15375	in	_	
30-87	15376-15378	AD	_	
30-88	15379-15382	and	_	
30-89	15383-15385	HC	_	
30-90	15386-15391	using	_	
30-91	15392-15403	Statistical	_	
30-92	15404-15412	Analysis	_	
30-93	15413-15419	System	_	
30-94	15420-15421	(	_	
30-95	15421-15424	SAS	_	
30-96	15425-15433	software	_	
30-97	15433-15434	,	_	
30-98	15435-15444	Copyright	_	
30-99	15444-15445	,	_	
30-100	15446-15449	SAS	_	
30-101	15450-15459	Institute	_	
30-102	15460-15463	Inc	_	
30-103	15463-15464	.	_	
30-104	15465-15468	SAS	_	
30-105	15469-15472	and	_	
30-106	15473-15476	all	_	
30-107	15477-15482	other	_	
30-108	15483-15486	SAS	_	
30-109	15487-15496	Institute	_	
30-110	15497-15500	Inc	_	
30-111	15500-15501	.	_	
30-112	15501-15502	)	_	
30-113	15502-15503	.	_	
30-114	15504-15511	Finally	_	
30-115	15511-15512	,	_	
30-116	15513-15516	the	_	
30-117	15517-15524	results	_	
30-118	15525-15529	were	_	
30-119	15530-15539	threshold	_	
30-120	15540-15542	at	_	
30-121	15543-15544	p	_	
30-122	15545-15546	<	_	
30-123	15547-15551	0.05	_	
30-124	15552-15572	bonferroni-corrected	_	
30-125	15573-15576	for	_	
30-126	15577-15585	multiple	_	
30-127	15586-15597	comparisons	_	
30-128	15597-15598	.	_	

#Text=The differences in age, years of education, and IQ between AD and HC do not make for ideal comparisons. To minimize the potential confounding influence of age, years of education and IQ in these results, these parameters were used as nuisance covariates for each network of interest. No effect of age, years of education and IQ was detected in the fMRI FC results.
31-1	15599-15602	The	_	
31-2	15603-15614	differences	_	
31-3	15615-15617	in	_	
31-4	15618-15621	age	_	
31-5	15621-15622	,	_	
31-6	15623-15628	years	_	
31-7	15629-15631	of	_	
31-8	15632-15641	education	_	
31-9	15641-15642	,	_	
31-10	15643-15646	and	_	
31-11	15647-15649	IQ	_	
31-12	15650-15657	between	_	
31-13	15658-15660	AD	_	
31-14	15661-15664	and	_	
31-15	15665-15667	HC	_	
31-16	15668-15670	do	_	
31-17	15671-15674	not	_	
31-18	15675-15679	make	_	
31-19	15680-15683	for	_	
31-20	15684-15689	ideal	_	
31-21	15690-15701	comparisons	_	
31-22	15701-15702	.	_	
31-23	15703-15705	To	_	
31-24	15706-15714	minimize	_	
31-25	15715-15718	the	_	
31-26	15719-15728	potential	_	
31-27	15729-15740	confounding	_	
31-28	15741-15750	influence	_	
31-29	15751-15753	of	_	
31-30	15754-15757	age	_	
31-31	15757-15758	,	_	
31-32	15759-15764	years	_	
31-33	15765-15767	of	_	
31-34	15768-15777	education	_	
31-35	15778-15781	and	_	
31-36	15782-15784	IQ	_	
31-37	15785-15787	in	_	
31-38	15788-15793	these	_	
31-39	15794-15801	results	_	
31-40	15801-15802	,	_	
31-41	15803-15808	these	_	
31-42	15809-15819	parameters	_	
31-43	15820-15824	were	_	
31-44	15825-15829	used	_	
31-45	15830-15832	as	_	
31-46	15833-15841	nuisance	_	
31-47	15842-15852	covariates	_	
31-48	15853-15856	for	_	
31-49	15857-15861	each	_	
31-50	15862-15869	network	_	
31-51	15870-15872	of	_	
31-52	15873-15881	interest	_	
31-53	15881-15882	.	_	
31-54	15883-15885	No	_	
31-55	15886-15892	effect	_	
31-56	15893-15895	of	_	
31-57	15896-15899	age	_	
31-58	15899-15900	,	_	
31-59	15901-15906	years	_	
31-60	15907-15909	of	_	
31-61	15910-15919	education	_	
31-62	15920-15923	and	_	
31-63	15924-15926	IQ	_	
31-64	15927-15930	was	_	
31-65	15931-15939	detected	_	
31-66	15940-15942	in	_	
31-67	15943-15946	the	_	
31-68	15947-15951	fMRI	_	
31-69	15952-15954	FC	_	
31-70	15955-15962	results	_	
31-71	15962-15963	.	_	

#Text=Results
32-1	15964-15971	Results	_	

#Text=The ICA decomposition resulted in 35 spatial component maps, which revealed all classically identified RSNs, including DMN, visual network, somatosensory network, auditory network and artifactual components.
33-1	15972-15975	The	_	
33-2	15976-15979	ICA	_	
33-3	15980-15993	decomposition	_	
33-4	15994-16002	resulted	_	
33-5	16003-16005	in	_	
33-6	16006-16008	35	_	
33-7	16009-16016	spatial	_	
33-8	16017-16026	component	_	
33-9	16027-16031	maps	_	
33-10	16031-16032	,	_	
33-11	16033-16038	which	_	
33-12	16039-16047	revealed	_	
33-13	16048-16051	all	_	
33-14	16052-16063	classically	_	
33-15	16064-16074	identified	_	
33-16	16075-16079	RSNs	_	
33-17	16079-16080	,	_	
33-18	16081-16090	including	_	
33-19	16091-16094	DMN	_	
33-20	16094-16095	,	_	
33-21	16096-16102	visual	_	
33-22	16103-16110	network	_	
33-23	16110-16111	,	_	
33-24	16112-16125	somatosensory	_	
33-25	16126-16133	network	_	
33-26	16133-16134	,	_	
33-27	16135-16143	auditory	_	
33-28	16144-16151	network	_	
33-29	16152-16155	and	_	
33-30	16156-16167	artifactual	_	
33-31	16168-16178	components	_	
33-32	16178-16179	.	_	

#Text=3.1 Addiction-related RSNs
34-1	16180-16183	3.1	_	
34-2	16184-16201	Addiction-related	_	
34-3	16202-16206	RSNs	_	

#Text=Six networks of interests (NOI) include the “impulsive system”: the ASN, which includes the entire striatum and extends into the thalamus, hippocampus, insula, and amygdala. The “reflective” system includes three networks: (1) the right ECN, which includes the anterior cingulate cortex (ACC), medial frontal gyrus (MFG), inferior frontal gyrus (IFG), right dorsal lateral prefrontal cortex (DLPFC), right temporal cortex and portions of parietal cortex; (2) the left ECN, which includes the left DLPFC, left IFG, left dorsal ACC extending to the MFG, and portions of left temporal and parietal cortex; (3) the OFCN, which includes the OFC, MPFC, bilateral ACC, and subcallosal cortex. SN includes the insula cortex, Heschl’s gyrus, and STG. In addition to the above networks, the DMN was split into posterior (pDMN) and anterior (aDMN) components in our results (Figure 1 and Table 2).
35-1	16207-16210	Six	_	
35-2	16211-16219	networks	_	
35-3	16220-16222	of	_	
35-4	16223-16232	interests	_	
35-5	16233-16234	(	_	
35-6	16234-16237	NOI	_	
35-7	16237-16238	)	_	
35-8	16239-16246	include	_	
35-9	16247-16250	the	_	
35-10	16251-16252	“	_	
35-11	16252-16261	impulsive	_	
35-12	16262-16268	system	_	
35-13	16268-16269	”	_	
35-14	16269-16270	:	_	
35-15	16271-16274	the	_	
35-16	16275-16278	ASN	_	
35-17	16278-16279	,	_	
35-18	16280-16285	which	_	
35-19	16286-16294	includes	_	
35-20	16295-16298	the	_	
35-21	16299-16305	entire	_	
35-22	16306-16314	striatum	_	
35-23	16315-16318	and	_	
35-24	16319-16326	extends	_	
35-25	16327-16331	into	_	
35-26	16332-16335	the	_	
35-27	16336-16344	thalamus	_	
35-28	16344-16345	,	_	
35-29	16346-16357	hippocampus	_	
35-30	16357-16358	,	_	
35-31	16359-16365	insula	_	
35-32	16365-16366	,	_	
35-33	16367-16370	and	_	
35-34	16371-16379	amygdala	_	
35-35	16379-16380	.	_	
35-36	16381-16384	The	_	
35-37	16385-16386	“	_	
35-38	16386-16396	reflective	_	
35-39	16396-16397	”	_	
35-40	16398-16404	system	_	
35-41	16405-16413	includes	_	
35-42	16414-16419	three	_	
35-43	16420-16428	networks	_	
35-44	16428-16429	:	_	
35-45	16430-16431	(	_	
35-46	16431-16432	1	_	
35-47	16432-16433	)	_	
35-48	16434-16437	the	_	
35-49	16438-16443	right	_	
35-50	16444-16447	ECN	_	
35-51	16447-16448	,	_	
35-52	16449-16454	which	_	
35-53	16455-16463	includes	_	
35-54	16464-16467	the	_	
35-55	16468-16476	anterior	_	
35-56	16477-16486	cingulate	_	
35-57	16487-16493	cortex	_	
35-58	16494-16495	(	_	
35-59	16495-16498	ACC	_	
35-60	16498-16499	)	_	
35-61	16499-16500	,	_	
35-62	16501-16507	medial	_	
35-63	16508-16515	frontal	_	
35-64	16516-16521	gyrus	_	
35-65	16522-16523	(	_	
35-66	16523-16526	MFG	_	
35-67	16526-16527	)	_	
35-68	16527-16528	,	_	
35-69	16529-16537	inferior	_	
35-70	16538-16545	frontal	_	
35-71	16546-16551	gyrus	_	
35-72	16552-16553	(	_	
35-73	16553-16556	IFG	_	
35-74	16556-16557	)	_	
35-75	16557-16558	,	_	
35-76	16559-16564	right	_	
35-77	16565-16571	dorsal	_	
35-78	16572-16579	lateral	_	
35-79	16580-16590	prefrontal	_	
35-80	16591-16597	cortex	_	
35-81	16598-16599	(	_	
35-82	16599-16604	DLPFC	_	
35-83	16604-16605	)	_	
35-84	16605-16606	,	_	
35-85	16607-16612	right	_	
35-86	16613-16621	temporal	_	
35-87	16622-16628	cortex	_	
35-88	16629-16632	and	_	
35-89	16633-16641	portions	_	
35-90	16642-16644	of	_	
35-91	16645-16653	parietal	_	
35-92	16654-16660	cortex	_	
35-93	16660-16661	;	_	
35-94	16662-16663	(	_	
35-95	16663-16664	2	_	
35-96	16664-16665	)	_	
35-97	16666-16669	the	_	
35-98	16670-16674	left	_	
35-99	16675-16678	ECN	_	
35-100	16678-16679	,	_	
35-101	16680-16685	which	_	
35-102	16686-16694	includes	_	
35-103	16695-16698	the	_	
35-104	16699-16703	left	_	
35-105	16704-16709	DLPFC	_	
35-106	16709-16710	,	_	
35-107	16711-16715	left	_	
35-108	16716-16719	IFG	_	
35-109	16719-16720	,	_	
35-110	16721-16725	left	_	
35-111	16726-16732	dorsal	_	
35-112	16733-16736	ACC	_	
35-113	16737-16746	extending	_	
35-114	16747-16749	to	_	
35-115	16750-16753	the	_	
35-116	16754-16757	MFG	_	
35-117	16757-16758	,	_	
35-118	16759-16762	and	_	
35-119	16763-16771	portions	_	
35-120	16772-16774	of	_	
35-121	16775-16779	left	_	
35-122	16780-16788	temporal	_	
35-123	16789-16792	and	_	
35-124	16793-16801	parietal	_	
35-125	16802-16808	cortex	_	
35-126	16808-16809	;	_	
35-127	16810-16811	(	_	
35-128	16811-16812	3	_	
35-129	16812-16813	)	_	
35-130	16814-16817	the	_	
35-131	16818-16822	OFCN	_	
35-132	16822-16823	,	_	
35-133	16824-16829	which	_	
35-134	16830-16838	includes	_	
35-135	16839-16842	the	_	
35-136	16843-16846	OFC	_	
35-137	16846-16847	,	_	
35-138	16848-16852	MPFC	_	
35-139	16852-16853	,	_	
35-140	16854-16863	bilateral	_	
35-141	16864-16867	ACC	_	
35-142	16867-16868	,	_	
35-143	16869-16872	and	_	
35-144	16873-16884	subcallosal	_	
35-145	16885-16891	cortex	_	
35-146	16891-16892	.	_	
35-147	16893-16895	SN	_	
35-148	16896-16904	includes	_	
35-149	16905-16908	the	_	
35-150	16909-16915	insula	_	
35-151	16916-16922	cortex	_	
35-152	16922-16923	,	_	
35-153	16924-16930	Heschl	_	
35-154	16930-16931	’	_	
35-155	16931-16932	s	_	
35-156	16933-16938	gyrus	_	
35-157	16938-16939	,	_	
35-158	16940-16943	and	_	
35-159	16944-16947	STG	_	
35-160	16947-16948	.	_	
35-161	16949-16951	In	_	
35-162	16952-16960	addition	_	
35-163	16961-16963	to	_	
35-164	16964-16967	the	_	
35-165	16968-16973	above	_	
35-166	16974-16982	networks	_	
35-167	16982-16983	,	_	
35-168	16984-16987	the	_	
35-169	16988-16991	DMN	_	
35-170	16992-16995	was	_	
35-171	16996-17001	split	_	
35-172	17002-17006	into	_	
35-173	17007-17016	posterior	_	
35-174	17017-17018	(	_	
35-175	17018-17022	pDMN	_	
35-176	17022-17023	)	_	
35-177	17024-17027	and	_	
35-178	17028-17036	anterior	_	
35-179	17037-17038	(	_	
35-180	17038-17042	aDMN	_	
35-181	17042-17043	)	_	
35-182	17044-17054	components	_	
35-183	17055-17057	in	_	
35-184	17058-17061	our	_	
35-185	17062-17069	results	_	
35-186	17070-17071	(	_	
35-187	17071-17077	Figure	_	
35-188	17078-17079	1	_	
35-189	17080-17083	and	_	
35-190	17084-17089	Table	_	
35-191	17090-17091	2	_	
35-192	17091-17092	)	_	
35-193	17092-17093	.	_	

#Text=3.2 Within-network AD and HC differences
36-1	17094-17097	3.2	_	
36-2	17098-17112	Within-network	_	
36-3	17113-17115	AD	_	
36-4	17116-17119	and	_	
36-5	17120-17122	HC	_	
36-6	17123-17134	differences	_	

#Text=When compared with HC, AD showed significantly (p<0.05, corrected) increased connectivity within “reflective” system: (1) the OFCN involving middle orbital gyrus, superior orbital gyrus, amygdala, insula, etc. (2) LECN containing angular gyrus. Also, enhanced connectivity was found in (3) ASN involving putamen, caudate, amygdala, hippocampus, subcallosal gyrus, and IFG, (4) SN involving hippocampus, insula and temporal pole. (5) aDMN including superior frontal gyrus, ACC, and superior medial gyrus, middle frontal gyrus, and (6) pDMN in middle cingulate cortex, posterior cingulate cortex (PCC), precuneus, insula, STG, caudate, thalamus (Figure 2).
37-1	17135-17139	When	_	
37-2	17140-17148	compared	_	
37-3	17149-17153	with	_	
37-4	17154-17156	HC	_	
37-5	17156-17157	,	_	
37-6	17158-17160	AD	_	
37-7	17161-17167	showed	_	
37-8	17168-17181	significantly	_	
37-9	17182-17183	(	_	
37-10	17183-17184	p	_	
37-11	17184-17185	<	_	
37-12	17185-17189	0.05	_	
37-13	17189-17190	,	_	
37-14	17191-17200	corrected	_	
37-15	17200-17201	)	_	
37-16	17202-17211	increased	_	
37-17	17212-17224	connectivity	_	
37-18	17225-17231	within	_	
37-19	17232-17233	“	_	
37-20	17233-17243	reflective	_	
37-21	17243-17244	”	_	
37-22	17245-17251	system	_	
37-23	17251-17252	:	_	
37-24	17253-17254	(	_	
37-25	17254-17255	1	_	
37-26	17255-17256	)	_	
37-27	17257-17260	the	_	
37-28	17261-17265	OFCN	_	
37-29	17266-17275	involving	_	
37-30	17276-17282	middle	_	
37-31	17283-17290	orbital	_	
37-32	17291-17296	gyrus	_	
37-33	17296-17297	,	_	
37-34	17298-17306	superior	_	
37-35	17307-17314	orbital	_	
37-36	17315-17320	gyrus	_	
37-37	17320-17321	,	_	
37-38	17322-17330	amygdala	_	
37-39	17330-17331	,	_	
37-40	17332-17338	insula	_	
37-41	17338-17339	,	_	
37-42	17340-17343	etc	_	
37-43	17343-17344	.	_	
37-44	17345-17346	(	_	
37-45	17346-17347	2	_	
37-46	17347-17348	)	_	
37-47	17349-17353	LECN	_	
37-48	17354-17364	containing	_	
37-49	17365-17372	angular	_	
37-50	17373-17378	gyrus	_	
37-51	17378-17379	.	_	
37-52	17380-17384	Also	_	
37-53	17384-17385	,	_	
37-54	17386-17394	enhanced	_	
37-55	17395-17407	connectivity	_	
37-56	17408-17411	was	_	
37-57	17412-17417	found	_	
37-58	17418-17420	in	_	
37-59	17421-17422	(	_	
37-60	17422-17423	3	_	
37-61	17423-17424	)	_	
37-62	17425-17428	ASN	_	
37-63	17429-17438	involving	_	
37-64	17439-17446	putamen	_	
37-65	17446-17447	,	_	
37-66	17448-17455	caudate	_	
37-67	17455-17456	,	_	
37-68	17457-17465	amygdala	_	
37-69	17465-17466	,	_	
37-70	17467-17478	hippocampus	_	
37-71	17478-17479	,	_	
37-72	17480-17491	subcallosal	_	
37-73	17492-17497	gyrus	_	
37-74	17497-17498	,	_	
37-75	17499-17502	and	_	
37-76	17503-17506	IFG	_	
37-77	17506-17507	,	_	
37-78	17508-17509	(	_	
37-79	17509-17510	4	_	
37-80	17510-17511	)	_	
37-81	17512-17514	SN	_	
37-82	17515-17524	involving	_	
37-83	17525-17536	hippocampus	_	
37-84	17536-17537	,	_	
37-85	17538-17544	insula	_	
37-86	17545-17548	and	_	
37-87	17549-17557	temporal	_	
37-88	17558-17562	pole	_	
37-89	17562-17563	.	_	
37-90	17564-17565	(	_	
37-91	17565-17566	5	_	
37-92	17566-17567	)	_	
37-93	17568-17572	aDMN	_	
37-94	17573-17582	including	_	
37-95	17583-17591	superior	_	
37-96	17592-17599	frontal	_	
37-97	17600-17605	gyrus	_	
37-98	17605-17606	,	_	
37-99	17607-17610	ACC	_	
37-100	17610-17611	,	_	
37-101	17612-17615	and	_	
37-102	17616-17624	superior	_	
37-103	17625-17631	medial	_	
37-104	17632-17637	gyrus	_	
37-105	17637-17638	,	_	
37-106	17639-17645	middle	_	
37-107	17646-17653	frontal	_	
37-108	17654-17659	gyrus	_	
37-109	17659-17660	,	_	
37-110	17661-17664	and	_	
37-111	17665-17666	(	_	
37-112	17666-17667	6	_	
37-113	17667-17668	)	_	
37-114	17669-17673	pDMN	_	
37-115	17674-17676	in	_	
37-116	17677-17683	middle	_	
37-117	17684-17693	cingulate	_	
37-118	17694-17700	cortex	_	
37-119	17700-17701	,	_	
37-120	17702-17711	posterior	_	
37-121	17712-17721	cingulate	_	
37-122	17722-17728	cortex	_	
37-123	17729-17730	(	_	
37-124	17730-17733	PCC	_	
37-125	17733-17734	)	_	
37-126	17734-17735	,	_	
37-127	17736-17745	precuneus	_	
37-128	17745-17746	,	_	
37-129	17747-17753	insula	_	
37-130	17753-17754	,	_	
37-131	17755-17758	STG	_	
37-132	17758-17759	,	_	
37-133	17760-17767	caudate	_	
37-134	17767-17768	,	_	
37-135	17769-17777	thalamus	_	
37-136	17778-17779	(	_	
37-137	17779-17785	Figure	_	
37-138	17786-17787	2	_	
37-139	17787-17788	)	_	
37-140	17788-17789	.	_	

#Text=3.3 Between-network AD and HC differences
38-1	17790-17793	3.3	_	
38-2	17794-17809	Between-network	_	
38-3	17810-17812	AD	_	
38-4	17813-17816	and	_	
38-5	17817-17819	HC	_	
38-6	17820-17831	differences	_	

#Text=From 21 pairwise network combinations, three pairs of coupling were significantly different after correcting for multiple comparison between AD and HC and in all of them AD had increased FC compared to HC. The three pairs were: (1) LECN and ASN, (2) LECN and SN, (3) SN and ASN. Another six pairs showed trend of increased FC between AD and HC, but did not survive correction for multiple comparison. They were as follows: (1) SN and RECN, (2) RECN and ASN (3) LECN and RECN, (4) LECN and pDMN, (5) OFCN and ASN, (6) aDMN and ASN (Figure 1).
39-1	17832-17836	From	_	
39-2	17837-17839	21	_	
39-3	17840-17848	pairwise	_	
39-4	17849-17856	network	_	
39-5	17857-17869	combinations	_	
39-6	17869-17870	,	_	
39-7	17871-17876	three	_	
39-8	17877-17882	pairs	_	
39-9	17883-17885	of	_	
39-10	17886-17894	coupling	_	
39-11	17895-17899	were	_	
39-12	17900-17913	significantly	_	
39-13	17914-17923	different	_	
39-14	17924-17929	after	_	
39-15	17930-17940	correcting	_	
39-16	17941-17944	for	_	
39-17	17945-17953	multiple	_	
39-18	17954-17964	comparison	_	
39-19	17965-17972	between	_	
39-20	17973-17975	AD	_	
39-21	17976-17979	and	_	
39-22	17980-17982	HC	_	
39-23	17983-17986	and	_	
39-24	17987-17989	in	_	
39-25	17990-17993	all	_	
39-26	17994-17996	of	_	
39-27	17997-18001	them	_	
39-28	18002-18004	AD	_	
39-29	18005-18008	had	_	
39-30	18009-18018	increased	_	
39-31	18019-18021	FC	_	
39-32	18022-18030	compared	_	
39-33	18031-18033	to	_	
39-34	18034-18036	HC	_	
39-35	18036-18037	.	_	
39-36	18038-18041	The	_	
39-37	18042-18047	three	_	
39-38	18048-18053	pairs	_	
39-39	18054-18058	were	_	
39-40	18058-18059	:	_	
39-41	18060-18061	(	_	
39-42	18061-18062	1	_	
39-43	18062-18063	)	_	
39-44	18064-18068	LECN	_	
39-45	18069-18072	and	_	
39-46	18073-18076	ASN	_	
39-47	18076-18077	,	_	
39-48	18078-18079	(	_	
39-49	18079-18080	2	_	
39-50	18080-18081	)	_	
39-51	18082-18086	LECN	_	
39-52	18087-18090	and	_	
39-53	18091-18093	SN	_	
39-54	18093-18094	,	_	
39-55	18095-18096	(	_	
39-56	18096-18097	3	_	
39-57	18097-18098	)	_	
39-58	18099-18101	SN	_	
39-59	18102-18105	and	_	
39-60	18106-18109	ASN	_	
39-61	18109-18110	.	_	
39-62	18111-18118	Another	_	
39-63	18119-18122	six	_	
39-64	18123-18128	pairs	_	
39-65	18129-18135	showed	_	
39-66	18136-18141	trend	_	
39-67	18142-18144	of	_	
39-68	18145-18154	increased	_	
39-69	18155-18157	FC	_	
39-70	18158-18165	between	_	
39-71	18166-18168	AD	_	
39-72	18169-18172	and	_	
39-73	18173-18175	HC	_	
39-74	18175-18176	,	_	
39-75	18177-18180	but	_	
39-76	18181-18184	did	_	
39-77	18185-18188	not	_	
39-78	18189-18196	survive	_	
39-79	18197-18207	correction	_	
39-80	18208-18211	for	_	
39-81	18212-18220	multiple	_	
39-82	18221-18231	comparison	_	
39-83	18231-18232	.	_	
39-84	18233-18237	They	_	
39-85	18238-18242	were	_	
39-86	18243-18245	as	_	
39-87	18246-18253	follows	_	
39-88	18253-18254	:	_	
39-89	18255-18256	(	_	
39-90	18256-18257	1	_	
39-91	18257-18258	)	_	
39-92	18259-18261	SN	_	
39-93	18262-18265	and	_	
39-94	18266-18270	RECN	_	
39-95	18270-18271	,	_	
39-96	18272-18273	(	_	
39-97	18273-18274	2	_	
39-98	18274-18275	)	_	
39-99	18276-18280	RECN	_	
39-100	18281-18284	and	_	
39-101	18285-18288	ASN	_	
39-102	18289-18290	(	_	
39-103	18290-18291	3	_	
39-104	18291-18292	)	_	
39-105	18293-18297	LECN	_	
39-106	18298-18301	and	_	
39-107	18302-18306	RECN	_	
39-108	18306-18307	,	_	
39-109	18308-18309	(	_	
39-110	18309-18310	4	_	
39-111	18310-18311	)	_	
39-112	18312-18316	LECN	_	
39-113	18317-18320	and	_	
39-114	18321-18325	pDMN	_	
39-115	18325-18326	,	_	
39-116	18327-18328	(	_	
39-117	18328-18329	5	_	
39-118	18329-18330	)	_	
39-119	18331-18335	OFCN	_	
39-120	18336-18339	and	_	
39-121	18340-18343	ASN	_	
39-122	18343-18344	,	_	
39-123	18345-18346	(	_	
39-124	18346-18347	6	_	
39-125	18347-18348	)	_	
39-126	18349-18353	aDMN	_	
39-127	18354-18357	and	_	
39-128	18358-18361	ASN	_	
39-129	18362-18363	(	_	
39-130	18363-18369	Figure	_	
39-131	18370-18371	1	_	
39-132	18371-18372	)	_	
39-133	18372-18373	.	_	

#Text=3.4 Relation between within-network FC and impulsivity
40-1	18374-18377	3.4	_	
40-2	18378-18386	Relation	_	
40-3	18387-18394	between	_	
40-4	18395-18409	within-network	_	
40-5	18410-18412	FC	_	
40-6	18413-18416	and	_	
40-7	18417-18428	impulsivity	_	

#Text=We performed correlation analyses of within-network connectivity with DDT, BIS-11, and the UPPS-P. In AD and HC, within-network FC strength was not significantly correlated with BIS-11 sum score and the DDT. UPPS (−) Urgency was significantly negatively correlated with within-network FC in ASN in AD, suggesting that when within-network FC of ASN increased, the UPPS (−) Urgency decreased. UPPS (+) Urgency was significantly negatively correlated with within-network FC in a-DMN in HC (Table 3).
41-1	18429-18431	We	_	
41-2	18432-18441	performed	_	
41-3	18442-18453	correlation	_	
41-4	18454-18462	analyses	_	
41-5	18463-18465	of	_	
41-6	18466-18480	within-network	_	
41-7	18481-18493	connectivity	_	
41-8	18494-18498	with	_	
41-9	18499-18502	DDT	_	
41-10	18502-18503	,	_	
41-11	18504-18507	BIS	_	
41-12	18507-18508	-	_	
41-13	18508-18510	11	_	
41-14	18510-18511	,	_	
41-15	18512-18515	and	_	
41-16	18516-18519	the	_	
41-17	18520-18526	UPPS-P	_	
41-18	18526-18527	.	_	
41-19	18528-18530	In	_	
41-20	18531-18533	AD	_	
41-21	18534-18537	and	_	
41-22	18538-18540	HC	_	
41-23	18540-18541	,	_	
41-24	18542-18556	within-network	_	
41-25	18557-18559	FC	_	
41-26	18560-18568	strength	_	
41-27	18569-18572	was	_	
41-28	18573-18576	not	_	
41-29	18577-18590	significantly	_	
41-30	18591-18601	correlated	_	
41-31	18602-18606	with	_	
41-32	18607-18610	BIS	_	
41-33	18610-18611	-	_	
41-34	18611-18613	11	_	
41-35	18614-18617	sum	_	
41-36	18618-18623	score	_	
41-37	18624-18627	and	_	
41-38	18628-18631	the	_	
41-39	18632-18635	DDT	_	
41-40	18635-18636	.	_	
41-41	18637-18641	UPPS	_	
41-42	18642-18643	(	_	
41-43	18643-18644	−	_	
41-44	18644-18645	)	_	
41-45	18646-18653	Urgency	_	
41-46	18654-18657	was	_	
41-47	18658-18671	significantly	_	
41-48	18672-18682	negatively	_	
41-49	18683-18693	correlated	_	
41-50	18694-18698	with	_	
41-51	18699-18713	within-network	_	
41-52	18714-18716	FC	_	
41-53	18717-18719	in	_	
41-54	18720-18723	ASN	_	
41-55	18724-18726	in	_	
41-56	18727-18729	AD	_	
41-57	18729-18730	,	_	
41-58	18731-18741	suggesting	_	
41-59	18742-18746	that	_	
41-60	18747-18751	when	_	
41-61	18752-18766	within-network	_	
41-62	18767-18769	FC	_	
41-63	18770-18772	of	_	
41-64	18773-18776	ASN	_	
41-65	18777-18786	increased	_	
41-66	18786-18787	,	_	
41-67	18788-18791	the	_	
41-68	18792-18796	UPPS	_	
41-69	18797-18798	(	_	
41-70	18798-18799	−	_	
41-71	18799-18800	)	_	
41-72	18801-18808	Urgency	_	
41-73	18809-18818	decreased	_	
41-74	18818-18819	.	_	
41-75	18820-18824	UPPS	_	
41-76	18825-18826	(	_	
41-77	18826-18827	+	_	
41-78	18827-18828	)	_	
41-79	18829-18836	Urgency	_	
41-80	18837-18840	was	_	
41-81	18841-18854	significantly	_	
41-82	18855-18865	negatively	_	
41-83	18866-18876	correlated	_	
41-84	18877-18881	with	_	
41-85	18882-18896	within-network	_	
41-86	18897-18899	FC	_	
41-87	18900-18902	in	_	
41-88	18903-18908	a-DMN	_	
41-89	18909-18911	in	_	
41-90	18912-18914	HC	_	
41-91	18915-18916	(	_	
41-92	18916-18921	Table	_	
41-93	18922-18923	3	_	
41-94	18923-18924	)	_	
41-95	18924-18925	.	_	

#Text=3.5 Relation between network coupling and impulsivity
42-1	18926-18929	3.5	_	
42-2	18930-18938	Relation	_	
42-3	18939-18946	between	_	
42-4	18947-18954	network	_	
42-5	18955-18963	coupling	_	
42-6	18964-18967	and	_	
42-7	18968-18979	impulsivity	_	

#Text=In AD, BIS-11 was not correlated with FC coupling. DDT was significantly positively correlated with FC coupling among LECN, SN and aDMN. UPPS (−) was significantly negatively correlated with FC coupling between OFCN and RECN, OFCN and aDMN, OFCN and pDMN (p<0.05, Figure 3 and 4). In HC, between-network coupling was not significantly correlated with BIS-11, DDT, and UPPS.
43-1	18980-18982	In	_	
43-2	18983-18985	AD	_	
43-3	18985-18986	,	_	
43-4	18987-18990	BIS	_	
43-5	18990-18991	-	_	
43-6	18991-18993	11	_	
43-7	18994-18997	was	_	
43-8	18998-19001	not	_	
43-9	19002-19012	correlated	_	
43-10	19013-19017	with	_	
43-11	19018-19020	FC	_	
43-12	19021-19029	coupling	_	
43-13	19029-19030	.	_	
43-14	19031-19034	DDT	_	
43-15	19035-19038	was	_	
43-16	19039-19052	significantly	_	
43-17	19053-19063	positively	_	
43-18	19064-19074	correlated	_	
43-19	19075-19079	with	_	
43-20	19080-19082	FC	_	
43-21	19083-19091	coupling	_	
43-22	19092-19097	among	_	
43-23	19098-19102	LECN	_	
43-24	19102-19103	,	_	
43-25	19104-19106	SN	_	
43-26	19107-19110	and	_	
43-27	19111-19115	aDMN	_	
43-28	19115-19116	.	_	
43-29	19117-19121	UPPS	_	
43-30	19122-19123	(	_	
43-31	19123-19124	−	_	
43-32	19124-19125	)	_	
43-33	19126-19129	was	_	
43-34	19130-19143	significantly	_	
43-35	19144-19154	negatively	_	
43-36	19155-19165	correlated	_	
43-37	19166-19170	with	_	
43-38	19171-19173	FC	_	
43-39	19174-19182	coupling	_	
43-40	19183-19190	between	_	
43-41	19191-19195	OFCN	_	
43-42	19196-19199	and	_	
43-43	19200-19204	RECN	_	
43-44	19204-19205	,	_	
43-45	19206-19210	OFCN	_	
43-46	19211-19214	and	_	
43-47	19215-19219	aDMN	_	
43-48	19219-19220	,	_	
43-49	19221-19225	OFCN	_	
43-50	19226-19229	and	_	
43-51	19230-19234	pDMN	_	
43-52	19235-19236	(	_	
43-53	19236-19237	p	_	
43-54	19237-19238	<	_	
43-55	19238-19242	0.05	_	
43-56	19242-19243	,	_	
43-57	19244-19250	Figure	_	
43-58	19251-19252	3	_	
43-59	19253-19256	and	_	
43-60	19257-19258	4	_	
43-61	19258-19259	)	_	
43-62	19259-19260	.	_	
43-63	19261-19263	In	_	
43-64	19264-19266	HC	_	
43-65	19266-19267	,	_	
43-66	19268-19283	between-network	_	
43-67	19284-19292	coupling	_	
43-68	19293-19296	was	_	
43-69	19297-19300	not	_	
43-70	19301-19314	significantly	_	
43-71	19315-19325	correlated	_	
43-72	19326-19330	with	_	
43-73	19331-19334	BIS	_	
43-74	19334-19335	-	_	
43-75	19335-19337	11	_	
43-76	19337-19338	,	_	
43-77	19339-19342	DDT	_	
43-78	19342-19343	,	_	
43-79	19344-19347	and	_	
43-80	19348-19352	UPPS	_	
43-81	19352-19353	.	_	

#Text=Discussion
44-1	19354-19364	Discussion	_	

#Text=The current study sought to investigate the differences in the functional connectivity (FC) between AD and HC using ICA. Based on previous studies we hypothesized altered FC in several networks elements of which are known to have been compromised in AD. Supporting our hypothesis, AD displayed an increased pattern of both within-network FC and between-network FC coupling among RSNs involving ASN, OFCN, SN, LECN and DMN compared to HC. Also, between-network FC differences between AD and HC exhibited significant correlation with impulsivity measures such as UPPS, and DDT.
45-1	19365-19368	The	_	
45-2	19369-19376	current	_	
45-3	19377-19382	study	_	
45-4	19383-19389	sought	_	
45-5	19390-19392	to	_	
45-6	19393-19404	investigate	_	
45-7	19405-19408	the	_	
45-8	19409-19420	differences	_	
45-9	19421-19423	in	_	
45-10	19424-19427	the	_	
45-11	19428-19438	functional	_	
45-12	19439-19451	connectivity	_	
45-13	19452-19453	(	_	
45-14	19453-19455	FC	_	
45-15	19455-19456	)	_	
45-16	19457-19464	between	_	
45-17	19465-19467	AD	_	
45-18	19468-19471	and	_	
45-19	19472-19474	HC	_	
45-20	19475-19480	using	_	
45-21	19481-19484	ICA	_	
45-22	19484-19485	.	_	
45-23	19486-19491	Based	_	
45-24	19492-19494	on	_	
45-25	19495-19503	previous	_	
45-26	19504-19511	studies	_	
45-27	19512-19514	we	_	
45-28	19515-19527	hypothesized	_	
45-29	19528-19535	altered	_	
45-30	19536-19538	FC	_	
45-31	19539-19541	in	_	
45-32	19542-19549	several	_	
45-33	19550-19558	networks	_	
45-34	19559-19567	elements	_	
45-35	19568-19570	of	_	
45-36	19571-19576	which	_	
45-37	19577-19580	are	_	
45-38	19581-19586	known	_	
45-39	19587-19589	to	_	
45-40	19590-19594	have	_	
45-41	19595-19599	been	_	
45-42	19600-19611	compromised	_	
45-43	19612-19614	in	_	
45-44	19615-19617	AD	_	
45-45	19617-19618	.	_	
45-46	19619-19629	Supporting	_	
45-47	19630-19633	our	_	
45-48	19634-19644	hypothesis	_	
45-49	19644-19645	,	_	
45-50	19646-19648	AD	_	
45-51	19649-19658	displayed	_	
45-52	19659-19661	an	_	
45-53	19662-19671	increased	_	
45-54	19672-19679	pattern	_	
45-55	19680-19682	of	_	
45-56	19683-19687	both	_	
45-57	19688-19702	within-network	_	
45-58	19703-19705	FC	_	
45-59	19706-19709	and	_	
45-60	19710-19725	between-network	_	
45-61	19726-19728	FC	_	
45-62	19729-19737	coupling	_	
45-63	19738-19743	among	_	
45-64	19744-19748	RSNs	_	
45-65	19749-19758	involving	_	
45-66	19759-19762	ASN	_	
45-67	19762-19763	,	_	
45-68	19764-19768	OFCN	_	
45-69	19768-19769	,	_	
45-70	19770-19772	SN	_	
45-71	19772-19773	,	_	
45-72	19774-19778	LECN	_	
45-73	19779-19782	and	_	
45-74	19783-19786	DMN	_	
45-75	19787-19795	compared	_	
45-76	19796-19798	to	_	
45-77	19799-19801	HC	_	
45-78	19801-19802	.	_	
45-79	19803-19807	Also	_	
45-80	19807-19808	,	_	
45-81	19809-19824	between-network	_	
45-82	19825-19827	FC	_	
45-83	19828-19839	differences	_	
45-84	19840-19847	between	_	
45-85	19848-19850	AD	_	
45-86	19851-19854	and	_	
45-87	19855-19857	HC	_	
45-88	19858-19867	exhibited	_	
45-89	19868-19879	significant	_	
45-90	19880-19891	correlation	_	
45-91	19892-19896	with	_	
45-92	19897-19908	impulsivity	_	
45-93	19909-19917	measures	_	
45-94	19918-19922	such	_	
45-95	19923-19925	as	_	
45-96	19926-19930	UPPS	_	
45-97	19930-19931	,	_	
45-98	19932-19935	and	_	
45-99	19936-19939	DDT	_	
45-100	19939-19940	.	_	

#Text=We found an increase in the intensity and extent of brain FC in AD during resting state. One explanation of this finding could be that this is a brain compensation mechanism for when a drug such as alcohol compromises the functionality of networks beyond self (within) compensation. Therefore, related networks such as OFCN, ASN, etc may utilize additional cognitive resources to achieve the same level of performance. Previous studies have shown long term effects of alcohol on both gray and white matter on human brain. Also, the hyperactivation in a variety of areas including the PFC, insula, thalamus, striatum, DLPFC, and ACC were also observed in AD patients during a multimodel stroop task. This enhanced recruitment of task-relevant areas may be interpreted as indicating an enhanced neural effort in cortical computation due to the structural damage of the brain. In our study, the increased FC may reflect the widespread structural disturbances in AD.
46-1	19941-19943	We	_	
46-2	19944-19949	found	_	
46-3	19950-19952	an	_	
46-4	19953-19961	increase	_	
46-5	19962-19964	in	_	
46-6	19965-19968	the	_	
46-7	19969-19978	intensity	_	
46-8	19979-19982	and	_	
46-9	19983-19989	extent	_	
46-10	19990-19992	of	_	
46-11	19993-19998	brain	_	
46-12	19999-20001	FC	_	
46-13	20002-20004	in	_	
46-14	20005-20007	AD	_	
46-15	20008-20014	during	_	
46-16	20015-20022	resting	_	
46-17	20023-20028	state	_	
46-18	20028-20029	.	_	
46-19	20030-20033	One	_	
46-20	20034-20045	explanation	_	
46-21	20046-20048	of	_	
46-22	20049-20053	this	_	
46-23	20054-20061	finding	_	
46-24	20062-20067	could	_	
46-25	20068-20070	be	_	
46-26	20071-20075	that	_	
46-27	20076-20080	this	_	
46-28	20081-20083	is	_	
46-29	20084-20085	a	_	
46-30	20086-20091	brain	_	
46-31	20092-20104	compensation	_	
46-32	20105-20114	mechanism	_	
46-33	20115-20118	for	_	
46-34	20119-20123	when	_	
46-35	20124-20125	a	_	
46-36	20126-20130	drug	_	
46-37	20131-20135	such	_	
46-38	20136-20138	as	_	
46-39	20139-20146	alcohol	_	
46-40	20147-20158	compromises	_	
46-41	20159-20162	the	_	
46-42	20163-20176	functionality	_	
46-43	20177-20179	of	_	
46-44	20180-20188	networks	_	
46-45	20189-20195	beyond	_	
46-46	20196-20200	self	_	
46-47	20201-20202	(	_	
46-48	20202-20208	within	_	
46-49	20208-20209	)	_	
46-50	20210-20222	compensation	_	
46-51	20222-20223	.	_	
46-52	20224-20233	Therefore	_	
46-53	20233-20234	,	_	
46-54	20235-20242	related	_	
46-55	20243-20251	networks	_	
46-56	20252-20256	such	_	
46-57	20257-20259	as	_	
46-58	20260-20264	OFCN	_	
46-59	20264-20265	,	_	
46-60	20266-20269	ASN	_	
46-61	20269-20270	,	_	
46-62	20271-20274	etc	_	
46-63	20275-20278	may	_	
46-64	20279-20286	utilize	_	
46-65	20287-20297	additional	_	
46-66	20298-20307	cognitive	_	
46-67	20308-20317	resources	_	
46-68	20318-20320	to	_	
46-69	20321-20328	achieve	_	
46-70	20329-20332	the	_	
46-71	20333-20337	same	_	
46-72	20338-20343	level	_	
46-73	20344-20346	of	_	
46-74	20347-20358	performance	_	
46-75	20358-20359	.	_	
46-76	20360-20368	Previous	_	
46-77	20369-20376	studies	_	
46-78	20377-20381	have	_	
46-79	20382-20387	shown	_	
46-80	20388-20392	long	_	
46-81	20393-20397	term	_	
46-82	20398-20405	effects	_	
46-83	20406-20408	of	_	
46-84	20409-20416	alcohol	_	
46-85	20417-20419	on	_	
46-86	20420-20424	both	_	
46-87	20425-20429	gray	_	
46-88	20430-20433	and	_	
46-89	20434-20439	white	_	
46-90	20440-20446	matter	_	
46-91	20447-20449	on	_	
46-92	20450-20455	human	_	
46-93	20456-20461	brain	_	
46-94	20461-20462	.	_	
46-95	20463-20467	Also	_	
46-96	20467-20468	,	_	
46-97	20469-20472	the	_	
46-98	20473-20488	hyperactivation	_	
46-99	20489-20491	in	_	
46-100	20492-20493	a	_	
46-101	20494-20501	variety	_	
46-102	20502-20504	of	_	
46-103	20505-20510	areas	_	
46-104	20511-20520	including	_	
46-105	20521-20524	the	_	
46-106	20525-20528	PFC	_	
46-107	20528-20529	,	_	
46-108	20530-20536	insula	_	
46-109	20536-20537	,	_	
46-110	20538-20546	thalamus	_	
46-111	20546-20547	,	_	
46-112	20548-20556	striatum	_	
46-113	20556-20557	,	_	
46-114	20558-20563	DLPFC	_	
46-115	20563-20564	,	_	
46-116	20565-20568	and	_	
46-117	20569-20572	ACC	_	
46-118	20573-20577	were	_	
46-119	20578-20582	also	_	
46-120	20583-20591	observed	_	
46-121	20592-20594	in	_	
46-122	20595-20597	AD	_	
46-123	20598-20606	patients	_	
46-124	20607-20613	during	_	
46-125	20614-20615	a	_	
46-126	20616-20626	multimodel	_	
46-127	20627-20633	stroop	_	
46-128	20634-20638	task	_	
46-129	20638-20639	.	_	
46-130	20640-20644	This	_	
46-131	20645-20653	enhanced	_	
46-132	20654-20665	recruitment	_	
46-133	20666-20668	of	_	
46-134	20669-20682	task-relevant	_	
46-135	20683-20688	areas	_	
46-136	20689-20692	may	_	
46-137	20693-20695	be	_	
46-138	20696-20707	interpreted	_	
46-139	20708-20710	as	_	
46-140	20711-20721	indicating	_	
46-141	20722-20724	an	_	
46-142	20725-20733	enhanced	_	
46-143	20734-20740	neural	_	
46-144	20741-20747	effort	_	
46-145	20748-20750	in	_	
46-146	20751-20759	cortical	_	
46-147	20760-20771	computation	_	
46-148	20772-20775	due	_	
46-149	20776-20778	to	_	
46-150	20779-20782	the	_	
46-151	20783-20793	structural	_	
46-152	20794-20800	damage	_	
46-153	20801-20803	of	_	
46-154	20804-20807	the	_	
46-155	20808-20813	brain	_	
46-156	20813-20814	.	_	
46-157	20815-20817	In	_	
46-158	20818-20821	our	_	
46-159	20822-20827	study	_	
46-160	20827-20828	,	_	
46-161	20829-20832	the	_	
46-162	20833-20842	increased	_	
46-163	20843-20845	FC	_	
46-164	20846-20849	may	_	
46-165	20850-20857	reflect	_	
46-166	20858-20861	the	_	
46-167	20862-20872	widespread	_	
46-168	20873-20883	structural	_	
46-169	20884-20896	disturbances	_	
46-170	20897-20899	in	_	
46-171	20900-20902	AD	_	
46-172	20902-20903	.	_	

#Text=To date, the resting-state FC has not been extensively studied. compared the resting state connectivity using two seeds - the nucleus accumbens (NAcc) and the subgenual anterior cingulate cortex (sgACC), between abstainers and relapsers. The results showed that compared with abstainer, relapsers exhibited significantly decreased resting state synchrony within the reward network, the executive control network, and the visual network. The same group also studied functional organization in long-term abstinent alcoholics. The results revealed that compared with normal controls, long-term abstinence led to decreased synchrony within the limbic reward regions, such as the caudate and the thalamus, when using the sgACC and the NAcc seeds. Seed-based methods have also been used to identify the role of the posterior cingulate cortex in the default mode network as well as the potential for the cerebellum to be a node within the DMN. The study revealed the compromised FC in the posterior cingulate and the frontocerebellar regions in alcoholics. Those studies focused on connectivity patterns of predefined seed regions. Our work identified differences between AD and HC within large-scale brain networks and between-network coupling that are important in addiction disorders using data-driven method. More specifically, the FC in the “impulsive” system (ASN) exhibited greater FC in AD relative to HC. ASN contains the nucleus accumbens, putamen, and caudate which are known to be involved in primary reward processing. It is widely accepted that alcohol stimulates dopamine release in the ventral striatum, and thus reinforces alcohol consumption. This suggested that AD might have enhanced intrinsic neuronal activity in the ASN at rest. This finding is consistent with preclinical reports showing that alcohol induces a persistent increase in the baseline sensitivity of brain reward systems. ASN also has been reported to exhibit greater FC in smokers than normal controls. Thus, the greater ASN FC we found in AD relative to HC may represent a chronic alcohol-induced increase in baseline reward-system sensitivity. AD also exhibited greater FC in amygdala within the ASN. The amygdala is thought to primarily contribute to the acquisition, consolidation, and expression of learning of the drug-related cues that drive relapse to drug-seeking behaviors. This area is also robustly activated under drug-related cues, and was found to exhibit robust resting-state FC with affective brain areas including OFC. Our finding of enhanced FC in the amygdala may be relevant to previous studies that have demonstrated the involvement of these areas in the pathology of addiction. The next system implicated in addiction is “reflective” system which contains three networks in our study: OFCN, LECN and RECN. Our findings indicate greater within-network FC within the OFCN in AD relative to HC. The OFC and MPFC are major areas of motivation, drive, and salience evaluation, which are impaired in drug addicts and play an important role in the output of compulsive drug-seeking behaviors. Studies have shown enhanced activation in specific mesocorticolimbic dopamine system areas including OFC in alcohol-cue exposure. In the present study, significantly increased resting-state FC was found, consistent with the previous results. The ECN serves a wide range of cognitive control functions. The prefrontal cortex is important for decision-making, inhibitory control and self-awareness, and it may become hypoactive in states of addiction. The ECN might be viewed as particularly pertinent to the field of substance dependence since it is thought to be involved in goal-directed behavior and cognitive control. The increased motivation to find and use drugs combined with an inability to inhibit drug-related behaviors is thought to represent a failure of executive control. Resting state studies have identified that this network operates in a lateralized manner. Studies have shown that Individuals with drug addictions have increased willingness to approach rewards. Approach behaviors are thought to involve executive control processes, and left prefrontal cortex is known to be more strongly involved in approach behaviors compared to right prefrontal cortex. Studies also suggest that the RECN was more strongly associated with avoidance. Compare to HC, our results showed that AD exhibited greater FC within the LECN, but there was no significant difference between AD and HC in terms of FC within the RECN. Studies have shown substance dependent individuals have greater left hemisphere connectivity in the LECN at rest. The enhanced FC within LECN we found in our results might further support the role of LECN in willingness to approach rewards.
47-1	20904-20906	To	_	
47-2	20907-20911	date	_	
47-3	20911-20912	,	_	
47-4	20913-20916	the	_	
47-5	20917-20930	resting-state	_	
47-6	20931-20933	FC	_	
47-7	20934-20937	has	_	
47-8	20938-20941	not	_	
47-9	20942-20946	been	_	
47-10	20947-20958	extensively	_	
47-11	20959-20966	studied	_	
47-12	20966-20967	.	_	
47-13	20968-20976	compared	_	
47-14	20977-20980	the	_	
47-15	20981-20988	resting	_	
47-16	20989-20994	state	_	
47-17	20995-21007	connectivity	_	
47-18	21008-21013	using	_	
47-19	21014-21017	two	_	
47-20	21018-21023	seeds	_	
47-21	21024-21025	-	_	
47-22	21026-21029	the	_	
47-23	21030-21037	nucleus	_	
47-24	21038-21047	accumbens	_	
47-25	21048-21049	(	_	
47-26	21049-21053	NAcc	_	
47-27	21053-21054	)	_	
47-28	21055-21058	and	_	
47-29	21059-21062	the	_	
47-30	21063-21072	subgenual	_	
47-31	21073-21081	anterior	_	
47-32	21082-21091	cingulate	_	
47-33	21092-21098	cortex	_	
47-34	21099-21100	(	_	
47-35	21100-21105	sgACC	_	
47-36	21105-21106	)	_	
47-37	21106-21107	,	_	
47-38	21108-21115	between	_	
47-39	21116-21126	abstainers	_	
47-40	21127-21130	and	_	
47-41	21131-21140	relapsers	_	
47-42	21140-21141	.	_	
47-43	21142-21145	The	_	
47-44	21146-21153	results	_	
47-45	21154-21160	showed	_	
47-46	21161-21165	that	_	
47-47	21166-21174	compared	_	
47-48	21175-21179	with	_	
47-49	21180-21189	abstainer	_	
47-50	21189-21190	,	_	
47-51	21191-21200	relapsers	_	
47-52	21201-21210	exhibited	_	
47-53	21211-21224	significantly	_	
47-54	21225-21234	decreased	_	
47-55	21235-21242	resting	_	
47-56	21243-21248	state	_	
47-57	21249-21258	synchrony	_	
47-58	21259-21265	within	_	
47-59	21266-21269	the	_	
47-60	21270-21276	reward	_	
47-61	21277-21284	network	_	
47-62	21284-21285	,	_	
47-63	21286-21289	the	_	
47-64	21290-21299	executive	_	
47-65	21300-21307	control	_	
47-66	21308-21315	network	_	
47-67	21315-21316	,	_	
47-68	21317-21320	and	_	
47-69	21321-21324	the	_	
47-70	21325-21331	visual	_	
47-71	21332-21339	network	_	
47-72	21339-21340	.	_	
47-73	21341-21344	The	_	
47-74	21345-21349	same	_	
47-75	21350-21355	group	_	
47-76	21356-21360	also	_	
47-77	21361-21368	studied	_	
47-78	21369-21379	functional	_	
47-79	21380-21392	organization	_	
47-80	21393-21395	in	_	
47-81	21396-21405	long-term	_	
47-82	21406-21415	abstinent	_	
47-83	21416-21426	alcoholics	_	
47-84	21426-21427	.	_	
47-85	21428-21431	The	_	
47-86	21432-21439	results	_	
47-87	21440-21448	revealed	_	
47-88	21449-21453	that	_	
47-89	21454-21462	compared	_	
47-90	21463-21467	with	_	
47-91	21468-21474	normal	_	
47-92	21475-21483	controls	_	
47-93	21483-21484	,	_	
47-94	21485-21494	long-term	_	
47-95	21495-21505	abstinence	_	
47-96	21506-21509	led	_	
47-97	21510-21512	to	_	
47-98	21513-21522	decreased	_	
47-99	21523-21532	synchrony	_	
47-100	21533-21539	within	_	
47-101	21540-21543	the	_	
47-102	21544-21550	limbic	_	
47-103	21551-21557	reward	_	
47-104	21558-21565	regions	_	
47-105	21565-21566	,	_	
47-106	21567-21571	such	_	
47-107	21572-21574	as	_	
47-108	21575-21578	the	_	
47-109	21579-21586	caudate	_	
47-110	21587-21590	and	_	
47-111	21591-21594	the	_	
47-112	21595-21603	thalamus	_	
47-113	21603-21604	,	_	
47-114	21605-21609	when	_	
47-115	21610-21615	using	_	
47-116	21616-21619	the	_	
47-117	21620-21625	sgACC	_	
47-118	21626-21629	and	_	
47-119	21630-21633	the	_	
47-120	21634-21638	NAcc	_	
47-121	21639-21644	seeds	_	
47-122	21644-21645	.	_	
47-123	21646-21656	Seed-based	_	
47-124	21657-21664	methods	_	
47-125	21665-21669	have	_	
47-126	21670-21674	also	_	
47-127	21675-21679	been	_	
47-128	21680-21684	used	_	
47-129	21685-21687	to	_	
47-130	21688-21696	identify	_	
47-131	21697-21700	the	_	
47-132	21701-21705	role	_	
47-133	21706-21708	of	_	
47-134	21709-21712	the	_	
47-135	21713-21722	posterior	_	
47-136	21723-21732	cingulate	_	
47-137	21733-21739	cortex	_	
47-138	21740-21742	in	_	
47-139	21743-21746	the	_	
47-140	21747-21754	default	_	
47-141	21755-21759	mode	_	
47-142	21760-21767	network	_	
47-143	21768-21770	as	_	
47-144	21771-21775	well	_	
47-145	21776-21778	as	_	
47-146	21779-21782	the	_	
47-147	21783-21792	potential	_	
47-148	21793-21796	for	_	
47-149	21797-21800	the	_	
47-150	21801-21811	cerebellum	_	
47-151	21812-21814	to	_	
47-152	21815-21817	be	_	
47-153	21818-21819	a	_	
47-154	21820-21824	node	_	
47-155	21825-21831	within	_	
47-156	21832-21835	the	_	
47-157	21836-21839	DMN	_	
47-158	21839-21840	.	_	
47-159	21841-21844	The	_	
47-160	21845-21850	study	_	
47-161	21851-21859	revealed	_	
47-162	21860-21863	the	_	
47-163	21864-21875	compromised	_	
47-164	21876-21878	FC	_	
47-165	21879-21881	in	_	
47-166	21882-21885	the	_	
47-167	21886-21895	posterior	_	
47-168	21896-21905	cingulate	_	
47-169	21906-21909	and	_	
47-170	21910-21913	the	_	
47-171	21914-21930	frontocerebellar	_	
47-172	21931-21938	regions	_	
47-173	21939-21941	in	_	
47-174	21942-21952	alcoholics	_	
47-175	21952-21953	.	_	
47-176	21954-21959	Those	_	
47-177	21960-21967	studies	_	
47-178	21968-21975	focused	_	
47-179	21976-21978	on	_	
47-180	21979-21991	connectivity	_	
47-181	21992-22000	patterns	_	
47-182	22001-22003	of	_	
47-183	22004-22014	predefined	_	
47-184	22015-22019	seed	_	
47-185	22020-22027	regions	_	
47-186	22027-22028	.	_	
47-187	22029-22032	Our	_	
47-188	22033-22037	work	_	
47-189	22038-22048	identified	_	
47-190	22049-22060	differences	_	
47-191	22061-22068	between	_	
47-192	22069-22071	AD	_	
47-193	22072-22075	and	_	
47-194	22076-22078	HC	_	
47-195	22079-22085	within	_	
47-196	22086-22097	large-scale	_	
47-197	22098-22103	brain	_	
47-198	22104-22112	networks	_	
47-199	22113-22116	and	_	
47-200	22117-22132	between-network	_	
47-201	22133-22141	coupling	_	
47-202	22142-22146	that	_	
47-203	22147-22150	are	_	
47-204	22151-22160	important	_	
47-205	22161-22163	in	_	
47-206	22164-22173	addiction	_	
47-207	22174-22183	disorders	_	
47-208	22184-22189	using	_	
47-209	22190-22201	data-driven	_	
47-210	22202-22208	method	_	
47-211	22208-22209	.	_	
47-212	22210-22214	More	_	
47-213	22215-22227	specifically	_	
47-214	22227-22228	,	_	
47-215	22229-22232	the	_	
47-216	22233-22235	FC	_	
47-217	22236-22238	in	_	
47-218	22239-22242	the	_	
47-219	22243-22244	“	_	
47-220	22244-22253	impulsive	_	
47-221	22253-22254	”	_	
47-222	22255-22261	system	_	
47-223	22262-22263	(	_	
47-224	22263-22266	ASN	_	
47-225	22266-22267	)	_	
47-226	22268-22277	exhibited	_	
47-227	22278-22285	greater	_	
47-228	22286-22288	FC	_	
47-229	22289-22291	in	_	
47-230	22292-22294	AD	_	
47-231	22295-22303	relative	_	
47-232	22304-22306	to	_	
47-233	22307-22309	HC	_	
47-234	22309-22310	.	_	
47-235	22311-22314	ASN	_	
47-236	22315-22323	contains	_	
47-237	22324-22327	the	_	
47-238	22328-22335	nucleus	_	
47-239	22336-22345	accumbens	_	
47-240	22345-22346	,	_	
47-241	22347-22354	putamen	_	
47-242	22354-22355	,	_	
47-243	22356-22359	and	_	
47-244	22360-22367	caudate	_	
47-245	22368-22373	which	_	
47-246	22374-22377	are	_	
47-247	22378-22383	known	_	
47-248	22384-22386	to	_	
47-249	22387-22389	be	_	
47-250	22390-22398	involved	_	
47-251	22399-22401	in	_	
47-252	22402-22409	primary	_	
47-253	22410-22416	reward	_	
47-254	22417-22427	processing	_	
47-255	22427-22428	.	_	
47-256	22429-22431	It	_	
47-257	22432-22434	is	_	
47-258	22435-22441	widely	_	
47-259	22442-22450	accepted	_	
47-260	22451-22455	that	_	
47-261	22456-22463	alcohol	_	
47-262	22464-22474	stimulates	_	
47-263	22475-22483	dopamine	_	
47-264	22484-22491	release	_	
47-265	22492-22494	in	_	
47-266	22495-22498	the	_	
47-267	22499-22506	ventral	_	
47-268	22507-22515	striatum	_	
47-269	22515-22516	,	_	
47-270	22517-22520	and	_	
47-271	22521-22525	thus	_	
47-272	22526-22536	reinforces	_	
47-273	22537-22544	alcohol	_	
47-274	22545-22556	consumption	_	
47-275	22556-22557	.	_	
47-276	22558-22562	This	_	
47-277	22563-22572	suggested	_	
47-278	22573-22577	that	_	
47-279	22578-22580	AD	_	
47-280	22581-22586	might	_	
47-281	22587-22591	have	_	
47-282	22592-22600	enhanced	_	
47-283	22601-22610	intrinsic	_	
47-284	22611-22619	neuronal	_	
47-285	22620-22628	activity	_	
47-286	22629-22631	in	_	
47-287	22632-22635	the	_	
47-288	22636-22639	ASN	_	
47-289	22640-22642	at	_	
47-290	22643-22647	rest	_	
47-291	22647-22648	.	_	
47-292	22649-22653	This	_	
47-293	22654-22661	finding	_	
47-294	22662-22664	is	_	
47-295	22665-22675	consistent	_	
47-296	22676-22680	with	_	
47-297	22681-22692	preclinical	_	
47-298	22693-22700	reports	_	
47-299	22701-22708	showing	_	
47-300	22709-22713	that	_	
47-301	22714-22721	alcohol	_	
47-302	22722-22729	induces	_	
47-303	22730-22731	a	_	
47-304	22732-22742	persistent	_	
47-305	22743-22751	increase	_	
47-306	22752-22754	in	_	
47-307	22755-22758	the	_	
47-308	22759-22767	baseline	_	
47-309	22768-22779	sensitivity	_	
47-310	22780-22782	of	_	
47-311	22783-22788	brain	_	
47-312	22789-22795	reward	_	
47-313	22796-22803	systems	_	
47-314	22803-22804	.	_	
47-315	22805-22808	ASN	_	
47-316	22809-22813	also	_	
47-317	22814-22817	has	_	
47-318	22818-22822	been	_	
47-319	22823-22831	reported	_	
47-320	22832-22834	to	_	
47-321	22835-22842	exhibit	_	
47-322	22843-22850	greater	_	
47-323	22851-22853	FC	_	
47-324	22854-22856	in	_	
47-325	22857-22864	smokers	_	
47-326	22865-22869	than	_	
47-327	22870-22876	normal	_	
47-328	22877-22885	controls	_	
47-329	22885-22886	.	_	
47-330	22887-22891	Thus	_	
47-331	22891-22892	,	_	
47-332	22893-22896	the	_	
47-333	22897-22904	greater	_	
47-334	22905-22908	ASN	_	
47-335	22909-22911	FC	_	
47-336	22912-22914	we	_	
47-337	22915-22920	found	_	
47-338	22921-22923	in	_	
47-339	22924-22926	AD	_	
47-340	22927-22935	relative	_	
47-341	22936-22938	to	_	
47-342	22939-22941	HC	_	
47-343	22942-22945	may	_	
47-344	22946-22955	represent	_	
47-345	22956-22957	a	_	
47-346	22958-22965	chronic	_	
47-347	22966-22981	alcohol-induced	_	
47-348	22982-22990	increase	_	
47-349	22991-22993	in	_	
47-350	22994-23002	baseline	_	
47-351	23003-23016	reward-system	_	
47-352	23017-23028	sensitivity	_	
47-353	23028-23029	.	_	
47-354	23030-23032	AD	_	
47-355	23033-23037	also	_	
47-356	23038-23047	exhibited	_	
47-357	23048-23055	greater	_	
47-358	23056-23058	FC	_	
47-359	23059-23061	in	_	
47-360	23062-23070	amygdala	_	
47-361	23071-23077	within	_	
47-362	23078-23081	the	_	
47-363	23082-23085	ASN	_	
47-364	23085-23086	.	_	
47-365	23087-23090	The	_	
47-366	23091-23099	amygdala	_	
47-367	23100-23102	is	_	
47-368	23103-23110	thought	_	
47-369	23111-23113	to	_	
47-370	23114-23123	primarily	_	
47-371	23124-23134	contribute	_	
47-372	23135-23137	to	_	
47-373	23138-23141	the	_	
47-374	23142-23153	acquisition	_	
47-375	23153-23154	,	_	
47-376	23155-23168	consolidation	_	
47-377	23168-23169	,	_	
47-378	23170-23173	and	_	
47-379	23174-23184	expression	_	
47-380	23185-23187	of	_	
47-381	23188-23196	learning	_	
47-382	23197-23199	of	_	
47-383	23200-23203	the	_	
47-384	23204-23216	drug-related	_	
47-385	23217-23221	cues	_	
47-386	23222-23226	that	_	
47-387	23227-23232	drive	_	
47-388	23233-23240	relapse	_	
47-389	23241-23243	to	_	
47-390	23244-23256	drug-seeking	_	
47-391	23257-23266	behaviors	_	
47-392	23266-23267	.	_	
47-393	23268-23272	This	_	
47-394	23273-23277	area	_	
47-395	23278-23280	is	_	
47-396	23281-23285	also	_	
47-397	23286-23294	robustly	_	
47-398	23295-23304	activated	_	
47-399	23305-23310	under	_	
47-400	23311-23323	drug-related	_	
47-401	23324-23328	cues	_	
47-402	23328-23329	,	_	
47-403	23330-23333	and	_	
47-404	23334-23337	was	_	
47-405	23338-23343	found	_	
47-406	23344-23346	to	_	
47-407	23347-23354	exhibit	_	
47-408	23355-23361	robust	_	
47-409	23362-23375	resting-state	_	
47-410	23376-23378	FC	_	
47-411	23379-23383	with	_	
47-412	23384-23393	affective	_	
47-413	23394-23399	brain	_	
47-414	23400-23405	areas	_	
47-415	23406-23415	including	_	
47-416	23416-23419	OFC	_	
47-417	23419-23420	.	_	
47-418	23421-23424	Our	_	
47-419	23425-23432	finding	_	
47-420	23433-23435	of	_	
47-421	23436-23444	enhanced	_	
47-422	23445-23447	FC	_	
47-423	23448-23450	in	_	
47-424	23451-23454	the	_	
47-425	23455-23463	amygdala	_	
47-426	23464-23467	may	_	
47-427	23468-23470	be	_	
47-428	23471-23479	relevant	_	
47-429	23480-23482	to	_	
47-430	23483-23491	previous	_	
47-431	23492-23499	studies	_	
47-432	23500-23504	that	_	
47-433	23505-23509	have	_	
47-434	23510-23522	demonstrated	_	
47-435	23523-23526	the	_	
47-436	23527-23538	involvement	_	
47-437	23539-23541	of	_	
47-438	23542-23547	these	_	
47-439	23548-23553	areas	_	
47-440	23554-23556	in	_	
47-441	23557-23560	the	_	
47-442	23561-23570	pathology	_	
47-443	23571-23573	of	_	
47-444	23574-23583	addiction	_	
47-445	23583-23584	.	_	
47-446	23585-23588	The	_	
47-447	23589-23593	next	_	
47-448	23594-23600	system	_	
47-449	23601-23611	implicated	_	
47-450	23612-23614	in	_	
47-451	23615-23624	addiction	_	
47-452	23625-23627	is	_	
47-453	23628-23629	“	_	
47-454	23629-23639	reflective	_	
47-455	23639-23640	”	_	
47-456	23641-23647	system	_	
47-457	23648-23653	which	_	
47-458	23654-23662	contains	_	
47-459	23663-23668	three	_	
47-460	23669-23677	networks	_	
47-461	23678-23680	in	_	
47-462	23681-23684	our	_	
47-463	23685-23690	study	_	
47-464	23690-23691	:	_	
47-465	23692-23696	OFCN	_	
47-466	23696-23697	,	_	
47-467	23698-23702	LECN	_	
47-468	23703-23706	and	_	
47-469	23707-23711	RECN	_	
47-470	23711-23712	.	_	
47-471	23713-23716	Our	_	
47-472	23717-23725	findings	_	
47-473	23726-23734	indicate	_	
47-474	23735-23742	greater	_	
47-475	23743-23757	within-network	_	
47-476	23758-23760	FC	_	
47-477	23761-23767	within	_	
47-478	23768-23771	the	_	
47-479	23772-23776	OFCN	_	
47-480	23777-23779	in	_	
47-481	23780-23782	AD	_	
47-482	23783-23791	relative	_	
47-483	23792-23794	to	_	
47-484	23795-23797	HC	_	
47-485	23797-23798	.	_	
47-486	23799-23802	The	_	
47-487	23803-23806	OFC	_	
47-488	23807-23810	and	_	
47-489	23811-23815	MPFC	_	
47-490	23816-23819	are	_	
47-491	23820-23825	major	_	
47-492	23826-23831	areas	_	
47-493	23832-23834	of	_	
47-494	23835-23845	motivation	_	
47-495	23845-23846	,	_	
47-496	23847-23852	drive	_	
47-497	23852-23853	,	_	
47-498	23854-23857	and	_	
47-499	23858-23866	salience	_	
47-500	23867-23877	evaluation	_	
47-501	23877-23878	,	_	
47-502	23879-23884	which	_	
47-503	23885-23888	are	_	
47-504	23889-23897	impaired	_	
47-505	23898-23900	in	_	
47-506	23901-23905	drug	_	
47-507	23906-23913	addicts	_	
47-508	23914-23917	and	_	
47-509	23918-23922	play	_	
47-510	23923-23925	an	_	
47-511	23926-23935	important	_	
47-512	23936-23940	role	_	
47-513	23941-23943	in	_	
47-514	23944-23947	the	_	
47-515	23948-23954	output	_	
47-516	23955-23957	of	_	
47-517	23958-23968	compulsive	_	
47-518	23969-23981	drug-seeking	_	
47-519	23982-23991	behaviors	_	
47-520	23991-23992	.	_	
47-521	23993-24000	Studies	_	
47-522	24001-24005	have	_	
47-523	24006-24011	shown	_	
47-524	24012-24020	enhanced	_	
47-525	24021-24031	activation	_	
47-526	24032-24034	in	_	
47-527	24035-24043	specific	_	
47-528	24044-24061	mesocorticolimbic	_	
47-529	24062-24070	dopamine	_	
47-530	24071-24077	system	_	
47-531	24078-24083	areas	_	
47-532	24084-24093	including	_	
47-533	24094-24097	OFC	_	
47-534	24098-24100	in	_	
47-535	24101-24112	alcohol-cue	_	
47-536	24113-24121	exposure	_	
47-537	24121-24122	.	_	
47-538	24123-24125	In	_	
47-539	24126-24129	the	_	
47-540	24130-24137	present	_	
47-541	24138-24143	study	_	
47-542	24143-24144	,	_	
47-543	24145-24158	significantly	_	
47-544	24159-24168	increased	_	
47-545	24169-24182	resting-state	_	
47-546	24183-24185	FC	_	
47-547	24186-24189	was	_	
47-548	24190-24195	found	_	
47-549	24195-24196	,	_	
47-550	24197-24207	consistent	_	
47-551	24208-24212	with	_	
47-552	24213-24216	the	_	
47-553	24217-24225	previous	_	
47-554	24226-24233	results	_	
47-555	24233-24234	.	_	
47-556	24235-24238	The	_	
47-557	24239-24242	ECN	_	
47-558	24243-24249	serves	_	
47-559	24250-24251	a	_	
47-560	24252-24256	wide	_	
47-561	24257-24262	range	_	
47-562	24263-24265	of	_	
47-563	24266-24275	cognitive	_	
47-564	24276-24283	control	_	
47-565	24284-24293	functions	_	
47-566	24293-24294	.	_	
47-567	24295-24298	The	_	
47-568	24299-24309	prefrontal	_	
47-569	24310-24316	cortex	_	
47-570	24317-24319	is	_	
47-571	24320-24329	important	_	
47-572	24330-24333	for	_	
47-573	24334-24349	decision-making	_	
47-574	24349-24350	,	_	
47-575	24351-24361	inhibitory	_	
47-576	24362-24369	control	_	
47-577	24370-24373	and	_	
47-578	24374-24388	self-awareness	_	
47-579	24388-24389	,	_	
47-580	24390-24393	and	_	
47-581	24394-24396	it	_	
47-582	24397-24400	may	_	
47-583	24401-24407	become	_	
47-584	24408-24418	hypoactive	_	
47-585	24419-24421	in	_	
47-586	24422-24428	states	_	
47-587	24429-24431	of	_	
47-588	24432-24441	addiction	_	
47-589	24441-24442	.	_	
47-590	24443-24446	The	_	
47-591	24447-24450	ECN	_	
47-592	24451-24456	might	_	
47-593	24457-24459	be	_	
47-594	24460-24466	viewed	_	
47-595	24467-24469	as	_	
47-596	24470-24482	particularly	_	
47-597	24483-24492	pertinent	_	
47-598	24493-24495	to	_	
47-599	24496-24499	the	_	
47-600	24500-24505	field	_	
47-601	24506-24508	of	_	
47-602	24509-24518	substance	_	
47-603	24519-24529	dependence	_	
47-604	24530-24535	since	_	
47-605	24536-24538	it	_	
47-606	24539-24541	is	_	
47-607	24542-24549	thought	_	
47-608	24550-24552	to	_	
47-609	24553-24555	be	_	
47-610	24556-24564	involved	_	
47-611	24565-24567	in	_	
47-612	24568-24581	goal-directed	_	
47-613	24582-24590	behavior	_	
47-614	24591-24594	and	_	
47-615	24595-24604	cognitive	_	
47-616	24605-24612	control	_	
47-617	24612-24613	.	_	
47-618	24614-24617	The	_	
47-619	24618-24627	increased	_	
47-620	24628-24638	motivation	_	
47-621	24639-24641	to	_	
47-622	24642-24646	find	_	
47-623	24647-24650	and	_	
47-624	24651-24654	use	_	
47-625	24655-24660	drugs	_	
47-626	24661-24669	combined	_	
47-627	24670-24674	with	_	
47-628	24675-24677	an	_	
47-629	24678-24687	inability	_	
47-630	24688-24690	to	_	
47-631	24691-24698	inhibit	_	
47-632	24699-24711	drug-related	_	
47-633	24712-24721	behaviors	_	
47-634	24722-24724	is	_	
47-635	24725-24732	thought	_	
47-636	24733-24735	to	_	
47-637	24736-24745	represent	_	
47-638	24746-24747	a	_	
47-639	24748-24755	failure	_	
47-640	24756-24758	of	_	
47-641	24759-24768	executive	_	
47-642	24769-24776	control	_	
47-643	24776-24777	.	_	
47-644	24778-24785	Resting	_	
47-645	24786-24791	state	_	
47-646	24792-24799	studies	_	
47-647	24800-24804	have	_	
47-648	24805-24815	identified	_	
47-649	24816-24820	that	_	
47-650	24821-24825	this	_	
47-651	24826-24833	network	_	
47-652	24834-24842	operates	_	
47-653	24843-24845	in	_	
47-654	24846-24847	a	_	
47-655	24848-24859	lateralized	_	
47-656	24860-24866	manner	_	
47-657	24866-24867	.	_	
47-658	24868-24875	Studies	_	
47-659	24876-24880	have	_	
47-660	24881-24886	shown	_	
47-661	24887-24891	that	_	
47-662	24892-24903	Individuals	_	
47-663	24904-24908	with	_	
47-664	24909-24913	drug	_	
47-665	24914-24924	addictions	_	
47-666	24925-24929	have	_	
47-667	24930-24939	increased	_	
47-668	24940-24951	willingness	_	
47-669	24952-24954	to	_	
47-670	24955-24963	approach	_	
47-671	24964-24971	rewards	_	
47-672	24971-24972	.	_	
47-673	24973-24981	Approach	_	
47-674	24982-24991	behaviors	_	
47-675	24992-24995	are	_	
47-676	24996-25003	thought	_	
47-677	25004-25006	to	_	
47-678	25007-25014	involve	_	
47-679	25015-25024	executive	_	
47-680	25025-25032	control	_	
47-681	25033-25042	processes	_	
47-682	25042-25043	,	_	
47-683	25044-25047	and	_	
47-684	25048-25052	left	_	
47-685	25053-25063	prefrontal	_	
47-686	25064-25070	cortex	_	
47-687	25071-25073	is	_	
47-688	25074-25079	known	_	
47-689	25080-25082	to	_	
47-690	25083-25085	be	_	
47-691	25086-25090	more	_	
47-692	25091-25099	strongly	_	
47-693	25100-25108	involved	_	
47-694	25109-25111	in	_	
47-695	25112-25120	approach	_	
47-696	25121-25130	behaviors	_	
47-697	25131-25139	compared	_	
47-698	25140-25142	to	_	
47-699	25143-25148	right	_	
47-700	25149-25159	prefrontal	_	
47-701	25160-25166	cortex	_	
47-702	25166-25167	.	_	
47-703	25168-25175	Studies	_	
47-704	25176-25180	also	_	
47-705	25181-25188	suggest	_	
47-706	25189-25193	that	_	
47-707	25194-25197	the	_	
47-708	25198-25202	RECN	_	
47-709	25203-25206	was	_	
47-710	25207-25211	more	_	
47-711	25212-25220	strongly	_	
47-712	25221-25231	associated	_	
47-713	25232-25236	with	_	
47-714	25237-25246	avoidance	_	
47-715	25246-25247	.	_	
47-716	25248-25255	Compare	_	
47-717	25256-25258	to	_	
47-718	25259-25261	HC	_	
47-719	25261-25262	,	_	
47-720	25263-25266	our	_	
47-721	25267-25274	results	_	
47-722	25275-25281	showed	_	
47-723	25282-25286	that	_	
47-724	25287-25289	AD	_	
47-725	25290-25299	exhibited	_	
47-726	25300-25307	greater	_	
47-727	25308-25310	FC	_	
47-728	25311-25317	within	_	
47-729	25318-25321	the	_	
47-730	25322-25326	LECN	_	
47-731	25326-25327	,	_	
47-732	25328-25331	but	_	
47-733	25332-25337	there	_	
47-734	25338-25341	was	_	
47-735	25342-25344	no	_	
47-736	25345-25356	significant	_	
47-737	25357-25367	difference	_	
47-738	25368-25375	between	_	
47-739	25376-25378	AD	_	
47-740	25379-25382	and	_	
47-741	25383-25385	HC	_	
47-742	25386-25388	in	_	
47-743	25389-25394	terms	_	
47-744	25395-25397	of	_	
47-745	25398-25400	FC	_	
47-746	25401-25407	within	_	
47-747	25408-25411	the	_	
47-748	25412-25416	RECN	_	
47-749	25416-25417	.	_	
47-750	25418-25425	Studies	_	
47-751	25426-25430	have	_	
47-752	25431-25436	shown	_	
47-753	25437-25446	substance	_	
47-754	25447-25456	dependent	_	
47-755	25457-25468	individuals	_	
47-756	25469-25473	have	_	
47-757	25474-25481	greater	_	
47-758	25482-25486	left	_	
47-759	25487-25497	hemisphere	_	
47-760	25498-25510	connectivity	_	
47-761	25511-25513	in	_	
47-762	25514-25517	the	_	
47-763	25518-25522	LECN	_	
47-764	25523-25525	at	_	
47-765	25526-25530	rest	_	
47-766	25530-25531	.	_	
47-767	25532-25535	The	_	
47-768	25536-25544	enhanced	_	
47-769	25545-25547	FC	_	
47-770	25548-25554	within	_	
47-771	25555-25559	LECN	_	
47-772	25560-25562	we	_	
47-773	25563-25568	found	_	
47-774	25569-25571	in	_	
47-775	25572-25575	our	_	
47-776	25576-25583	results	_	
47-777	25584-25589	might	_	
47-778	25590-25597	further	_	
47-779	25598-25605	support	_	
47-780	25606-25609	the	_	
47-781	25610-25614	role	_	
47-782	25615-25617	of	_	
47-783	25618-25622	LECN	_	
47-784	25623-25625	in	_	
47-785	25626-25637	willingness	_	
47-786	25638-25640	to	_	
47-787	25641-25649	approach	_	
47-788	25650-25657	rewards	_	
47-789	25657-25658	.	_	

#Text=SN plays a key function in addiction disorders that integrate incentive salience with cognitive control and decision-making processes. Specifically, the dorsal posterior insula cortex is known to represent the actual bodily changes associated with changes in motivational states and the anterior insula proposed to associate with affective and cognitive processes, and mediate subjective awareness of the craving states. In this study, we found enhanced within-network FC in bilateral anterior insula and right posterior insula in AD. This may reflect the changes of motivational states as well as the subjective awareness of the craving state in AD. We also found enhanced between-network coupling among SN, ASN and ECN. This may provide some evidence that these three networks were working together to compensate the compromised functionality caused by structural damage of alcohol. However, the FC only reflects the temporal correlations between regions, and on its face value it does not provide any direct information how these correlations are mediated. How these three systems interacted with each other was still unknown. Further studies and analyses such as mediation analysis on these three systems as well as DTI data to provide more detailed information about structural connectivity are needed to test the hypothesis proposed by Noël et al. that the insula would modulate the dynamics between the impulsive system and reflective system.
48-1	25659-25661	SN	_	
48-2	25662-25667	plays	_	
48-3	25668-25669	a	_	
48-4	25670-25673	key	_	
48-5	25674-25682	function	_	
48-6	25683-25685	in	_	
48-7	25686-25695	addiction	_	
48-8	25696-25705	disorders	_	
48-9	25706-25710	that	_	
48-10	25711-25720	integrate	_	
48-11	25721-25730	incentive	_	
48-12	25731-25739	salience	_	
48-13	25740-25744	with	_	
48-14	25745-25754	cognitive	_	
48-15	25755-25762	control	_	
48-16	25763-25766	and	_	
48-17	25767-25782	decision-making	_	
48-18	25783-25792	processes	_	
48-19	25792-25793	.	_	
48-20	25794-25806	Specifically	_	
48-21	25806-25807	,	_	
48-22	25808-25811	the	_	
48-23	25812-25818	dorsal	_	
48-24	25819-25828	posterior	_	
48-25	25829-25835	insula	_	
48-26	25836-25842	cortex	_	
48-27	25843-25845	is	_	
48-28	25846-25851	known	_	
48-29	25852-25854	to	_	
48-30	25855-25864	represent	_	
48-31	25865-25868	the	_	
48-32	25869-25875	actual	_	
48-33	25876-25882	bodily	_	
48-34	25883-25890	changes	_	
48-35	25891-25901	associated	_	
48-36	25902-25906	with	_	
48-37	25907-25914	changes	_	
48-38	25915-25917	in	_	
48-39	25918-25930	motivational	_	
48-40	25931-25937	states	_	
48-41	25938-25941	and	_	
48-42	25942-25945	the	_	
48-43	25946-25954	anterior	_	
48-44	25955-25961	insula	_	
48-45	25962-25970	proposed	_	
48-46	25971-25973	to	_	
48-47	25974-25983	associate	_	
48-48	25984-25988	with	_	
48-49	25989-25998	affective	_	
48-50	25999-26002	and	_	
48-51	26003-26012	cognitive	_	
48-52	26013-26022	processes	_	
48-53	26022-26023	,	_	
48-54	26024-26027	and	_	
48-55	26028-26035	mediate	_	
48-56	26036-26046	subjective	_	
48-57	26047-26056	awareness	_	
48-58	26057-26059	of	_	
48-59	26060-26063	the	_	
48-60	26064-26071	craving	_	
48-61	26072-26078	states	_	
48-62	26078-26079	.	_	
48-63	26080-26082	In	_	
48-64	26083-26087	this	_	
48-65	26088-26093	study	_	
48-66	26093-26094	,	_	
48-67	26095-26097	we	_	
48-68	26098-26103	found	_	
48-69	26104-26112	enhanced	_	
48-70	26113-26127	within-network	_	
48-71	26128-26130	FC	_	
48-72	26131-26133	in	_	
48-73	26134-26143	bilateral	_	
48-74	26144-26152	anterior	_	
48-75	26153-26159	insula	_	
48-76	26160-26163	and	_	
48-77	26164-26169	right	_	
48-78	26170-26179	posterior	_	
48-79	26180-26186	insula	_	
48-80	26187-26189	in	_	
48-81	26190-26192	AD	_	
48-82	26192-26193	.	_	
48-83	26194-26198	This	_	
48-84	26199-26202	may	_	
48-85	26203-26210	reflect	_	
48-86	26211-26214	the	_	
48-87	26215-26222	changes	_	
48-88	26223-26225	of	_	
48-89	26226-26238	motivational	_	
48-90	26239-26245	states	_	
48-91	26246-26248	as	_	
48-92	26249-26253	well	_	
48-93	26254-26256	as	_	
48-94	26257-26260	the	_	
48-95	26261-26271	subjective	_	
48-96	26272-26281	awareness	_	
48-97	26282-26284	of	_	
48-98	26285-26288	the	_	
48-99	26289-26296	craving	_	
48-100	26297-26302	state	_	
48-101	26303-26305	in	_	
48-102	26306-26308	AD	_	
48-103	26308-26309	.	_	
48-104	26310-26312	We	_	
48-105	26313-26317	also	_	
48-106	26318-26323	found	_	
48-107	26324-26332	enhanced	_	
48-108	26333-26348	between-network	_	
48-109	26349-26357	coupling	_	
48-110	26358-26363	among	_	
48-111	26364-26366	SN	_	
48-112	26366-26367	,	_	
48-113	26368-26371	ASN	_	
48-114	26372-26375	and	_	
48-115	26376-26379	ECN	_	
48-116	26379-26380	.	_	
48-117	26381-26385	This	_	
48-118	26386-26389	may	_	
48-119	26390-26397	provide	_	
48-120	26398-26402	some	_	
48-121	26403-26411	evidence	_	
48-122	26412-26416	that	_	
48-123	26417-26422	these	_	
48-124	26423-26428	three	_	
48-125	26429-26437	networks	_	
48-126	26438-26442	were	_	
48-127	26443-26450	working	_	
48-128	26451-26459	together	_	
48-129	26460-26462	to	_	
48-130	26463-26473	compensate	_	
48-131	26474-26477	the	_	
48-132	26478-26489	compromised	_	
48-133	26490-26503	functionality	_	
48-134	26504-26510	caused	_	
48-135	26511-26513	by	_	
48-136	26514-26524	structural	_	
48-137	26525-26531	damage	_	
48-138	26532-26534	of	_	
48-139	26535-26542	alcohol	_	
48-140	26542-26543	.	_	
48-141	26544-26551	However	_	
48-142	26551-26552	,	_	
48-143	26553-26556	the	_	
48-144	26557-26559	FC	_	
48-145	26560-26564	only	_	
48-146	26565-26573	reflects	_	
48-147	26574-26577	the	_	
48-148	26578-26586	temporal	_	
48-149	26587-26599	correlations	_	
48-150	26600-26607	between	_	
48-151	26608-26615	regions	_	
48-152	26615-26616	,	_	
48-153	26617-26620	and	_	
48-154	26621-26623	on	_	
48-155	26624-26627	its	_	
48-156	26628-26632	face	_	
48-157	26633-26638	value	_	
48-158	26639-26641	it	_	
48-159	26642-26646	does	_	
48-160	26647-26650	not	_	
48-161	26651-26658	provide	_	
48-162	26659-26662	any	_	
48-163	26663-26669	direct	_	
48-164	26670-26681	information	_	
48-165	26682-26685	how	_	
48-166	26686-26691	these	_	
48-167	26692-26704	correlations	_	
48-168	26705-26708	are	_	
48-169	26709-26717	mediated	_	
48-170	26717-26718	.	_	
48-171	26719-26722	How	_	
48-172	26723-26728	these	_	
48-173	26729-26734	three	_	
48-174	26735-26742	systems	_	
48-175	26743-26753	interacted	_	
48-176	26754-26758	with	_	
48-177	26759-26763	each	_	
48-178	26764-26769	other	_	
48-179	26770-26773	was	_	
48-180	26774-26779	still	_	
48-181	26780-26787	unknown	_	
48-182	26787-26788	.	_	
48-183	26789-26796	Further	_	
48-184	26797-26804	studies	_	
48-185	26805-26808	and	_	
48-186	26809-26817	analyses	_	
48-187	26818-26822	such	_	
48-188	26823-26825	as	_	
48-189	26826-26835	mediation	_	
48-190	26836-26844	analysis	_	
48-191	26845-26847	on	_	
48-192	26848-26853	these	_	
48-193	26854-26859	three	_	
48-194	26860-26867	systems	_	
48-195	26868-26870	as	_	
48-196	26871-26875	well	_	
48-197	26876-26878	as	_	
48-198	26879-26882	DTI	_	
48-199	26883-26887	data	_	
48-200	26888-26890	to	_	
48-201	26891-26898	provide	_	
48-202	26899-26903	more	_	
48-203	26904-26912	detailed	_	
48-204	26913-26924	information	_	
48-205	26925-26930	about	_	
48-206	26931-26941	structural	_	
48-207	26942-26954	connectivity	_	
48-208	26955-26958	are	_	
48-209	26959-26965	needed	_	
48-210	26966-26968	to	_	
48-211	26969-26973	test	_	
48-212	26974-26977	the	_	
48-213	26978-26988	hypothesis	_	
48-214	26989-26997	proposed	_	
48-215	26998-27000	by	_	
48-216	27001-27005	Noël	_	
48-217	27006-27008	et	_	
48-218	27009-27011	al	_	
48-219	27011-27012	.	_	
48-220	27013-27017	that	_	
48-221	27018-27021	the	_	
48-222	27022-27028	insula	_	
48-223	27029-27034	would	_	
48-224	27035-27043	modulate	_	
48-225	27044-27047	the	_	
48-226	27048-27056	dynamics	_	
48-227	27057-27064	between	_	
48-228	27065-27068	the	_	
48-229	27069-27078	impulsive	_	
48-230	27079-27085	system	_	
48-231	27086-27089	and	_	
48-232	27090-27100	reflective	_	
48-233	27101-27107	system	_	
48-234	27107-27108	.	_	

#Text=Connectivity of DMN has been linked to the core processes of human cognition, including mind-wandering and self-monitoring, the integration of cognitive and emotional processing, and introspective thoughts. As we hypothesized, compared with controls, AD showed increased FC in our study in brain regions including the PCC within the p-DMN, impairment of which is prevalent in alcohol addiction. In this study, we also found increased FC in ACC within a-DMN which has been known as an important region in cognitive control and error monitoring. This result may underline addiction-related impairment of cognitive control. Task-based fMRI studies have shown that impaired suppression of the DMN is related to poor cognitive performance such as memory formation and compromised learning of cognitive skill. Thus, a failure in this suppression would lead to a cognitive challenge. Our results showed overall impaired DMN connectivity which may indicate the compromised suppression detected in AD.
49-1	27109-27121	Connectivity	_	
49-2	27122-27124	of	_	
49-3	27125-27128	DMN	_	
49-4	27129-27132	has	_	
49-5	27133-27137	been	_	
49-6	27138-27144	linked	_	
49-7	27145-27147	to	_	
49-8	27148-27151	the	_	
49-9	27152-27156	core	_	
49-10	27157-27166	processes	_	
49-11	27167-27169	of	_	
49-12	27170-27175	human	_	
49-13	27176-27185	cognition	_	
49-14	27185-27186	,	_	
49-15	27187-27196	including	_	
49-16	27197-27211	mind-wandering	_	
49-17	27212-27215	and	_	
49-18	27216-27231	self-monitoring	_	
49-19	27231-27232	,	_	
49-20	27233-27236	the	_	
49-21	27237-27248	integration	_	
49-22	27249-27251	of	_	
49-23	27252-27261	cognitive	_	
49-24	27262-27265	and	_	
49-25	27266-27275	emotional	_	
49-26	27276-27286	processing	_	
49-27	27286-27287	,	_	
49-28	27288-27291	and	_	
49-29	27292-27305	introspective	_	
49-30	27306-27314	thoughts	_	
49-31	27314-27315	.	_	
49-32	27316-27318	As	_	
49-33	27319-27321	we	_	
49-34	27322-27334	hypothesized	_	
49-35	27334-27335	,	_	
49-36	27336-27344	compared	_	
49-37	27345-27349	with	_	
49-38	27350-27358	controls	_	
49-39	27358-27359	,	_	
49-40	27360-27362	AD	_	
49-41	27363-27369	showed	_	
49-42	27370-27379	increased	_	
49-43	27380-27382	FC	_	
49-44	27383-27385	in	_	
49-45	27386-27389	our	_	
49-46	27390-27395	study	_	
49-47	27396-27398	in	_	
49-48	27399-27404	brain	_	
49-49	27405-27412	regions	_	
49-50	27413-27422	including	_	
49-51	27423-27426	the	_	
49-52	27427-27430	PCC	_	
49-53	27431-27437	within	_	
49-54	27438-27441	the	_	
49-55	27442-27447	p-DMN	_	
49-56	27447-27448	,	_	
49-57	27449-27459	impairment	_	
49-58	27460-27462	of	_	
49-59	27463-27468	which	_	
49-60	27469-27471	is	_	
49-61	27472-27481	prevalent	_	
49-62	27482-27484	in	_	
49-63	27485-27492	alcohol	_	
49-64	27493-27502	addiction	_	
49-65	27502-27503	.	_	
49-66	27504-27506	In	_	
49-67	27507-27511	this	_	
49-68	27512-27517	study	_	
49-69	27517-27518	,	_	
49-70	27519-27521	we	_	
49-71	27522-27526	also	_	
49-72	27527-27532	found	_	
49-73	27533-27542	increased	_	
49-74	27543-27545	FC	_	
49-75	27546-27548	in	_	
49-76	27549-27552	ACC	_	
49-77	27553-27559	within	_	
49-78	27560-27565	a-DMN	_	
49-79	27566-27571	which	_	
49-80	27572-27575	has	_	
49-81	27576-27580	been	_	
49-82	27581-27586	known	_	
49-83	27587-27589	as	_	
49-84	27590-27592	an	_	
49-85	27593-27602	important	_	
49-86	27603-27609	region	_	
49-87	27610-27612	in	_	
49-88	27613-27622	cognitive	_	
49-89	27623-27630	control	_	
49-90	27631-27634	and	_	
49-91	27635-27640	error	_	
49-92	27641-27651	monitoring	_	
49-93	27651-27652	.	_	
49-94	27653-27657	This	_	
49-95	27658-27664	result	_	
49-96	27665-27668	may	_	
49-97	27669-27678	underline	_	
49-98	27679-27696	addiction-related	_	
49-99	27697-27707	impairment	_	
49-100	27708-27710	of	_	
49-101	27711-27720	cognitive	_	
49-102	27721-27728	control	_	
49-103	27728-27729	.	_	
49-104	27730-27740	Task-based	_	
49-105	27741-27745	fMRI	_	
49-106	27746-27753	studies	_	
49-107	27754-27758	have	_	
49-108	27759-27764	shown	_	
49-109	27765-27769	that	_	
49-110	27770-27778	impaired	_	
49-111	27779-27790	suppression	_	
49-112	27791-27793	of	_	
49-113	27794-27797	the	_	
49-114	27798-27801	DMN	_	
49-115	27802-27804	is	_	
49-116	27805-27812	related	_	
49-117	27813-27815	to	_	
49-118	27816-27820	poor	_	
49-119	27821-27830	cognitive	_	
49-120	27831-27842	performance	_	
49-121	27843-27847	such	_	
49-122	27848-27850	as	_	
49-123	27851-27857	memory	_	
49-124	27858-27867	formation	_	
49-125	27868-27871	and	_	
49-126	27872-27883	compromised	_	
49-127	27884-27892	learning	_	
49-128	27893-27895	of	_	
49-129	27896-27905	cognitive	_	
49-130	27906-27911	skill	_	
49-131	27911-27912	.	_	
49-132	27913-27917	Thus	_	
49-133	27917-27918	,	_	
49-134	27919-27920	a	_	
49-135	27921-27928	failure	_	
49-136	27929-27931	in	_	
49-137	27932-27936	this	_	
49-138	27937-27948	suppression	_	
49-139	27949-27954	would	_	
49-140	27955-27959	lead	_	
49-141	27960-27962	to	_	
49-142	27963-27964	a	_	
49-143	27965-27974	cognitive	_	
49-144	27975-27984	challenge	_	
49-145	27984-27985	.	_	
49-146	27986-27989	Our	_	
49-147	27990-27997	results	_	
49-148	27998-28004	showed	_	
49-149	28005-28012	overall	_	
49-150	28013-28021	impaired	_	
49-151	28022-28025	DMN	_	
49-152	28026-28038	connectivity	_	
49-153	28039-28044	which	_	
49-154	28045-28048	may	_	
49-155	28049-28057	indicate	_	
49-156	28058-28061	the	_	
49-157	28062-28073	compromised	_	
49-158	28074-28085	suppression	_	
49-159	28086-28094	detected	_	
49-160	28095-28097	in	_	
49-161	28098-28100	AD	_	
49-162	28100-28101	.	_	

#Text=A better understanding of the distinct neural mechanisms underlying alcohol-related impairments and their relationships with clinical and outcome measures may help in determining the pathophysiology of alcoholism and lead to the development of improved treatment strategies. In our study, we examined the correlation of both within-network and between-network coupling and two dimensions of impulsivity. One is trait-impulsivity measured by BIS-11 and UPPS. Studies have shown that BIS-11 and UPPS cover different aspects of impulsivity. The other one is choice impulsivity which was measured by the DDT.
50-1	28102-28103	A	_	
50-2	28104-28110	better	_	
50-3	28111-28124	understanding	_	
50-4	28125-28127	of	_	
50-5	28128-28131	the	_	
50-6	28132-28140	distinct	_	
50-7	28141-28147	neural	_	
50-8	28148-28158	mechanisms	_	
50-9	28159-28169	underlying	_	
50-10	28170-28185	alcohol-related	_	
50-11	28186-28197	impairments	_	
50-12	28198-28201	and	_	
50-13	28202-28207	their	_	
50-14	28208-28221	relationships	_	
50-15	28222-28226	with	_	
50-16	28227-28235	clinical	_	
50-17	28236-28239	and	_	
50-18	28240-28247	outcome	_	
50-19	28248-28256	measures	_	
50-20	28257-28260	may	_	
50-21	28261-28265	help	_	
50-22	28266-28268	in	_	
50-23	28269-28280	determining	_	
50-24	28281-28284	the	_	
50-25	28285-28300	pathophysiology	_	
50-26	28301-28303	of	_	
50-27	28304-28314	alcoholism	_	
50-28	28315-28318	and	_	
50-29	28319-28323	lead	_	
50-30	28324-28326	to	_	
50-31	28327-28330	the	_	
50-32	28331-28342	development	_	
50-33	28343-28345	of	_	
50-34	28346-28354	improved	_	
50-35	28355-28364	treatment	_	
50-36	28365-28375	strategies	_	
50-37	28375-28376	.	_	
50-38	28377-28379	In	_	
50-39	28380-28383	our	_	
50-40	28384-28389	study	_	
50-41	28389-28390	,	_	
50-42	28391-28393	we	_	
50-43	28394-28402	examined	_	
50-44	28403-28406	the	_	
50-45	28407-28418	correlation	_	
50-46	28419-28421	of	_	
50-47	28422-28426	both	_	
50-48	28427-28441	within-network	_	
50-49	28442-28445	and	_	
50-50	28446-28461	between-network	_	
50-51	28462-28470	coupling	_	
50-52	28471-28474	and	_	
50-53	28475-28478	two	_	
50-54	28479-28489	dimensions	_	
50-55	28490-28492	of	_	
50-56	28493-28504	impulsivity	_	
50-57	28504-28505	.	_	
50-58	28506-28509	One	_	
50-59	28510-28512	is	_	
50-60	28513-28530	trait-impulsivity	_	
50-61	28531-28539	measured	_	
50-62	28540-28542	by	_	
50-63	28543-28546	BIS	_	
50-64	28546-28547	-	_	
50-65	28547-28549	11	_	
50-66	28550-28553	and	_	
50-67	28554-28558	UPPS	_	
50-68	28558-28559	.	_	
50-69	28560-28567	Studies	_	
50-70	28568-28572	have	_	
50-71	28573-28578	shown	_	
50-72	28579-28583	that	_	
50-73	28584-28587	BIS	_	
50-74	28587-28588	-	_	
50-75	28588-28590	11	_	
50-76	28591-28594	and	_	
50-77	28595-28599	UPPS	_	
50-78	28600-28605	cover	_	
50-79	28606-28615	different	_	
50-80	28616-28623	aspects	_	
50-81	28624-28626	of	_	
50-82	28627-28638	impulsivity	_	
50-83	28638-28639	.	_	
50-84	28640-28643	The	_	
50-85	28644-28649	other	_	
50-86	28650-28653	one	_	
50-87	28654-28656	is	_	
50-88	28657-28663	choice	_	
50-89	28664-28675	impulsivity	_	
50-90	28676-28681	which	_	
50-91	28682-28685	was	_	
50-92	28686-28694	measured	_	
50-93	28695-28697	by	_	
50-94	28698-28701	the	_	
50-95	28702-28705	DDT	_	
50-96	28705-28706	.	_	

#Text=The neural mechanisms in the addicted brain are complex due to the dynamic changes of different regions and their connectivity. Despite this complexity, a simple but key approach models neurocognitive aspects of addiction onto three neural systems and proposes this triadic model as the basis of personalized medicine. A similar approach focusing on impulsivity as an outcome (as measured by the DDT) has been proposed for developing improved prevention and treatment strategies. These approaches center the outcomes as a result of the balance of the Impulsive and reflexive circuits. This Reflexive/Impulsive model has been used for explaining the relationship among RSN. A more complex circuitry that explains the relationship among the RSNs of this reflexive-Impulse system in addiction incorporates not only the connectivity among RSNs but also the connectivity between regions within each RSN. Within this compound framework, we found that the relationship between the networks and their correlations with different measures of impulsivity is even more complex and affecting between-network FC.
51-1	28707-28710	The	_	
51-2	28711-28717	neural	_	
51-3	28718-28728	mechanisms	_	
51-4	28729-28731	in	_	
51-5	28732-28735	the	_	
51-6	28736-28744	addicted	_	
51-7	28745-28750	brain	_	
51-8	28751-28754	are	_	
51-9	28755-28762	complex	_	
51-10	28763-28766	due	_	
51-11	28767-28769	to	_	
51-12	28770-28773	the	_	
51-13	28774-28781	dynamic	_	
51-14	28782-28789	changes	_	
51-15	28790-28792	of	_	
51-16	28793-28802	different	_	
51-17	28803-28810	regions	_	
51-18	28811-28814	and	_	
51-19	28815-28820	their	_	
51-20	28821-28833	connectivity	_	
51-21	28833-28834	.	_	
51-22	28835-28842	Despite	_	
51-23	28843-28847	this	_	
51-24	28848-28858	complexity	_	
51-25	28858-28859	,	_	
51-26	28860-28861	a	_	
51-27	28862-28868	simple	_	
51-28	28869-28872	but	_	
51-29	28873-28876	key	_	
51-30	28877-28885	approach	_	
51-31	28886-28892	models	_	
51-32	28893-28907	neurocognitive	_	
51-33	28908-28915	aspects	_	
51-34	28916-28918	of	_	
51-35	28919-28928	addiction	_	
51-36	28929-28933	onto	_	
51-37	28934-28939	three	_	
51-38	28940-28946	neural	_	
51-39	28947-28954	systems	_	
51-40	28955-28958	and	_	
51-41	28959-28967	proposes	_	
51-42	28968-28972	this	_	
51-43	28973-28980	triadic	_	
51-44	28981-28986	model	_	
51-45	28987-28989	as	_	
51-46	28990-28993	the	_	
51-47	28994-28999	basis	_	
51-48	29000-29002	of	_	
51-49	29003-29015	personalized	_	
51-50	29016-29024	medicine	_	
51-51	29024-29025	.	_	
51-52	29026-29027	A	_	
51-53	29028-29035	similar	_	
51-54	29036-29044	approach	_	
51-55	29045-29053	focusing	_	
51-56	29054-29056	on	_	
51-57	29057-29068	impulsivity	_	
51-58	29069-29071	as	_	
51-59	29072-29074	an	_	
51-60	29075-29082	outcome	_	
51-61	29083-29084	(	_	
51-62	29084-29086	as	_	
51-63	29087-29095	measured	_	
51-64	29096-29098	by	_	
51-65	29099-29102	the	_	
51-66	29103-29106	DDT	_	
51-67	29106-29107	)	_	
51-68	29108-29111	has	_	
51-69	29112-29116	been	_	
51-70	29117-29125	proposed	_	
51-71	29126-29129	for	_	
51-72	29130-29140	developing	_	
51-73	29141-29149	improved	_	
51-74	29150-29160	prevention	_	
51-75	29161-29164	and	_	
51-76	29165-29174	treatment	_	
51-77	29175-29185	strategies	_	
51-78	29185-29186	.	_	
51-79	29187-29192	These	_	
51-80	29193-29203	approaches	_	
51-81	29204-29210	center	_	
51-82	29211-29214	the	_	
51-83	29215-29223	outcomes	_	
51-84	29224-29226	as	_	
51-85	29227-29228	a	_	
51-86	29229-29235	result	_	
51-87	29236-29238	of	_	
51-88	29239-29242	the	_	
51-89	29243-29250	balance	_	
51-90	29251-29253	of	_	
51-91	29254-29257	the	_	
51-92	29258-29267	Impulsive	_	
51-93	29268-29271	and	_	
51-94	29272-29281	reflexive	_	
51-95	29282-29290	circuits	_	
51-96	29290-29291	.	_	
51-97	29292-29296	This	_	
51-98	29297-29306	Reflexive	_	
51-99	29306-29307	/	_	
51-100	29307-29316	Impulsive	_	
51-101	29317-29322	model	_	
51-102	29323-29326	has	_	
51-103	29327-29331	been	_	
51-104	29332-29336	used	_	
51-105	29337-29340	for	_	
51-106	29341-29351	explaining	_	
51-107	29352-29355	the	_	
51-108	29356-29368	relationship	_	
51-109	29369-29374	among	_	
51-110	29375-29378	RSN	_	
51-111	29378-29379	.	_	
51-112	29380-29381	A	_	
51-113	29382-29386	more	_	
51-114	29387-29394	complex	_	
51-115	29395-29404	circuitry	_	
51-116	29405-29409	that	_	
51-117	29410-29418	explains	_	
51-118	29419-29422	the	_	
51-119	29423-29435	relationship	_	
51-120	29436-29441	among	_	
51-121	29442-29445	the	_	
51-122	29446-29450	RSNs	_	
51-123	29451-29453	of	_	
51-124	29454-29458	this	_	
51-125	29459-29476	reflexive-Impulse	_	
51-126	29477-29483	system	_	
51-127	29484-29486	in	_	
51-128	29487-29496	addiction	_	
51-129	29497-29509	incorporates	_	
51-130	29510-29513	not	_	
51-131	29514-29518	only	_	
51-132	29519-29522	the	_	
51-133	29523-29535	connectivity	_	
51-134	29536-29541	among	_	
51-135	29542-29546	RSNs	_	
51-136	29547-29550	but	_	
51-137	29551-29555	also	_	
51-138	29556-29559	the	_	
51-139	29560-29572	connectivity	_	
51-140	29573-29580	between	_	
51-141	29581-29588	regions	_	
51-142	29589-29595	within	_	
51-143	29596-29600	each	_	
51-144	29601-29604	RSN	_	
51-145	29604-29605	.	_	
51-146	29606-29612	Within	_	
51-147	29613-29617	this	_	
51-148	29618-29626	compound	_	
51-149	29627-29636	framework	_	
51-150	29636-29637	,	_	
51-151	29638-29640	we	_	
51-152	29641-29646	found	_	
51-153	29647-29651	that	_	
51-154	29652-29655	the	_	
51-155	29656-29668	relationship	_	
51-156	29669-29676	between	_	
51-157	29677-29680	the	_	
51-158	29681-29689	networks	_	
51-159	29690-29693	and	_	
51-160	29694-29699	their	_	
51-161	29700-29712	correlations	_	
51-162	29713-29717	with	_	
51-163	29718-29727	different	_	
51-164	29728-29736	measures	_	
51-165	29737-29739	of	_	
51-166	29740-29751	impulsivity	_	
51-167	29752-29754	is	_	
51-168	29755-29759	even	_	
51-169	29760-29764	more	_	
51-170	29765-29772	complex	_	
51-171	29773-29776	and	_	
51-172	29777-29786	affecting	_	
51-173	29787-29802	between-network	_	
51-174	29803-29805	FC	_	
51-175	29805-29806	.	_	

#Text=The UPPS-P correlations within RSN’s are for the negative-urgency score in AD subjects where it inversely correlated with the ASN mediated by the left putamen. This shows that the connectivity within the ASN network diminishes in the presence of high negative emotions, which in turn increases impulsivity. In HC, the positive-urgency score correlated negatively with the a-DMN (mediated by the precuneus) suggesting a link between down-regulation of past representations in the precuneus in order to drive the impulsive system. These results suggest that decreased connectivity in the impulsive system and the absence of a healthy down-regulation of the precuneus may weaken the ability to access and control representations of negative consequences, which is the hallmark of addiction behavior.
52-1	29807-29810	The	_	
52-2	29811-29817	UPPS-P	_	
52-3	29818-29830	correlations	_	
52-4	29831-29837	within	_	
52-5	29838-29841	RSN	_	
52-6	29841-29842	’	_	
52-7	29842-29843	s	_	
52-8	29844-29847	are	_	
52-9	29848-29851	for	_	
52-10	29852-29855	the	_	
52-11	29856-29872	negative-urgency	_	
52-12	29873-29878	score	_	
52-13	29879-29881	in	_	
52-14	29882-29884	AD	_	
52-15	29885-29893	subjects	_	
52-16	29894-29899	where	_	
52-17	29900-29902	it	_	
52-18	29903-29912	inversely	_	
52-19	29913-29923	correlated	_	
52-20	29924-29928	with	_	
52-21	29929-29932	the	_	
52-22	29933-29936	ASN	_	
52-23	29937-29945	mediated	_	
52-24	29946-29948	by	_	
52-25	29949-29952	the	_	
52-26	29953-29957	left	_	
52-27	29958-29965	putamen	_	
52-28	29965-29966	.	_	
52-29	29967-29971	This	_	
52-30	29972-29977	shows	_	
52-31	29978-29982	that	_	
52-32	29983-29986	the	_	
52-33	29987-29999	connectivity	_	
52-34	30000-30006	within	_	
52-35	30007-30010	the	_	
52-36	30011-30014	ASN	_	
52-37	30015-30022	network	_	
52-38	30023-30033	diminishes	_	
52-39	30034-30036	in	_	
52-40	30037-30040	the	_	
52-41	30041-30049	presence	_	
52-42	30050-30052	of	_	
52-43	30053-30057	high	_	
52-44	30058-30066	negative	_	
52-45	30067-30075	emotions	_	
52-46	30075-30076	,	_	
52-47	30077-30082	which	_	
52-48	30083-30085	in	_	
52-49	30086-30090	turn	_	
52-50	30091-30100	increases	_	
52-51	30101-30112	impulsivity	_	
52-52	30112-30113	.	_	
52-53	30114-30116	In	_	
52-54	30117-30119	HC	_	
52-55	30119-30120	,	_	
52-56	30121-30124	the	_	
52-57	30125-30141	positive-urgency	_	
52-58	30142-30147	score	_	
52-59	30148-30158	correlated	_	
52-60	30159-30169	negatively	_	
52-61	30170-30174	with	_	
52-62	30175-30178	the	_	
52-63	30179-30184	a-DMN	_	
52-64	30185-30186	(	_	
52-65	30186-30194	mediated	_	
52-66	30195-30197	by	_	
52-67	30198-30201	the	_	
52-68	30202-30211	precuneus	_	
52-69	30211-30212	)	_	
52-70	30213-30223	suggesting	_	
52-71	30224-30225	a	_	
52-72	30226-30230	link	_	
52-73	30231-30238	between	_	
52-74	30239-30254	down-regulation	_	
52-75	30255-30257	of	_	
52-76	30258-30262	past	_	
52-77	30263-30278	representations	_	
52-78	30279-30281	in	_	
52-79	30282-30285	the	_	
52-80	30286-30295	precuneus	_	
52-81	30296-30298	in	_	
52-82	30299-30304	order	_	
52-83	30305-30307	to	_	
52-84	30308-30313	drive	_	
52-85	30314-30317	the	_	
52-86	30318-30327	impulsive	_	
52-87	30328-30334	system	_	
52-88	30334-30335	.	_	
52-89	30336-30341	These	_	
52-90	30342-30349	results	_	
52-91	30350-30357	suggest	_	
52-92	30358-30362	that	_	
52-93	30363-30372	decreased	_	
52-94	30373-30385	connectivity	_	
52-95	30386-30388	in	_	
52-96	30389-30392	the	_	
52-97	30393-30402	impulsive	_	
52-98	30403-30409	system	_	
52-99	30410-30413	and	_	
52-100	30414-30417	the	_	
52-101	30418-30425	absence	_	
52-102	30426-30428	of	_	
52-103	30429-30430	a	_	
52-104	30431-30438	healthy	_	
52-105	30439-30454	down-regulation	_	
52-106	30455-30457	of	_	
52-107	30458-30461	the	_	
52-108	30462-30471	precuneus	_	
52-109	30472-30475	may	_	
52-110	30476-30482	weaken	_	
52-111	30483-30486	the	_	
52-112	30487-30494	ability	_	
52-113	30495-30497	to	_	
52-114	30498-30504	access	_	
52-115	30505-30508	and	_	
52-116	30509-30516	control	_	
52-117	30517-30532	representations	_	
52-118	30533-30535	of	_	
52-119	30536-30544	negative	_	
52-120	30545-30557	consequences	_	
52-121	30557-30558	,	_	
52-122	30559-30564	which	_	
52-123	30565-30567	is	_	
52-124	30568-30571	the	_	
52-125	30572-30580	hallmark	_	
52-126	30581-30583	of	_	
52-127	30584-30593	addiction	_	
52-128	30594-30602	behavior	_	
52-129	30602-30603	.	_	

#Text=Figure 3 shows that in AD, the OFCN between-network connectivity with RECN, aDMN, and pDMN inversely correlate with the negative urgency measure of the UPPS (−). This implies that a weaker OFCN connectivity with the aforementioned networks might be a biomarker for higher impulsivity under intense negative emotional conditions. The DDT was significantly positively correlated with network coupling in AD, forming a closed circuit among the LECN, aDMN, and the SN. This suggests that the choice impulsivity in AD may be due to altered FC among the LECN, aDMN and the SN. This circuit has the potential for being used as a biomarker in the clinical arena. BIS-11 was not significantly correlated with any network coupling in AD or HC.
53-1	30604-30610	Figure	_	
53-2	30611-30612	3	_	
53-3	30613-30618	shows	_	
53-4	30619-30623	that	_	
53-5	30624-30626	in	_	
53-6	30627-30629	AD	_	
53-7	30629-30630	,	_	
53-8	30631-30634	the	_	
53-9	30635-30639	OFCN	_	
53-10	30640-30655	between-network	_	
53-11	30656-30668	connectivity	_	
53-12	30669-30673	with	_	
53-13	30674-30678	RECN	_	
53-14	30678-30679	,	_	
53-15	30680-30684	aDMN	_	
53-16	30684-30685	,	_	
53-17	30686-30689	and	_	
53-18	30690-30694	pDMN	_	
53-19	30695-30704	inversely	_	
53-20	30705-30714	correlate	_	
53-21	30715-30719	with	_	
53-22	30720-30723	the	_	
53-23	30724-30732	negative	_	
53-24	30733-30740	urgency	_	
53-25	30741-30748	measure	_	
53-26	30749-30751	of	_	
53-27	30752-30755	the	_	
53-28	30756-30760	UPPS	_	
53-29	30761-30762	(	_	
53-30	30762-30763	−	_	
53-31	30763-30764	)	_	
53-32	30764-30765	.	_	
53-33	30766-30770	This	_	
53-34	30771-30778	implies	_	
53-35	30779-30783	that	_	
53-36	30784-30785	a	_	
53-37	30786-30792	weaker	_	
53-38	30793-30797	OFCN	_	
53-39	30798-30810	connectivity	_	
53-40	30811-30815	with	_	
53-41	30816-30819	the	_	
53-42	30820-30834	aforementioned	_	
53-43	30835-30843	networks	_	
53-44	30844-30849	might	_	
53-45	30850-30852	be	_	
53-46	30853-30854	a	_	
53-47	30855-30864	biomarker	_	
53-48	30865-30868	for	_	
53-49	30869-30875	higher	_	
53-50	30876-30887	impulsivity	_	
53-51	30888-30893	under	_	
53-52	30894-30901	intense	_	
53-53	30902-30910	negative	_	
53-54	30911-30920	emotional	_	
53-55	30921-30931	conditions	_	
53-56	30931-30932	.	_	
53-57	30933-30936	The	_	
53-58	30937-30940	DDT	_	
53-59	30941-30944	was	_	
53-60	30945-30958	significantly	_	
53-61	30959-30969	positively	_	
53-62	30970-30980	correlated	_	
53-63	30981-30985	with	_	
53-64	30986-30993	network	_	
53-65	30994-31002	coupling	_	
53-66	31003-31005	in	_	
53-67	31006-31008	AD	_	
53-68	31008-31009	,	_	
53-69	31010-31017	forming	_	
53-70	31018-31019	a	_	
53-71	31020-31026	closed	_	
53-72	31027-31034	circuit	_	
53-73	31035-31040	among	_	
53-74	31041-31044	the	_	
53-75	31045-31049	LECN	_	
53-76	31049-31050	,	_	
53-77	31051-31055	aDMN	_	
53-78	31055-31056	,	_	
53-79	31057-31060	and	_	
53-80	31061-31064	the	_	
53-81	31065-31067	SN	_	
53-82	31067-31068	.	_	
53-83	31069-31073	This	_	
53-84	31074-31082	suggests	_	
53-85	31083-31087	that	_	
53-86	31088-31091	the	_	
53-87	31092-31098	choice	_	
53-88	31099-31110	impulsivity	_	
53-89	31111-31113	in	_	
53-90	31114-31116	AD	_	
53-91	31117-31120	may	_	
53-92	31121-31123	be	_	
53-93	31124-31127	due	_	
53-94	31128-31130	to	_	
53-95	31131-31138	altered	_	
53-96	31139-31141	FC	_	
53-97	31142-31147	among	_	
53-98	31148-31151	the	_	
53-99	31152-31156	LECN	_	
53-100	31156-31157	,	_	
53-101	31158-31162	aDMN	_	
53-102	31163-31166	and	_	
53-103	31167-31170	the	_	
53-104	31171-31173	SN	_	
53-105	31173-31174	.	_	
53-106	31175-31179	This	_	
53-107	31180-31187	circuit	_	
53-108	31188-31191	has	_	
53-109	31192-31195	the	_	
53-110	31196-31205	potential	_	
53-111	31206-31209	for	_	
53-112	31210-31215	being	_	
53-113	31216-31220	used	_	
53-114	31221-31223	as	_	
53-115	31224-31225	a	_	
53-116	31226-31235	biomarker	_	
53-117	31236-31238	in	_	
53-118	31239-31242	the	_	
53-119	31243-31251	clinical	_	
53-120	31252-31257	arena	_	
53-121	31257-31258	.	_	
53-122	31259-31262	BIS	_	
53-123	31262-31263	-	_	
53-124	31263-31265	11	_	
53-125	31266-31269	was	_	
53-126	31270-31273	not	_	
53-127	31274-31287	significantly	_	
53-128	31288-31298	correlated	_	
53-129	31299-31303	with	_	
53-130	31304-31307	any	_	
53-131	31308-31315	network	_	
53-132	31316-31324	coupling	_	
53-133	31325-31327	in	_	
53-134	31328-31330	AD	_	
53-135	31331-31333	or	_	
53-136	31334-31336	HC	_	
53-137	31336-31337	.	_	

#Text=Taken together, a compromised within-ASN connectivity together with an altered between-network connectivity among OFCN, ECN and DMN could be used as an intermediate phenotype in alcohol addiction. Further investigation of this possibility is needed.
54-1	31338-31343	Taken	_	
54-2	31344-31352	together	_	
54-3	31352-31353	,	_	
54-4	31354-31355	a	_	
54-5	31356-31367	compromised	_	
54-6	31368-31378	within-ASN	_	
54-7	31379-31391	connectivity	_	
54-8	31392-31400	together	_	
54-9	31401-31405	with	_	
54-10	31406-31408	an	_	
54-11	31409-31416	altered	_	
54-12	31417-31432	between-network	_	
54-13	31433-31445	connectivity	_	
54-14	31446-31451	among	_	
54-15	31452-31456	OFCN	_	
54-16	31456-31457	,	_	
54-17	31458-31461	ECN	_	
54-18	31462-31465	and	_	
54-19	31466-31469	DMN	_	
54-20	31470-31475	could	_	
54-21	31476-31478	be	_	
54-22	31479-31483	used	_	
54-23	31484-31486	as	_	
54-24	31487-31489	an	_	
54-25	31490-31502	intermediate	_	
54-26	31503-31512	phenotype	_	
54-27	31513-31515	in	_	
54-28	31516-31523	alcohol	_	
54-29	31524-31533	addiction	_	
54-30	31533-31534	.	_	
54-31	31535-31542	Further	_	
54-32	31543-31556	investigation	_	
54-33	31557-31559	of	_	
54-34	31560-31564	this	_	
54-35	31565-31576	possibility	_	
54-36	31577-31579	is	_	
54-37	31580-31586	needed	_	
54-38	31586-31587	.	_	

#Text=Conclusion
55-1	31588-31598	Conclusion	_	

#Text=This study provides new insight of whole brain network analysis of AD using data-driven, unbiased search for brain regions showing FC. The results demonstrated altered FC both within- and between-network FC in both “impulsive”, “reflective” systems, SN and DMN in AD, further supporting the concept that AD is a disorder affecting neural networks. We also showed that impaired connectivity in the RSNs was associated with impulsivity in AD. Our finding suggested that the altered RSN connectivity patterns might be used as a potential biomarker to detect subtle brain alterations in AD.
56-1	31599-31603	This	_	
56-2	31604-31609	study	_	
56-3	31610-31618	provides	_	
56-4	31619-31622	new	_	
56-5	31623-31630	insight	_	
56-6	31631-31633	of	_	
56-7	31634-31639	whole	_	
56-8	31640-31645	brain	_	
56-9	31646-31653	network	_	
56-10	31654-31662	analysis	_	
56-11	31663-31665	of	_	
56-12	31666-31668	AD	_	
56-13	31669-31674	using	_	
56-14	31675-31686	data-driven	_	
56-15	31686-31687	,	_	
56-16	31688-31696	unbiased	_	
56-17	31697-31703	search	_	
56-18	31704-31707	for	_	
56-19	31708-31713	brain	_	
56-20	31714-31721	regions	_	
56-21	31722-31729	showing	_	
56-22	31730-31732	FC	_	
56-23	31732-31733	.	_	
56-24	31734-31737	The	_	
56-25	31738-31745	results	_	
56-26	31746-31758	demonstrated	_	
56-27	31759-31766	altered	_	
56-28	31767-31769	FC	_	
56-29	31770-31774	both	_	
56-30	31775-31781	within	_	
56-31	31781-31782	-	_	
56-32	31783-31786	and	_	
56-33	31787-31802	between-network	_	
56-34	31803-31805	FC	_	
56-35	31806-31808	in	_	
56-36	31809-31813	both	_	
56-37	31814-31815	“	_	
56-38	31815-31824	impulsive	_	
56-39	31824-31825	”	_	
56-40	31825-31826	,	_	
56-41	31827-31828	“	_	
56-42	31828-31838	reflective	_	
56-43	31838-31839	”	_	
56-44	31840-31847	systems	_	
56-45	31847-31848	,	_	
56-46	31849-31851	SN	_	
56-47	31852-31855	and	_	
56-48	31856-31859	DMN	_	
56-49	31860-31862	in	_	
56-50	31863-31865	AD	_	
56-51	31865-31866	,	_	
56-52	31867-31874	further	_	
56-53	31875-31885	supporting	_	
56-54	31886-31889	the	_	
56-55	31890-31897	concept	_	
56-56	31898-31902	that	_	
56-57	31903-31905	AD	_	
56-58	31906-31908	is	_	
56-59	31909-31910	a	_	
56-60	31911-31919	disorder	_	
56-61	31920-31929	affecting	_	
56-62	31930-31936	neural	_	
56-63	31937-31945	networks	_	
56-64	31945-31946	.	_	
56-65	31947-31949	We	_	
56-66	31950-31954	also	_	
56-67	31955-31961	showed	_	
56-68	31962-31966	that	_	
56-69	31967-31975	impaired	_	
56-70	31976-31988	connectivity	_	
56-71	31989-31991	in	_	
56-72	31992-31995	the	_	
56-73	31996-32000	RSNs	_	
56-74	32001-32004	was	_	
56-75	32005-32015	associated	_	
56-76	32016-32020	with	_	
56-77	32021-32032	impulsivity	_	
56-78	32033-32035	in	_	
56-79	32036-32038	AD	_	
56-80	32038-32039	.	_	
56-81	32040-32043	Our	_	
56-82	32044-32051	finding	_	
56-83	32052-32061	suggested	_	
56-84	32062-32066	that	_	
56-85	32067-32070	the	_	
56-86	32071-32078	altered	_	
56-87	32079-32082	RSN	_	
56-88	32083-32095	connectivity	_	
56-89	32096-32104	patterns	_	
56-90	32105-32110	might	_	
56-91	32111-32113	be	_	
56-92	32114-32118	used	_	
56-93	32119-32121	as	_	
56-94	32122-32123	a	_	
56-95	32124-32133	potential	_	
56-96	32134-32143	biomarker	_	
56-97	32144-32146	to	_	
56-98	32147-32153	detect	_	
56-99	32154-32160	subtle	_	
56-100	32161-32166	brain	_	
56-101	32167-32178	alterations	_	
56-102	32179-32181	in	_	
56-103	32182-32184	AD	_	
56-104	32184-32185	.	_	

#Text=Limitations
57-1	32186-32197	Limitations	_	

#Text=In this study, most patients, as is common amongst alcohol-dependent subjects, are smokers. The FC strength might have been influenced by this confounding factor in the AD group. Therefore, further studies with either patients who are not smokers or healthy controls who are smokers should be performed to isolate the effect of alcohol from that of smoking on FC. Also, ten AD subjects have current or past use of other drugs, such as cocaine, cannabis, or opioid etc. and psychiatric disorders (Table 4). However, different subjects have different types of drug use or psychiatric disorders, and it was not consistent across the subjects. The alcohol use may still be the dominant factor contributing to the FC difference between AD and HC.
58-1	32198-32200	In	_	
58-2	32201-32205	this	_	
58-3	32206-32211	study	_	
58-4	32211-32212	,	_	
58-5	32213-32217	most	_	
58-6	32218-32226	patients	_	
58-7	32226-32227	,	_	
58-8	32228-32230	as	_	
58-9	32231-32233	is	_	
58-10	32234-32240	common	_	
58-11	32241-32248	amongst	_	
58-12	32249-32266	alcohol-dependent	_	
58-13	32267-32275	subjects	_	
58-14	32275-32276	,	_	
58-15	32277-32280	are	_	
58-16	32281-32288	smokers	_	
58-17	32288-32289	.	_	
58-18	32290-32293	The	_	
58-19	32294-32296	FC	_	
58-20	32297-32305	strength	_	
58-21	32306-32311	might	_	
58-22	32312-32316	have	_	
58-23	32317-32321	been	_	
58-24	32322-32332	influenced	_	
58-25	32333-32335	by	_	
58-26	32336-32340	this	_	
58-27	32341-32352	confounding	_	
58-28	32353-32359	factor	_	
58-29	32360-32362	in	_	
58-30	32363-32366	the	_	
58-31	32367-32369	AD	_	
58-32	32370-32375	group	_	
58-33	32375-32376	.	_	
58-34	32377-32386	Therefore	_	
58-35	32386-32387	,	_	
58-36	32388-32395	further	_	
58-37	32396-32403	studies	_	
58-38	32404-32408	with	_	
58-39	32409-32415	either	_	
58-40	32416-32424	patients	_	
58-41	32425-32428	who	_	
58-42	32429-32432	are	_	
58-43	32433-32436	not	_	
58-44	32437-32444	smokers	_	
58-45	32445-32447	or	_	
58-46	32448-32455	healthy	_	
58-47	32456-32464	controls	_	
58-48	32465-32468	who	_	
58-49	32469-32472	are	_	
58-50	32473-32480	smokers	_	
58-51	32481-32487	should	_	
58-52	32488-32490	be	_	
58-53	32491-32500	performed	_	
58-54	32501-32503	to	_	
58-55	32504-32511	isolate	_	
58-56	32512-32515	the	_	
58-57	32516-32522	effect	_	
58-58	32523-32525	of	_	
58-59	32526-32533	alcohol	_	
58-60	32534-32538	from	_	
58-61	32539-32543	that	_	
58-62	32544-32546	of	_	
58-63	32547-32554	smoking	_	
58-64	32555-32557	on	_	
58-65	32558-32560	FC	_	
58-66	32560-32561	.	_	
58-67	32562-32566	Also	_	
58-68	32566-32567	,	_	
58-69	32568-32571	ten	_	
58-70	32572-32574	AD	_	
58-71	32575-32583	subjects	_	
58-72	32584-32588	have	_	
58-73	32589-32596	current	_	
58-74	32597-32599	or	_	
58-75	32600-32604	past	_	
58-76	32605-32608	use	_	
58-77	32609-32611	of	_	
58-78	32612-32617	other	_	
58-79	32618-32623	drugs	_	
58-80	32623-32624	,	_	
58-81	32625-32629	such	_	
58-82	32630-32632	as	_	
58-83	32633-32640	cocaine	_	
58-84	32640-32641	,	_	
58-85	32642-32650	cannabis	_	
58-86	32650-32651	,	_	
58-87	32652-32654	or	_	
58-88	32655-32661	opioid	_	
58-89	32662-32665	etc	_	
58-90	32665-32666	.	_	
58-91	32667-32670	and	_	
58-92	32671-32682	psychiatric	_	
58-93	32683-32692	disorders	_	
58-94	32693-32694	(	_	
58-95	32694-32699	Table	_	
58-96	32700-32701	4	_	
58-97	32701-32702	)	_	
58-98	32702-32703	.	_	
58-99	32704-32711	However	_	
58-100	32711-32712	,	_	
58-101	32713-32722	different	_	
58-102	32723-32731	subjects	_	
58-103	32732-32736	have	_	
58-104	32737-32746	different	_	
58-105	32747-32752	types	_	
58-106	32753-32755	of	_	
58-107	32756-32760	drug	_	
58-108	32761-32764	use	_	
58-109	32765-32767	or	_	
58-110	32768-32779	psychiatric	_	
58-111	32780-32789	disorders	_	
58-112	32789-32790	,	_	
58-113	32791-32794	and	_	
58-114	32795-32797	it	_	
58-115	32798-32801	was	_	
58-116	32802-32805	not	_	
58-117	32806-32816	consistent	_	
58-118	32817-32823	across	_	
58-119	32824-32827	the	_	
58-120	32828-32836	subjects	_	
58-121	32836-32837	.	_	
58-122	32838-32841	The	_	
58-123	32842-32849	alcohol	_	
58-124	32850-32853	use	_	
58-125	32854-32857	may	_	
58-126	32858-32863	still	_	
58-127	32864-32866	be	_	
58-128	32867-32870	the	_	
58-129	32871-32879	dominant	_	
58-130	32880-32886	factor	_	
58-131	32887-32899	contributing	_	
58-132	32900-32902	to	_	
58-133	32903-32906	the	_	
58-134	32907-32909	FC	_	
58-135	32910-32920	difference	_	
58-136	32921-32928	between	_	
58-137	32929-32931	AD	_	
58-138	32932-32935	and	_	
58-139	32936-32938	HC	_	
58-140	32938-32939	.	_	

#Text=The age, year of education, and IQ differences between AD and HC is another limitation of the study. To ensure that any significant differences were not the result of these factors, we performed a group wise post-hoc analysis of covariance for each network of interest in SPM8. No voxel survival the threshold of p<0.05 FWE-corrected in any of the NOIs. Therefore, we did not detect any effects of age, years of education and IQ. Since the between-group IQ has the largest difference, we repeated our analyses with 9 IQ-matched subset of the each group (AD: 110.87±11.57; HC: 110.22±12.18; p=0.9135). Similarly we age-matched 10 subjects from each group (AD: 27.47±5; HC: 27.47±3.84; p=0.9984). In both cases we were able to reproduce the same results as trends (as opposed to statistically significant). This result points to the fact that adding to the sample size by subjects (in both groups) that did not match in IQ (but used IQ as covariate) has not altered the results. Only that it has increased the power of the analysis.
59-1	32940-32943	The	_	
59-2	32944-32947	age	_	
59-3	32947-32948	,	_	
59-4	32949-32953	year	_	
59-5	32954-32956	of	_	
59-6	32957-32966	education	_	
59-7	32966-32967	,	_	
59-8	32968-32971	and	_	
59-9	32972-32974	IQ	_	
59-10	32975-32986	differences	_	
59-11	32987-32994	between	_	
59-12	32995-32997	AD	_	
59-13	32998-33001	and	_	
59-14	33002-33004	HC	_	
59-15	33005-33007	is	_	
59-16	33008-33015	another	_	
59-17	33016-33026	limitation	_	
59-18	33027-33029	of	_	
59-19	33030-33033	the	_	
59-20	33034-33039	study	_	
59-21	33039-33040	.	_	
59-22	33041-33043	To	_	
59-23	33044-33050	ensure	_	
59-24	33051-33055	that	_	
59-25	33056-33059	any	_	
59-26	33060-33071	significant	_	
59-27	33072-33083	differences	_	
59-28	33084-33088	were	_	
59-29	33089-33092	not	_	
59-30	33093-33096	the	_	
59-31	33097-33103	result	_	
59-32	33104-33106	of	_	
59-33	33107-33112	these	_	
59-34	33113-33120	factors	_	
59-35	33120-33121	,	_	
59-36	33122-33124	we	_	
59-37	33125-33134	performed	_	
59-38	33135-33136	a	_	
59-39	33137-33142	group	_	
59-40	33143-33147	wise	_	
59-41	33148-33156	post-hoc	_	
59-42	33157-33165	analysis	_	
59-43	33166-33168	of	_	
59-44	33169-33179	covariance	_	
59-45	33180-33183	for	_	
59-46	33184-33188	each	_	
59-47	33189-33196	network	_	
59-48	33197-33199	of	_	
59-49	33200-33208	interest	_	
59-50	33209-33211	in	_	
59-51	33212-33216	SPM8	_	
59-52	33216-33217	.	_	
59-53	33218-33220	No	_	
59-54	33221-33226	voxel	_	
59-55	33227-33235	survival	_	
59-56	33236-33239	the	_	
59-57	33240-33249	threshold	_	
59-58	33250-33252	of	_	
59-59	33253-33254	p	_	
59-60	33254-33255	<	_	
59-61	33255-33259	0.05	_	
59-62	33260-33273	FWE-corrected	_	
59-63	33274-33276	in	_	
59-64	33277-33280	any	_	
59-65	33281-33283	of	_	
59-66	33284-33287	the	_	
59-67	33288-33292	NOIs	_	
59-68	33292-33293	.	_	
59-69	33294-33303	Therefore	_	
59-70	33303-33304	,	_	
59-71	33305-33307	we	_	
59-72	33308-33311	did	_	
59-73	33312-33315	not	_	
59-74	33316-33322	detect	_	
59-75	33323-33326	any	_	
59-76	33327-33334	effects	_	
59-77	33335-33337	of	_	
59-78	33338-33341	age	_	
59-79	33341-33342	,	_	
59-80	33343-33348	years	_	
59-81	33349-33351	of	_	
59-82	33352-33361	education	_	
59-83	33362-33365	and	_	
59-84	33366-33368	IQ	_	
59-85	33368-33369	.	_	
59-86	33370-33375	Since	_	
59-87	33376-33379	the	_	
59-88	33380-33393	between-group	_	
59-89	33394-33396	IQ	_	
59-90	33397-33400	has	_	
59-91	33401-33404	the	_	
59-92	33405-33412	largest	_	
59-93	33413-33423	difference	_	
59-94	33423-33424	,	_	
59-95	33425-33427	we	_	
59-96	33428-33436	repeated	_	
59-97	33437-33440	our	_	
59-98	33441-33449	analyses	_	
59-99	33450-33454	with	_	
59-100	33455-33456	9	_	
59-101	33457-33467	IQ-matched	_	
59-102	33468-33474	subset	_	
59-103	33475-33477	of	_	
59-104	33478-33481	the	_	
59-105	33482-33486	each	_	
59-106	33487-33492	group	_	
59-107	33493-33494	(	_	
59-108	33494-33496	AD	_	
59-109	33496-33497	:	_	
59-110	33498-33504	110.87	_	
59-111	33504-33505	±	_	
59-112	33505-33510	11.57	_	
59-113	33510-33511	;	_	
59-114	33512-33514	HC	_	
59-115	33514-33515	:	_	
59-116	33516-33522	110.22	_	
59-117	33522-33523	±	_	
59-118	33523-33528	12.18	_	
59-119	33528-33529	;	_	
59-120	33530-33531	p	_	
59-121	33531-33532	=	_	
59-122	33532-33538	0.9135	_	
59-123	33538-33539	)	_	
59-124	33539-33540	.	_	
59-125	33541-33550	Similarly	_	
59-126	33551-33553	we	_	
59-127	33554-33565	age-matched	_	
59-128	33566-33568	10	_	
59-129	33569-33577	subjects	_	
59-130	33578-33582	from	_	
59-131	33583-33587	each	_	
59-132	33588-33593	group	_	
59-133	33594-33595	(	_	
59-134	33595-33597	AD	_	
59-135	33597-33598	:	_	
59-136	33599-33604	27.47	_	
59-137	33604-33605	±	_	
59-138	33605-33606	5	_	
59-139	33606-33607	;	_	
59-140	33608-33610	HC	_	
59-141	33610-33611	:	_	
59-142	33612-33617	27.47	_	
59-143	33617-33618	±	_	
59-144	33618-33622	3.84	_	
59-145	33622-33623	;	_	
59-146	33624-33625	p	_	
59-147	33625-33626	=	_	
59-148	33626-33632	0.9984	_	
59-149	33632-33633	)	_	
59-150	33633-33634	.	_	
59-151	33635-33637	In	_	
59-152	33638-33642	both	_	
59-153	33643-33648	cases	_	
59-154	33649-33651	we	_	
59-155	33652-33656	were	_	
59-156	33657-33661	able	_	
59-157	33662-33664	to	_	
59-158	33665-33674	reproduce	_	
59-159	33675-33678	the	_	
59-160	33679-33683	same	_	
59-161	33684-33691	results	_	
59-162	33692-33694	as	_	
59-163	33695-33701	trends	_	
59-164	33702-33703	(	_	
59-165	33703-33705	as	_	
59-166	33706-33713	opposed	_	
59-167	33714-33716	to	_	
59-168	33717-33730	statistically	_	
59-169	33731-33742	significant	_	
59-170	33742-33743	)	_	
59-171	33743-33744	.	_	
59-172	33745-33749	This	_	
59-173	33750-33756	result	_	
59-174	33757-33763	points	_	
59-175	33764-33766	to	_	
59-176	33767-33770	the	_	
59-177	33771-33775	fact	_	
59-178	33776-33780	that	_	
59-179	33781-33787	adding	_	
59-180	33788-33790	to	_	
59-181	33791-33794	the	_	
59-182	33795-33801	sample	_	
59-183	33802-33806	size	_	
59-184	33807-33809	by	_	
59-185	33810-33818	subjects	_	
59-186	33819-33820	(	_	
59-187	33820-33822	in	_	
59-188	33823-33827	both	_	
59-189	33828-33834	groups	_	
59-190	33834-33835	)	_	
59-191	33836-33840	that	_	
59-192	33841-33844	did	_	
59-193	33845-33848	not	_	
59-194	33849-33854	match	_	
59-195	33855-33857	in	_	
59-196	33858-33860	IQ	_	
59-197	33861-33862	(	_	
59-198	33862-33865	but	_	
59-199	33866-33870	used	_	
59-200	33871-33873	IQ	_	
59-201	33874-33876	as	_	
59-202	33877-33886	covariate	_	
59-203	33886-33887	)	_	
59-204	33888-33891	has	_	
59-205	33892-33895	not	_	
59-206	33896-33903	altered	_	
59-207	33904-33907	the	_	
59-208	33908-33915	results	_	
59-209	33915-33916	.	_	
59-210	33917-33921	Only	_	
59-211	33922-33926	that	_	
59-212	33927-33929	it	_	
59-213	33930-33933	has	_	
59-214	33934-33943	increased	_	
59-215	33944-33947	the	_	
59-216	33948-33953	power	_	
59-217	33954-33956	of	_	
59-218	33957-33960	the	_	
59-219	33961-33969	analysis	_	
59-220	33969-33970	.	_	

#Text=Finally, larger sample sizes are recommended, so that more AD subjects without other drug use can be enrolled. The relatively small sample sizes mean that these findings, though informative, remain preliminary and require replication and/or larger sample study currently in progress.
60-1	33971-33978	Finally	_	
60-2	33978-33979	,	_	
60-3	33980-33986	larger	_	
60-4	33987-33993	sample	_	
60-5	33994-33999	sizes	_	
60-6	34000-34003	are	_	
60-7	34004-34015	recommended	_	
60-8	34015-34016	,	_	
60-9	34017-34019	so	_	
60-10	34020-34024	that	_	
60-11	34025-34029	more	_	
60-12	34030-34032	AD	_	
60-13	34033-34041	subjects	_	
60-14	34042-34049	without	_	
60-15	34050-34055	other	_	
60-16	34056-34060	drug	_	
60-17	34061-34064	use	_	
60-18	34065-34068	can	_	
60-19	34069-34071	be	_	
60-20	34072-34080	enrolled	_	
60-21	34080-34081	.	_	
60-22	34082-34085	The	_	
60-23	34086-34096	relatively	_	
60-24	34097-34102	small	_	
60-25	34103-34109	sample	_	
60-26	34110-34115	sizes	_	
60-27	34116-34120	mean	_	
60-28	34121-34125	that	_	
60-29	34126-34131	these	_	
60-30	34132-34140	findings	_	
60-31	34140-34141	,	_	
60-32	34142-34148	though	_	
60-33	34149-34160	informative	_	
60-34	34160-34161	,	_	
60-35	34162-34168	remain	_	
60-36	34169-34180	preliminary	_	
60-37	34181-34184	and	_	
60-38	34185-34192	require	_	
60-39	34193-34204	replication	_	
60-40	34205-34208	and	_	
60-41	34208-34209	/	_	
60-42	34209-34211	or	_	
60-43	34212-34218	larger	_	
60-44	34219-34225	sample	_	
60-45	34226-34231	study	_	
60-46	34232-34241	currently	_	
60-47	34242-34244	in	_	
60-48	34245-34253	progress	_	
60-49	34253-34254	.	_	

#Text=Conflict of Interest:
61-1	34266-34274	Conflict	_	
61-2	34275-34277	of	_	
61-3	34278-34286	Interest	_	
61-4	34286-34287	:	_	

#Text=All authors acknowledge that there is no conflict of biomedical financial interests in performing this study or in preparing this manuscript.
62-1	34297-34300	All	_	
62-2	34301-34308	authors	_	
62-3	34309-34320	acknowledge	_	
62-4	34321-34325	that	_	
62-5	34326-34331	there	_	
62-6	34332-34334	is	_	
62-7	34335-34337	no	_	
62-8	34338-34346	conflict	_	
62-9	34347-34349	of	_	
62-10	34350-34360	biomedical	_	
62-11	34361-34370	financial	_	
62-12	34371-34380	interests	_	
62-13	34381-34383	in	_	
62-14	34384-34394	performing	_	
62-15	34395-34399	this	_	
62-16	34400-34405	study	_	
62-17	34406-34408	or	_	
62-18	34409-34411	in	_	
62-19	34412-34421	preparing	_	
62-20	34422-34426	this	_	
62-21	34427-34437	manuscript	_	
62-22	34437-34438	.	_	

#Text=Authors’ contribution:
63-1	34450-34457	Authors	_	
63-2	34457-34458	’	_	
63-3	34459-34471	contribution	_	
63-4	34471-34472	:	_	

#Text=RM and XZ were responsible for the study concept, and design. RM was responsible for the acquisition of fMRI data. XZ performed the data analysis. KM and CC assisted with data analysis and interpretation of findings. XZ and CC drafted the manuscript. DD provided critical revision of the manuscript for important intellectual content. All authors critically reviewed content and approved final version for publication.
64-1	34482-34484	RM	_	
64-2	34485-34488	and	_	
64-3	34489-34491	XZ	_	
64-4	34492-34496	were	_	
64-5	34497-34508	responsible	_	
64-6	34509-34512	for	_	
64-7	34513-34516	the	_	
64-8	34517-34522	study	_	
64-9	34523-34530	concept	_	
64-10	34530-34531	,	_	
64-11	34532-34535	and	_	
64-12	34536-34542	design	_	
64-13	34542-34543	.	_	
64-14	34544-34546	RM	_	
64-15	34547-34550	was	_	
64-16	34551-34562	responsible	_	
64-17	34563-34566	for	_	
64-18	34567-34570	the	_	
64-19	34571-34582	acquisition	_	
64-20	34583-34585	of	_	
64-21	34586-34590	fMRI	_	
64-22	34591-34595	data	_	
64-23	34595-34596	.	_	
64-24	34597-34599	XZ	_	
64-25	34600-34609	performed	_	
64-26	34610-34613	the	_	
64-27	34614-34618	data	_	
64-28	34619-34627	analysis	_	
64-29	34627-34628	.	_	
64-30	34629-34631	KM	_	
64-31	34632-34635	and	_	
64-32	34636-34638	CC	_	
64-33	34639-34647	assisted	_	
64-34	34648-34652	with	_	
64-35	34653-34657	data	_	
64-36	34658-34666	analysis	_	
64-37	34667-34670	and	_	
64-38	34671-34685	interpretation	_	
64-39	34686-34688	of	_	
64-40	34689-34697	findings	_	
64-41	34697-34698	.	_	
64-42	34699-34701	XZ	_	
64-43	34702-34705	and	_	
64-44	34706-34708	CC	_	
64-45	34709-34716	drafted	_	
64-46	34717-34720	the	_	
64-47	34721-34731	manuscript	_	
64-48	34731-34732	.	_	
64-49	34733-34735	DD	_	
64-50	34736-34744	provided	_	
64-51	34745-34753	critical	_	
64-52	34754-34762	revision	_	
64-53	34763-34765	of	_	
64-54	34766-34769	the	_	
64-55	34770-34780	manuscript	_	
64-56	34781-34784	for	_	
64-57	34785-34794	important	_	
64-58	34795-34807	intellectual	_	
64-59	34808-34815	content	_	
64-60	34815-34816	.	_	
64-61	34817-34820	All	_	
64-62	34821-34828	authors	_	
64-63	34829-34839	critically	_	
64-64	34840-34848	reviewed	_	
64-65	34849-34856	content	_	
64-66	34857-34860	and	_	
64-67	34861-34869	approved	_	
64-68	34870-34875	final	_	
64-69	34876-34883	version	_	
64-70	34884-34887	for	_	
64-71	34888-34899	publication	_	
64-72	34899-34900	.	_	

#Text=Reference
65-1	34901-34910	Reference	_	

#Text=Functional connectivity in the motor cortex of resting human brain using echo-planar MRI
66-1	34911-34921	Functional	_	
66-2	34922-34934	connectivity	_	
66-3	34935-34937	in	_	
66-4	34938-34941	the	_	
66-5	34942-34947	motor	_	
66-6	34948-34954	cortex	_	
66-7	34955-34957	of	_	
66-8	34958-34965	resting	_	
66-9	34966-34971	human	_	
66-10	34972-34977	brain	_	
66-11	34978-34983	using	_	
66-12	34984-34995	echo-planar	_	
66-13	34996-34999	MRI	_	

#Text=Resting-state synchrony during early alcohol abstinence can predict subsequent relapse
67-1	35000-35013	Resting-state	_	
67-2	35014-35023	synchrony	_	
67-3	35024-35030	during	_	
67-4	35031-35036	early	_	
67-5	35037-35044	alcohol	_	
67-6	35045-35055	abstinence	_	
67-7	35056-35059	can	_	
67-8	35060-35067	predict	_	
67-9	35068-35078	subsequent	_	
67-10	35079-35086	relapse	_	

#Text=Resting-state synchrony in short-term versus long-term abstinent alcoholics
68-1	35087-35100	Resting-state	_	
68-2	35101-35110	synchrony	_	
68-3	35111-35113	in	_	
68-4	35114-35124	short-term	_	
68-5	35125-35131	versus	_	
68-6	35132-35141	long-term	_	
68-7	35142-35151	abstinent	_	
68-8	35152-35162	alcoholics	_	

#Text=Disruption of functional connectivity of the default-mode network in alcoholism
69-1	35163-35173	Disruption	_	
69-2	35174-35176	of	_	
69-3	35177-35187	functional	_	
69-4	35188-35200	connectivity	_	
69-5	35201-35203	of	_	
69-6	35204-35207	the	_	
69-7	35208-35220	default-mode	_	
69-8	35221-35228	network	_	
69-9	35229-35231	in	_	
69-10	35232-35242	alcoholism	_	

#Text=A validation of the post concussion symptom scale in the assessment of complex concussion using cognitive testing and functional MRI
70-1	35243-35244	A	_	
70-2	35245-35255	validation	_	
70-3	35256-35258	of	_	
70-4	35259-35262	the	_	
70-5	35263-35267	post	_	
70-6	35268-35278	concussion	_	
70-7	35279-35286	symptom	_	
70-8	35287-35292	scale	_	
70-9	35293-35295	in	_	
70-10	35296-35299	the	_	
70-11	35300-35310	assessment	_	
70-12	35311-35313	of	_	
70-13	35314-35321	complex	_	
70-14	35322-35332	concussion	_	
70-15	35333-35338	using	_	
70-16	35339-35348	cognitive	_	
70-17	35349-35356	testing	_	
70-18	35357-35360	and	_	
70-19	35361-35371	functional	_	
70-20	35372-35375	MRI	_	

#Text=White matter microstructure alterations: a study of alcoholics with and without post-traumatic stress disorder
71-1	35376-35381	White	_	
71-2	35382-35388	matter	_	
71-3	35389-35403	microstructure	_	
71-4	35404-35415	alterations	_	
71-5	35415-35416	:	_	
71-6	35417-35418	a	_	
71-7	35419-35424	study	_	
71-8	35425-35427	of	_	
71-9	35428-35438	alcoholics	_	
71-10	35439-35443	with	_	
71-11	35444-35447	and	_	
71-12	35448-35455	without	_	
71-13	35456-35470	post-traumatic	_	
71-14	35471-35477	stress	_	
71-15	35478-35486	disorder	_	

#Text=Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele
72-1	35487-35495	Distinct	_	
72-2	35496-35504	patterns	_	
72-3	35505-35507	of	_	
72-4	35508-35513	brain	_	
72-5	35514-35522	activity	_	
72-6	35523-35525	in	_	
72-7	35526-35531	young	_	
72-8	35532-35540	carriers	_	
72-9	35541-35543	of	_	
72-10	35544-35547	the	_	
72-11	35548-35561	APOE-epsilon4	_	
72-12	35562-35568	allele	_	

#Text=Deficits in cortical, diencephalic and midbrain gray matter in alcoholism measured by VBM: Effects of co-morbid substance abuse
73-1	35569-35577	Deficits	_	
73-2	35578-35580	in	_	
73-3	35581-35589	cortical	_	
73-4	35589-35590	,	_	
73-5	35591-35603	diencephalic	_	
73-6	35604-35607	and	_	
73-7	35608-35616	midbrain	_	
73-8	35617-35621	gray	_	
73-9	35622-35628	matter	_	
73-10	35629-35631	in	_	
73-11	35632-35642	alcoholism	_	
73-12	35643-35651	measured	_	
73-13	35652-35654	by	_	
73-14	35655-35658	VBM	_	
73-15	35658-35659	:	_	
73-16	35660-35667	Effects	_	
73-17	35668-35670	of	_	
73-18	35671-35680	co-morbid	_	
73-19	35681-35690	substance	_	
73-20	35691-35696	abuse	_	

#Text=Relations among Delay Discounting, Addictions, and Money Mismanagement: Implications and Future Directions
74-1	35697-35706	Relations	_	
74-2	35707-35712	among	_	
74-3	35713-35718	Delay	_	
74-4	35719-35730	Discounting	_	
74-5	35730-35731	,	_	
74-6	35732-35742	Addictions	_	
74-7	35742-35743	,	_	
74-8	35744-35747	and	_	
74-9	35748-35753	Money	_	
74-10	35754-35767	Mismanagement	_	
74-11	35767-35768	:	_	
74-12	35769-35781	Implications	_	
74-13	35782-35785	and	_	
74-14	35786-35792	Future	_	
74-15	35793-35803	Directions	_	

#Text=To permute or not to permute
75-1	35804-35806	To	_	
75-2	35807-35814	permute	_	
75-3	35815-35817	or	_	
75-4	35818-35821	not	_	
75-5	35822-35824	to	_	
75-6	35825-35832	permute	_	

#Text=Brain function during cognitive flexibility and white matter integrity in alcohol-dependent patients, problematic drinkers and healthy controls
76-1	35833-35838	Brain	_	
76-2	35839-35847	function	_	
76-3	35848-35854	during	_	
76-4	35855-35864	cognitive	_	
76-5	35865-35876	flexibility	_	
76-6	35877-35880	and	_	
76-7	35881-35886	white	_	
76-8	35887-35893	matter	_	
76-9	35894-35903	integrity	_	
76-10	35904-35906	in	_	
76-11	35907-35924	alcohol-dependent	_	
76-12	35925-35933	patients	_	
76-13	35933-35934	,	_	
76-14	35935-35946	problematic	_	
76-15	35947-35955	drinkers	_	
76-16	35956-35959	and	_	
76-17	35960-35967	healthy	_	
76-18	35968-35976	controls	_	

#Text=Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function
77-1	35977-35988	Large-scale	_	
77-2	35989-35994	brain	_	
77-3	35995-36002	network	_	
77-4	36003-36011	coupling	_	
77-5	36012-36020	predicts	_	
77-6	36021-36026	acute	_	
77-7	36027-36035	nicotine	_	
77-8	36036-36046	abstinence	_	
77-9	36047-36054	effects	_	
77-10	36055-36057	on	_	
77-11	36058-36065	craving	_	
77-12	36066-36069	and	_	
77-13	36070-36079	cognitive	_	
77-14	36080-36088	function	_	

#Text=Resting state functional connectivity: its physiological basis and application in neuropharmacology
78-1	36089-36096	Resting	_	
78-2	36097-36102	state	_	
78-3	36103-36113	functional	_	
78-4	36114-36126	connectivity	_	
78-5	36126-36127	:	_	
78-6	36128-36131	its	_	
78-7	36132-36145	physiological	_	
78-8	36146-36151	basis	_	
78-9	36152-36155	and	_	
78-10	36156-36167	application	_	
78-11	36168-36170	in	_	
78-12	36171-36188	neuropharmacology	_	

#Text=Enhanced behavioral inhibition in restrained eaters
79-1	36189-36197	Enhanced	_	
79-2	36198-36208	behavioral	_	
79-3	36209-36219	inhibition	_	
79-4	36220-36222	in	_	
79-5	36223-36233	restrained	_	
79-6	36234-36240	eaters	_	

#Text=Measures of impulsivity in cigarette smokers and non-smokers
80-1	36241-36249	Measures	_	
80-2	36250-36252	of	_	
80-3	36253-36264	impulsivity	_	
80-4	36265-36267	in	_	
80-5	36268-36277	cigarette	_	
80-6	36278-36285	smokers	_	
80-7	36286-36289	and	_	
80-8	36290-36301	non-smokers	_	

#Text=Effects of alcohol dependence on cortical thickness as determined by magnetic resonance imaging
81-1	36302-36309	Effects	_	
81-2	36310-36312	of	_	
81-3	36313-36320	alcohol	_	
81-4	36321-36331	dependence	_	
81-5	36332-36334	on	_	
81-6	36335-36343	cortical	_	
81-7	36344-36353	thickness	_	
81-8	36354-36356	as	_	
81-9	36357-36367	determined	_	
81-10	36368-36370	by	_	
81-11	36371-36379	magnetic	_	
81-12	36380-36389	resonance	_	
81-13	36390-36397	imaging	_	

#Text=The hidden island of addiction: the insula
82-1	36398-36401	The	_	
82-2	36402-36408	hidden	_	
82-3	36409-36415	island	_	
82-4	36416-36418	of	_	
82-5	36419-36428	addiction	_	
82-6	36428-36429	:	_	
82-7	36430-36433	the	_	
82-8	36434-36440	insula	_	

#Text=A triadic neurocognitive approach to addiction for clinical interventions
83-1	36441-36442	A	_	
83-2	36443-36450	triadic	_	
83-3	36451-36465	neurocognitive	_	
83-4	36466-36474	approach	_	
83-5	36475-36477	to	_	
83-6	36478-36487	addiction	_	
83-7	36488-36491	for	_	
83-8	36492-36500	clinical	_	
83-9	36501-36514	interventions	_	

#Text=Supratentorial profile of white matter microstructural integrity in recovering alcoholic men and women
84-1	36515-36529	Supratentorial	_	
84-2	36530-36537	profile	_	
84-3	36538-36540	of	_	
84-4	36541-36546	white	_	
84-5	36547-36553	matter	_	
84-6	36554-36569	microstructural	_	
84-7	36570-36579	integrity	_	
84-8	36580-36582	in	_	
84-9	36583-36593	recovering	_	
84-10	36594-36603	alcoholic	_	
84-11	36604-36607	men	_	
84-12	36608-36611	and	_	
84-13	36612-36617	women	_	

#Text=Neuroscience of behavioral and pharmacological treatments for addictions
85-1	36618-36630	Neuroscience	_	
85-2	36631-36633	of	_	
85-3	36634-36644	behavioral	_	
85-4	36645-36648	and	_	
85-5	36649-36664	pharmacological	_	
85-6	36665-36675	treatments	_	
85-7	36676-36679	for	_	
85-8	36680-36690	addictions	_	

#Text=Methods to detect, characterize, and remove motion artifact in resting state fMRI
86-1	36691-36698	Methods	_	
86-2	36699-36701	to	_	
86-3	36702-36708	detect	_	
86-4	36708-36709	,	_	
86-5	36710-36722	characterize	_	
86-6	36722-36723	,	_	
86-7	36724-36727	and	_	
86-8	36728-36734	remove	_	
86-9	36735-36741	motion	_	
86-10	36742-36750	artifact	_	
86-11	36751-36753	in	_	
86-12	36754-36761	resting	_	
86-13	36762-36767	state	_	
86-14	36768-36772	fMRI	_	

#Text=Increased amygdala activity during successful memory encoding in adolescent major depressive disorder: An FMRI study
87-1	36773-36782	Increased	_	
87-2	36783-36791	amygdala	_	
87-3	36792-36800	activity	_	
87-4	36801-36807	during	_	
87-5	36808-36818	successful	_	
87-6	36819-36825	memory	_	
87-7	36826-36834	encoding	_	
87-8	36835-36837	in	_	
87-9	36838-36848	adolescent	_	
87-10	36849-36854	major	_	
87-11	36855-36865	depressive	_	
87-12	36866-36874	disorder	_	
87-13	36874-36875	:	_	
87-14	36876-36878	An	_	
87-15	36879-36883	FMRI	_	
87-16	36884-36889	study	_	

#Text=Model-free group analysis shows altered BOLD FMRI networks in dementia
88-1	36890-36900	Model-free	_	
88-2	36901-36906	group	_	
88-3	36907-36915	analysis	_	
88-4	36916-36921	shows	_	
88-5	36922-36929	altered	_	
88-6	36930-36934	BOLD	_	
88-7	36935-36939	FMRI	_	
88-8	36940-36948	networks	_	
88-9	36949-36951	in	_	
88-10	36952-36960	dementia	_	

#Text=Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease
89-1	36961-36968	Delayed	_	
89-2	36969-36975	rather	_	
89-3	36976-36980	than	_	
89-4	36981-36990	decreased	_	
89-5	36991-36995	BOLD	_	
89-6	36996-37004	response	_	
89-7	37005-37007	as	_	
89-8	37008-37009	a	_	
89-9	37010-37016	marker	_	
89-10	37017-37020	for	_	
89-11	37021-37026	early	_	
89-12	37027-37038	Alzheimer's	_	
89-13	37039-37046	disease	_	

#Text=Resting state functional connectivity in addiction: Lessons learned and a road ahead
90-1	37047-37054	Resting	_	
90-2	37055-37060	state	_	
90-3	37061-37071	functional	_	
90-4	37072-37084	connectivity	_	
90-5	37085-37087	in	_	
90-6	37088-37097	addiction	_	
90-7	37097-37098	:	_	
90-8	37099-37106	Lessons	_	
90-9	37107-37114	learned	_	
90-10	37115-37118	and	_	
90-11	37119-37120	a	_	
90-12	37121-37125	road	_	
90-13	37126-37131	ahead	_	

#Text=Functional Connectivity of Default Mode Network Components: Correlation, Anticorrelation, and Causality
91-1	37132-37142	Functional	_	
91-2	37143-37155	Connectivity	_	
91-3	37156-37158	of	_	
91-4	37159-37166	Default	_	
91-5	37167-37171	Mode	_	
91-6	37172-37179	Network	_	
91-7	37180-37190	Components	_	
91-8	37190-37191	:	_	
91-9	37192-37203	Correlation	_	
91-10	37203-37204	,	_	
91-11	37205-37220	Anticorrelation	_	
91-12	37220-37221	,	_	
91-13	37222-37225	and	_	
91-14	37226-37235	Causality	_	

#Text=Addiction science: Uncovering neurobiological complexity
92-1	37236-37245	Addiction	_	
92-2	37246-37253	science	_	
92-3	37253-37254	:	_	
92-4	37255-37265	Uncovering	_	
92-5	37266-37281	neurobiological	_	
92-6	37282-37292	complexity	_	

#Text=Neuropsychosocial profiles of current and future adolescent alcohol misusers
93-1	37293-37310	Neuropsychosocial	_	
93-2	37311-37319	profiles	_	
93-3	37320-37322	of	_	
93-4	37323-37330	current	_	
93-5	37331-37334	and	_	
93-6	37335-37341	future	_	
93-7	37342-37352	adolescent	_	
93-8	37353-37360	alcohol	_	
93-9	37361-37369	misusers	_	

#Text=Cognitive control network function in alcohol use disorder before and during treatment with Lorazepam
94-1	37370-37379	Cognitive	_	
94-2	37380-37387	control	_	
94-3	37388-37395	network	_	
94-4	37396-37404	function	_	
94-5	37405-37407	in	_	
94-6	37408-37415	alcohol	_	
94-7	37416-37419	use	_	
94-8	37420-37428	disorder	_	
94-9	37429-37435	before	_	
94-10	37436-37439	and	_	
94-11	37440-37446	during	_	
94-12	37447-37456	treatment	_	
94-13	37457-37461	with	_	
94-14	37462-37471	Lorazepam	_	

#Text=Permutation inference for the general linear model
95-1	37472-37483	Permutation	_	
95-2	37484-37493	inference	_	
95-3	37494-37497	for	_	
95-4	37498-37501	the	_	
95-5	37502-37509	general	_	
95-6	37510-37516	linear	_	
95-7	37517-37522	model	_	

#Text=Within-network connectivity for 6 addiction related networks and increased between-network connectivity in AD than HC
96-1	37523-37537	Within-network	_	
96-2	37538-37550	connectivity	_	
96-3	37551-37554	for	_	
96-4	37555-37556	6	_	
96-5	37557-37566	addiction	_	
96-6	37567-37574	related	_	
96-7	37575-37583	networks	_	
96-8	37584-37587	and	_	
96-9	37588-37597	increased	_	
96-10	37598-37613	between-network	_	
96-11	37614-37626	connectivity	_	
96-12	37627-37629	in	_	
96-13	37630-37632	AD	_	
96-14	37633-37637	than	_	
96-15	37638-37640	HC	_	

#Text=Group difference of the within-network connectivity between AD and HC (red: AD>HC; green: HC>AD), p<0.05 corrected
97-1	37641-37646	Group	_	
97-2	37647-37657	difference	_	
97-3	37658-37660	of	_	
97-4	37661-37664	the	_	
97-5	37665-37679	within-network	_	
97-6	37680-37692	connectivity	_	
97-7	37693-37700	between	_	
97-8	37701-37703	AD	_	
97-9	37704-37707	and	_	
97-10	37708-37710	HC	_	
97-11	37711-37712	(	_	
97-12	37712-37715	red	_	
97-13	37715-37716	:	_	
97-14	37717-37719	AD	_	
97-15	37719-37720	>	_	
97-16	37720-37722	HC	_	
97-17	37722-37723	;	_	
97-18	37724-37729	green	_	
97-19	37729-37730	:	_	
97-20	37731-37733	HC	_	
97-21	37733-37734	>	_	
97-22	37734-37736	AD	_	
97-23	37736-37737	)	_	
97-24	37737-37738	,	_	
97-25	37739-37740	p	_	
97-26	37740-37741	<	_	
97-27	37741-37745	0.05	_	
97-28	37746-37755	corrected	_	

#Text=Increased (red) and decreased (blue) correlation between impulsivity (BIS-11, UPPS, and DDT) and network coupling of RSNs in AD
98-1	37756-37765	Increased	_	
98-2	37766-37767	(	_	
98-3	37767-37770	red	_	
98-4	37770-37771	)	_	
98-5	37772-37775	and	_	
98-6	37776-37785	decreased	_	
98-7	37786-37787	(	_	
98-8	37787-37791	blue	_	
98-9	37791-37792	)	_	
98-10	37793-37804	correlation	_	
98-11	37805-37812	between	_	
98-12	37813-37824	impulsivity	_	
98-13	37825-37826	(	_	
98-14	37826-37829	BIS	_	
98-15	37829-37830	-	_	
98-16	37830-37832	11	_	
98-17	37832-37833	,	_	
98-18	37834-37838	UPPS	_	
98-19	37838-37839	,	_	
98-20	37840-37843	and	_	
98-21	37844-37847	DDT	_	
98-22	37847-37848	)	_	
98-23	37849-37852	and	_	
98-24	37853-37860	network	_	
98-25	37861-37869	coupling	_	
98-26	37870-37872	of	_	
98-27	37873-37877	RSNs	_	
98-28	37878-37880	in	_	
98-29	37881-37883	AD	_	

#Text=Fisher z-transformed correlation coefficients (Z score) between Delay Discounting and network coupling (left panel top to bottom); UPPS (-) and network coupling (right panel top to bottom)
99-1	37884-37890	Fisher	_	
99-2	37891-37904	z-transformed	_	
99-3	37905-37916	correlation	_	
99-4	37917-37929	coefficients	_	
99-5	37930-37931	(	_	
99-6	37931-37932	Z	_	
99-7	37933-37938	score	_	
99-8	37938-37939	)	_	
99-9	37940-37947	between	_	
99-10	37948-37953	Delay	_	
99-11	37954-37965	Discounting	_	
99-12	37966-37969	and	_	
99-13	37970-37977	network	_	
99-14	37978-37986	coupling	_	
99-15	37987-37988	(	_	
99-16	37988-37992	left	_	
99-17	37993-37998	panel	_	
99-18	37999-38002	top	_	
99-19	38003-38005	to	_	
99-20	38006-38012	bottom	_	
99-21	38012-38013	)	_	
99-22	38013-38014	;	_	
99-23	38015-38019	UPPS	_	
99-24	38020-38021	(	_	
99-25	38021-38022	-	_	
99-26	38022-38023	)	_	
99-27	38024-38027	and	_	
99-28	38028-38035	network	_	
99-29	38036-38044	coupling	_	
99-30	38045-38046	(	_	
99-31	38046-38051	right	_	
99-32	38052-38057	panel	_	
99-33	38058-38061	top	_	
99-34	38062-38064	to	_	
99-35	38065-38071	bottom	_	
99-36	38071-38072	)	_	

#Text=Demographic and clinical profile of the participants in this study
100-1	38073-38084	Demographic	_	
100-2	38085-38088	and	_	
100-3	38089-38097	clinical	_	
100-4	38098-38105	profile	_	
100-5	38106-38108	of	_	
100-6	38109-38112	the	_	
100-7	38113-38125	participants	_	
100-8	38126-38128	in	_	
100-9	38129-38133	this	_	
100-10	38134-38139	study	_	

#Text=AD mean (SD)\tHC mean (SD)\tmissing data\tt\tAD vs HC\t \tN\t25\t26\t\t\t\t \tGender (female)\t17 (8)\t11 (15)\t0\t\t\t \tSmoker (%)\t42%\t0\t0\t\t\t \tAge (years)\t31.9 (7.7)\t26.3 (3.9)\t0\t3.30\tP=0.002\t \tEducation (years)\t13 (2.6)\t17 (2.3)\t0\t5.94\tp < 0.001\t \tWAIS\t88.2 (15.2)\t117.2 (11.1)\t2\t5.57\tp < 0.001\t \tDays in abstinence\t16.5 (7.04)\tN/A\t0\t\t\t \tYears of dependence\t6.8 (6.9)\tN/A\t1\t\t\t \tTLFB (Drinks/week)\t76.2 (57.2)\t4.1 (3.6)\t0\t−6.3\tp < 0.001\t \tBIS-11\t67.0 (14.8)\t52.1 (8.2)\t0\t−4.4\tp < 0.001\t \tDelay Discounting\t−2.7 (2.6)\t−5.2 (1.8)\t3\t−3.3\tp = 0.003
101-1	38141-38143	AD	_	
101-2	38144-38148	mean	_	
101-3	38149-38150	(	_	
101-4	38150-38152	SD	_	
101-5	38152-38153	)	_	
101-6	38154-38156	HC	_	
101-7	38157-38161	mean	_	
101-8	38162-38163	(	_	
101-9	38163-38165	SD	_	
101-10	38165-38166	)	_	
101-11	38167-38174	missing	_	
101-12	38175-38179	data	_	
101-13	38180-38181	t	_	
101-14	38182-38184	AD	_	
101-15	38185-38187	vs	_	
101-16	38188-38190	HC	_	
101-17	38193-38194	N	_	
101-18	38195-38197	25	_	
101-19	38198-38200	26	_	
101-20	38206-38212	Gender	_	
101-21	38213-38214	(	_	
101-22	38214-38220	female	_	
101-23	38220-38221	)	_	
101-24	38222-38224	17	_	
101-25	38225-38226	(	_	
101-26	38226-38227	8	_	
101-27	38227-38228	)	_	
101-28	38229-38231	11	_	
101-29	38232-38233	(	_	
101-30	38233-38235	15	_	
101-31	38235-38236	)	_	
101-32	38237-38238	0	_	
101-33	38243-38249	Smoker	_	
101-34	38250-38251	(	_	
101-35	38251-38252	%	_	
101-36	38252-38253	)	_	
101-37	38254-38257	42%	_	
101-38	38258-38259	0	_	
101-39	38260-38261	0	_	
101-40	38266-38269	Age	_	
101-41	38270-38271	(	_	
101-42	38271-38276	years	_	
101-43	38276-38277	)	_	
101-44	38278-38282	31.9	_	
101-45	38283-38284	(	_	
101-46	38284-38287	7.7	_	
101-47	38287-38288	)	_	
101-48	38289-38293	26.3	_	
101-49	38294-38295	(	_	
101-50	38295-38298	3.9	_	
101-51	38298-38299	)	_	
101-52	38300-38301	0	_	
101-53	38302-38306	3.30	_	
101-54	38307-38308	P	_	
101-55	38308-38309	=	_	
101-56	38309-38314	0.002	_	
101-57	38317-38326	Education	_	
101-58	38327-38328	(	_	
101-59	38328-38333	years	_	
101-60	38333-38334	)	_	
101-61	38335-38337	13	_	
101-62	38338-38339	(	_	
101-63	38339-38342	2.6	_	
101-64	38342-38343	)	_	
101-65	38344-38346	17	_	
101-66	38347-38348	(	_	
101-67	38348-38351	2.3	_	
101-68	38351-38352	)	_	
101-69	38353-38354	0	_	
101-70	38355-38359	5.94	_	
101-71	38360-38361	p	_	
101-72	38362-38363	<	_	
101-73	38364-38369	0.001	_	
101-74	38372-38376	WAIS	_	
101-75	38377-38381	88.2	_	
101-76	38382-38383	(	_	
101-77	38383-38387	15.2	_	
101-78	38387-38388	)	_	
101-79	38389-38394	117.2	_	
101-80	38395-38396	(	_	
101-81	38396-38400	11.1	_	
101-82	38400-38401	)	_	
101-83	38402-38403	2	_	
101-84	38404-38408	5.57	_	
101-85	38409-38410	p	_	
101-86	38411-38412	<	_	
101-87	38413-38418	0.001	_	
101-88	38421-38425	Days	_	
101-89	38426-38428	in	_	
101-90	38429-38439	abstinence	_	
101-91	38440-38444	16.5	_	
101-92	38445-38446	(	_	
101-93	38446-38450	7.04	_	
101-94	38450-38451	)	_	
101-95	38452-38453	N	_	
101-96	38453-38454	/	_	
101-97	38454-38455	A	_	
101-98	38456-38457	0	_	
101-99	38462-38467	Years	_	
101-100	38468-38470	of	_	
101-101	38471-38481	dependence	_	
101-102	38482-38485	6.8	_	
101-103	38486-38487	(	_	
101-104	38487-38490	6.9	_	
101-105	38490-38491	)	_	
101-106	38492-38493	N	_	
101-107	38493-38494	/	_	
101-108	38494-38495	A	_	
101-109	38496-38497	1	_	
101-110	38502-38506	TLFB	_	
101-111	38507-38508	(	_	
101-112	38508-38514	Drinks	_	
101-113	38514-38515	/	_	
101-114	38515-38519	week	_	
101-115	38519-38520	)	_	
101-116	38521-38525	76.2	_	
101-117	38526-38527	(	_	
101-118	38527-38531	57.2	_	
101-119	38531-38532	)	_	
101-120	38533-38536	4.1	_	
101-121	38537-38538	(	_	
101-122	38538-38541	3.6	_	
101-123	38541-38542	)	_	
101-124	38543-38544	0	_	
101-125	38545-38546	−	_	
101-126	38546-38549	6.3	_	
101-127	38550-38551	p	_	
101-128	38552-38553	<	_	
101-129	38554-38559	0.001	_	
101-130	38562-38565	BIS	_	
101-131	38565-38566	-	_	
101-132	38566-38568	11	_	
101-133	38569-38573	67.0	_	
101-134	38574-38575	(	_	
101-135	38575-38579	14.8	_	
101-136	38579-38580	)	_	
101-137	38581-38585	52.1	_	
101-138	38586-38587	(	_	
101-139	38587-38590	8.2	_	
101-140	38590-38591	)	_	
101-141	38592-38593	0	_	
101-142	38594-38595	−	_	
101-143	38595-38598	4.4	_	
101-144	38599-38600	p	_	
101-145	38601-38602	<	_	
101-146	38603-38608	0.001	_	
101-147	38611-38616	Delay	_	
101-148	38617-38628	Discounting	_	
101-149	38629-38630	−	_	
101-150	38630-38633	2.7	_	
101-151	38634-38635	(	_	
101-152	38635-38638	2.6	_	
101-153	38638-38639	)	_	
101-154	38640-38641	−	_	
101-155	38641-38644	5.2	_	
101-156	38645-38646	(	_	
101-157	38646-38649	1.8	_	
101-158	38649-38650	)	_	
101-159	38651-38652	3	_	
101-160	38653-38654	−	_	
101-161	38654-38657	3.3	_	
101-162	38658-38659	p	_	
101-163	38660-38661	=	_	
101-164	38662-38667	0.003	_	

#Text=Common regions of 6 addition related spatial component maps identified by ICA in both AD and HC group (MTG: Middle Temporal Gyrus; SFG: Superior Frontal Gyrus; IPL: Inferior Parietal Lobule; ITG: Inferior Temporal gyrus; SG: SupramarginalGyrus; MFG: Middle Frontal Gyrus; AG: Angular Gyrus)
102-1	38671-38677	Common	_	
102-2	38678-38685	regions	_	
102-3	38686-38688	of	_	
102-4	38689-38690	6	_	
102-5	38691-38699	addition	_	
102-6	38700-38707	related	_	
102-7	38708-38715	spatial	_	
102-8	38716-38725	component	_	
102-9	38726-38730	maps	_	
102-10	38731-38741	identified	_	
102-11	38742-38744	by	_	
102-12	38745-38748	ICA	_	
102-13	38749-38751	in	_	
102-14	38752-38756	both	_	
102-15	38757-38759	AD	_	
102-16	38760-38763	and	_	
102-17	38764-38766	HC	_	
102-18	38767-38772	group	_	
102-19	38773-38774	(	_	
102-20	38774-38777	MTG	_	
102-21	38777-38778	:	_	
102-22	38779-38785	Middle	_	
102-23	38786-38794	Temporal	_	
102-24	38795-38800	Gyrus	_	
102-25	38800-38801	;	_	
102-26	38802-38805	SFG	_	
102-27	38805-38806	:	_	
102-28	38807-38815	Superior	_	
102-29	38816-38823	Frontal	_	
102-30	38824-38829	Gyrus	_	
102-31	38829-38830	;	_	
102-32	38831-38834	IPL	_	
102-33	38834-38835	:	_	
102-34	38836-38844	Inferior	_	
102-35	38845-38853	Parietal	_	
102-36	38854-38860	Lobule	_	
102-37	38860-38861	;	_	
102-38	38862-38865	ITG	_	
102-39	38865-38866	:	_	
102-40	38867-38875	Inferior	_	
102-41	38876-38884	Temporal	_	
102-42	38885-38890	gyrus	_	
102-43	38890-38891	;	_	
102-44	38892-38894	SG	_	
102-45	38894-38895	:	_	
102-46	38896-38914	SupramarginalGyrus	_	
102-47	38914-38915	;	_	
102-48	38916-38919	MFG	_	
102-49	38919-38920	:	_	
102-50	38921-38927	Middle	_	
102-51	38928-38935	Frontal	_	
102-52	38936-38941	Gyrus	_	
102-53	38941-38942	;	_	
102-54	38943-38945	AG	_	
102-55	38945-38946	:	_	
102-56	38947-38954	Angular	_	
102-57	38955-38960	Gyrus	_	
102-58	38960-38961	)	_	

#Text=Networks\tExplainedvariance(%)\tTotalvariance(%)\tRegions\tBA\tVoxels\tX\tY\tZ\tt-scoremaxHC\tt-scoremaxAD\t \tASN\t2.87\t2.22\tPutamen, Pallidum, Insula, Subcallosal Gyrus\t34\t842\t−26\t6\t−4\t7.64\t12.57\t \t\t \tOFC\t2.8\t2.17\tACC, SFG, Medial FG\t10, 11\t214\t2\t54\t−8\t6.67\t10.26\t \t\t \tSN\t3.21\t2.49\tInsula, STG\t13\t1591\t−38\t−14\t8\t11.16\t12.12\t \t\t \t\t\t\tACC, Medial FG\t24, 32\t58\t−2\t6\t40\t8.22\t8.38\t \t\t\t\t\t \ta-DMN\t3.11\t2.41\tSFG, Medial FG\t9, 10\t506\t2\t58\t28\t8.67\t10.64\t \t\t \t\t\t\tPCC, Precuneus\t7, 23, 30, 31\t88\t−6\t−50\t28\t6.76\t11.01\t \t\t\t\t\t \t\t\t\tMTG, STG\t19, 22, 39\t12\t−50\t−66\t20\t4.24\t7.32\t \t\t \tp-DMN\t3.04\t2.35\tPrecuneus, PCC\t31\t1167\t−2\t−66\t24\t10.88\t13.89\t \t\t\t\t\t \t\t\t\tACC, Medial FG\t9, 10, 32\t12\t2\t42\t16\t5.21\t5.04\t \t\t\t\t\t \tLECN\t3.12\t2.42\tMFG, SFG\t6, 8\t451\t−26\t16\t43\t5.82\t7.78\t \t\t\t\t\t \t\t\t\tAG, SG, STG, MTG, Precuneus, IPL\t39, 40\t344\t−42\t−62\t32\t11.54\t15.39\t \t\t\t\t\t \t\t\t\tITG, MTG, Fusiform Gyrus\t20, 21, 37\t111\t−58\t−42\t−20\t8.51\t10.01\t \t\t\t\t\t \t\t\t\tPCC, Precuneus\t23, 31\t95\t−2\t−38\t32\t7.37\t10.89\t \t\t\t\t\t \t\t\t\tAG, IFL, Precuneus, SG, MTG\t39, 40\t71\t46\t−66\t36\t8.49\t10.2\t \t\t \tRECN\t3.23\t2.5\tAG, SG, STG, MTG, IPL, Precuneus\t39, 40\t415\t46\t−62\t32\t10.03\t13.59\t \t\t \t\t\t\tMFG, SFG\t6, 8\t396\t26\t18\t48\t10.15\t12.6\t \t\t\t\t\t \t\t\t\tMFG, IFG\t10, 11, 47\t132\t38\t46\t−4\t7.5\t9.48\t \t\t \t\t\t\tPCC, precuneus\t23, 31\t54\t6\t−34\t32\t7.01\t9.65\t \t\t\t\t\t \t\t\t\tMTG, ITG\t20, 21\t31\t62\t−34\t−12\t5.42\t8.15
103-1	38962-38970	Networks	_	
103-2	38971-38988	Explainedvariance	_	
103-3	38988-38989	(	_	
103-4	38989-38990	%	_	
103-5	38990-38991	)	_	
103-6	38992-39005	Totalvariance	_	
103-7	39005-39006	(	_	
103-8	39006-39007	%	_	
103-9	39007-39008	)	_	
103-10	39009-39016	Regions	_	
103-11	39017-39019	BA	_	
103-12	39020-39026	Voxels	_	
103-13	39027-39028	X	_	
103-14	39029-39030	Y	_	
103-15	39031-39032	Z	_	
103-16	39033-39045	t-scoremaxHC	_	
103-17	39046-39058	t-scoremaxAD	_	
103-18	39061-39064	ASN	_	
103-19	39065-39069	2.87	_	
103-20	39070-39074	2.22	_	
103-21	39075-39082	Putamen	_	
103-22	39082-39083	,	_	
103-23	39084-39092	Pallidum	_	
103-24	39092-39093	,	_	
103-25	39094-39100	Insula	_	
103-26	39100-39101	,	_	
103-27	39102-39113	Subcallosal	_	
103-28	39114-39119	Gyrus	_	
103-29	39120-39122	34	_	
103-30	39123-39126	842	_	
103-31	39127-39128	−	_	
103-32	39128-39130	26	_	
103-33	39131-39132	6	_	
103-34	39133-39134	−	_	
103-35	39134-39135	4	_	
103-36	39136-39140	7.64	_	
103-37	39141-39146	12.57	_	
103-38	39152-39155	OFC	_	
103-39	39156-39159	2.8	_	
103-40	39160-39164	2.17	_	
103-41	39165-39168	ACC	_	
103-42	39168-39169	,	_	
103-43	39170-39173	SFG	_	
103-44	39173-39174	,	_	
103-45	39175-39181	Medial	_	
103-46	39182-39184	FG	_	
103-47	39185-39187	10	_	
103-48	39187-39188	,	_	
103-49	39189-39191	11	_	
103-50	39192-39195	214	_	
103-51	39196-39197	2	_	
103-52	39198-39200	54	_	
103-53	39201-39202	−	_	
103-54	39202-39203	8	_	
103-55	39204-39208	6.67	_	
103-56	39209-39214	10.26	_	
103-57	39220-39222	SN	_	
103-58	39223-39227	3.21	_	
103-59	39228-39232	2.49	_	
103-60	39233-39239	Insula	_	
103-61	39239-39240	,	_	
103-62	39241-39244	STG	_	
103-63	39245-39247	13	_	
103-64	39248-39252	1591	_	
103-65	39253-39254	−	_	
103-66	39254-39256	38	_	
103-67	39257-39258	−	_	
103-68	39258-39260	14	_	
103-69	39261-39262	8	_	
103-70	39263-39268	11.16	_	
103-71	39269-39274	12.12	_	
103-72	39283-39286	ACC	_	
103-73	39286-39287	,	_	
103-74	39288-39294	Medial	_	
103-75	39295-39297	FG	_	
103-76	39298-39300	24	_	
103-77	39300-39301	,	_	
103-78	39302-39304	32	_	
103-79	39305-39307	58	_	
103-80	39308-39309	−	_	
103-81	39309-39310	2	_	
103-82	39311-39312	6	_	
103-83	39313-39315	40	_	
103-84	39316-39320	8.22	_	
103-85	39321-39325	8.38	_	
103-86	39334-39339	a-DMN	_	
103-87	39340-39344	3.11	_	
103-88	39345-39349	2.41	_	
103-89	39350-39353	SFG	_	
103-90	39353-39354	,	_	
103-91	39355-39361	Medial	_	
103-92	39362-39364	FG	_	
103-93	39365-39366	9	_	
103-94	39366-39367	,	_	
103-95	39368-39370	10	_	
103-96	39371-39374	506	_	
103-97	39375-39376	2	_	
103-98	39377-39379	58	_	
103-99	39380-39382	28	_	
103-100	39383-39387	8.67	_	
103-101	39388-39393	10.64	_	
103-102	39402-39405	PCC	_	
103-103	39405-39406	,	_	
103-104	39407-39416	Precuneus	_	
103-105	39417-39418	7	_	
103-106	39418-39419	,	_	
103-107	39420-39422	23	_	
103-108	39422-39423	,	_	
103-109	39424-39426	30	_	
103-110	39426-39427	,	_	
103-111	39428-39430	31	_	
103-112	39431-39433	88	_	
103-113	39434-39435	−	_	
103-114	39435-39436	6	_	
103-115	39437-39438	−	_	
103-116	39438-39440	50	_	
103-117	39441-39443	28	_	
103-118	39444-39448	6.76	_	
103-119	39449-39454	11.01	_	
103-120	39466-39469	MTG	_	
103-121	39469-39470	,	_	
103-122	39471-39474	STG	_	
103-123	39475-39477	19	_	
103-124	39477-39478	,	_	
103-125	39479-39481	22	_	
103-126	39481-39482	,	_	
103-127	39483-39485	39	_	
103-128	39486-39488	12	_	
103-129	39489-39490	−	_	
103-130	39490-39492	50	_	
103-131	39493-39494	−	_	
103-132	39494-39496	66	_	
103-133	39497-39499	20	_	
103-134	39500-39504	4.24	_	
103-135	39505-39509	7.32	_	
103-136	39515-39520	p-DMN	_	
103-137	39521-39525	3.04	_	
103-138	39526-39530	2.35	_	
103-139	39531-39540	Precuneus	_	
103-140	39540-39541	,	_	
103-141	39542-39545	PCC	_	
103-142	39546-39548	31	_	
103-143	39549-39553	1167	_	
103-144	39554-39555	−	_	
103-145	39555-39556	2	_	
103-146	39557-39558	−	_	
103-147	39558-39560	66	_	
103-148	39561-39563	24	_	
103-149	39564-39569	10.88	_	
103-150	39570-39575	13.89	_	
103-151	39587-39590	ACC	_	
103-152	39590-39591	,	_	
103-153	39592-39598	Medial	_	
103-154	39599-39601	FG	_	
103-155	39602-39603	9	_	
103-156	39603-39604	,	_	
103-157	39605-39607	10	_	
103-158	39607-39608	,	_	
103-159	39609-39611	32	_	
103-160	39612-39614	12	_	
103-161	39615-39616	2	_	
103-162	39617-39619	42	_	
103-163	39620-39622	16	_	
103-164	39623-39627	5.21	_	
103-165	39628-39632	5.04	_	
103-166	39641-39645	LECN	_	
103-167	39646-39650	3.12	_	
103-168	39651-39655	2.42	_	
103-169	39656-39659	MFG	_	
103-170	39659-39660	,	_	
103-171	39661-39664	SFG	_	
103-172	39665-39666	6	_	
103-173	39666-39667	,	_	
103-174	39668-39669	8	_	
103-175	39670-39673	451	_	
103-176	39674-39675	−	_	
103-177	39675-39677	26	_	
103-178	39678-39680	16	_	
103-179	39681-39683	43	_	
103-180	39684-39688	5.82	_	
103-181	39689-39693	7.78	_	
103-182	39705-39707	AG	_	
103-183	39707-39708	,	_	
103-184	39709-39711	SG	_	
103-185	39711-39712	,	_	
103-186	39713-39716	STG	_	
103-187	39716-39717	,	_	
103-188	39718-39721	MTG	_	
103-189	39721-39722	,	_	
103-190	39723-39732	Precuneus	_	
103-191	39732-39733	,	_	
103-192	39734-39737	IPL	_	
103-193	39738-39740	39	_	
103-194	39740-39741	,	_	
103-195	39742-39744	40	_	
103-196	39745-39748	344	_	
103-197	39749-39750	−	_	
103-198	39750-39752	42	_	
103-199	39753-39754	−	_	
103-200	39754-39756	62	_	
103-201	39757-39759	32	_	
103-202	39760-39765	11.54	_	
103-203	39766-39771	15.39	_	
103-204	39783-39786	ITG	_	
103-205	39786-39787	,	_	
103-206	39788-39791	MTG	_	
103-207	39791-39792	,	_	
103-208	39793-39801	Fusiform	_	
103-209	39802-39807	Gyrus	_	
103-210	39808-39810	20	_	
103-211	39810-39811	,	_	
103-212	39812-39814	21	_	
103-213	39814-39815	,	_	
103-214	39816-39818	37	_	
103-215	39819-39822	111	_	
103-216	39823-39824	−	_	
103-217	39824-39826	58	_	
103-218	39827-39828	−	_	
103-219	39828-39830	42	_	
103-220	39831-39832	−	_	
103-221	39832-39834	20	_	
103-222	39835-39839	8.51	_	
103-223	39840-39845	10.01	_	
103-224	39857-39860	PCC	_	
103-225	39860-39861	,	_	
103-226	39862-39871	Precuneus	_	
103-227	39872-39874	23	_	
103-228	39874-39875	,	_	
103-229	39876-39878	31	_	
103-230	39879-39881	95	_	
103-231	39882-39883	−	_	
103-232	39883-39884	2	_	
103-233	39885-39886	−	_	
103-234	39886-39888	38	_	
103-235	39889-39891	32	_	
103-236	39892-39896	7.37	_	
103-237	39897-39902	10.89	_	
103-238	39914-39916	AG	_	
103-239	39916-39917	,	_	
103-240	39918-39921	IFL	_	
103-241	39921-39922	,	_	
103-242	39923-39932	Precuneus	_	
103-243	39932-39933	,	_	
103-244	39934-39936	SG	_	
103-245	39936-39937	,	_	
103-246	39938-39941	MTG	_	
103-247	39942-39944	39	_	
103-248	39944-39945	,	_	
103-249	39946-39948	40	_	
103-250	39949-39951	71	_	
103-251	39952-39954	46	_	
103-252	39955-39956	−	_	
103-253	39956-39958	66	_	
103-254	39959-39961	36	_	
103-255	39962-39966	8.49	_	
103-256	39967-39971	10.2	_	
103-257	39977-39981	RECN	_	
103-258	39982-39986	3.23	_	
103-259	39987-39990	2.5	_	
103-260	39991-39993	AG	_	
103-261	39993-39994	,	_	
103-262	39995-39997	SG	_	
103-263	39997-39998	,	_	
103-264	39999-40002	STG	_	
103-265	40002-40003	,	_	
103-266	40004-40007	MTG	_	
103-267	40007-40008	,	_	
103-268	40009-40012	IPL	_	
103-269	40012-40013	,	_	
103-270	40014-40023	Precuneus	_	
103-271	40024-40026	39	_	
103-272	40026-40027	,	_	
103-273	40028-40030	40	_	
103-274	40031-40034	415	_	
103-275	40035-40037	46	_	
103-276	40038-40039	−	_	
103-277	40039-40041	62	_	
103-278	40042-40044	32	_	
103-279	40045-40050	10.03	_	
103-280	40051-40056	13.59	_	
103-281	40065-40068	MFG	_	
103-282	40068-40069	,	_	
103-283	40070-40073	SFG	_	
103-284	40074-40075	6	_	
103-285	40075-40076	,	_	
103-286	40077-40078	8	_	
103-287	40079-40082	396	_	
103-288	40083-40085	26	_	
103-289	40086-40088	18	_	
103-290	40089-40091	48	_	
103-291	40092-40097	10.15	_	
103-292	40098-40102	12.6	_	
103-293	40114-40117	MFG	_	
103-294	40117-40118	,	_	
103-295	40119-40122	IFG	_	
103-296	40123-40125	10	_	
103-297	40125-40126	,	_	
103-298	40127-40129	11	_	
103-299	40129-40130	,	_	
103-300	40131-40133	47	_	
103-301	40134-40137	132	_	
103-302	40138-40140	38	_	
103-303	40141-40143	46	_	
103-304	40144-40145	−	_	
103-305	40145-40146	4	_	
103-306	40147-40150	7.5	_	
103-307	40151-40155	9.48	_	
103-308	40164-40167	PCC	_	
103-309	40167-40168	,	_	
103-310	40169-40178	precuneus	_	
103-311	40179-40181	23	_	
103-312	40181-40182	,	_	
103-313	40183-40185	31	_	
103-314	40186-40188	54	_	
103-315	40189-40190	6	_	
103-316	40191-40192	−	_	
103-317	40192-40194	34	_	
103-318	40195-40197	32	_	
103-319	40198-40202	7.01	_	
103-320	40203-40207	9.65	_	
103-321	40219-40222	MTG	_	
103-322	40222-40223	,	_	
103-323	40224-40227	ITG	_	
103-324	40228-40230	20	_	
103-325	40230-40231	,	_	
103-326	40232-40234	21	_	
103-327	40235-40237	31	_	
103-328	40238-40240	62	_	
103-329	40241-40242	−	_	
103-330	40242-40244	34	_	
103-331	40245-40246	−	_	
103-332	40246-40248	12	_	
103-333	40249-40253	5.42	_	
103-334	40254-40258	8.15	_	

#Text=Networks that showed significant correlation between within-network FC and impulsivity, the a-DMN negatively correlated with UPPS(+) Urgency in precuneus in HC, and the ASN negatively correlated with UPPS(−) Urgency in putamen in AD
104-1	40262-40270	Networks	_	
104-2	40271-40275	that	_	
104-3	40276-40282	showed	_	
104-4	40283-40294	significant	_	
104-5	40295-40306	correlation	_	
104-6	40307-40314	between	_	
104-7	40315-40329	within-network	_	
104-8	40330-40332	FC	_	
104-9	40333-40336	and	_	
104-10	40337-40348	impulsivity	_	
104-11	40348-40349	,	_	
104-12	40350-40353	the	_	
104-13	40354-40359	a-DMN	_	
104-14	40360-40370	negatively	_	
104-15	40371-40381	correlated	_	
104-16	40382-40386	with	_	
104-17	40387-40391	UPPS	_	
104-18	40391-40392	(	_	
104-19	40392-40393	+	_	
104-20	40393-40394	)	_	
104-21	40395-40402	Urgency	_	
104-22	40403-40405	in	_	
104-23	40406-40415	precuneus	_	
104-24	40416-40418	in	_	
104-25	40419-40421	HC	_	
104-26	40421-40422	,	_	
104-27	40423-40426	and	_	
104-28	40427-40430	the	_	
104-29	40431-40434	ASN	_	
104-30	40435-40445	negatively	_	
104-31	40446-40456	correlated	_	
104-32	40457-40461	with	_	
104-33	40462-40466	UPPS	_	
104-34	40466-40467	(	_	
104-35	40467-40468	−	_	
104-36	40468-40469	)	_	
104-37	40470-40477	Urgency	_	
104-38	40478-40480	in	_	
104-39	40481-40488	putamen	_	
104-40	40489-40491	in	_	
104-41	40492-40494	AD	_	

#Text=Impulsivity\tNetworks\tGroup\tFWE-corr p\tClustersize\tT\tZ\tmm\tmm\tmm\tRegions\t \tUPPS (+)\ta-DMN\tHC (−)\t0.006\t26\t5.4\t4.3\t−18\t−58\t28\tPrecuneus\t \tUPPS (−)\tASN\tAD (−)\t0.047\t13\t4.2\t3.6\t−22\t2\t12\tPutamen\t \t\t\t3.8\t3.3\t−26\t−10\t8\tPutamen
105-1	40495-40506	Impulsivity	_	
105-2	40507-40515	Networks	_	
105-3	40516-40521	Group	_	
105-4	40522-40530	FWE-corr	_	
105-5	40531-40532	p	_	
105-6	40533-40544	Clustersize	_	
105-7	40545-40546	T	_	
105-8	40547-40548	Z	_	
105-9	40549-40551	mm	_	
105-10	40552-40554	mm	_	
105-11	40555-40557	mm	_	
105-12	40558-40565	Regions	_	
105-13	40568-40572	UPPS	_	
105-14	40573-40574	(	_	
105-15	40574-40575	+	_	
105-16	40575-40576	)	_	
105-17	40577-40582	a-DMN	_	
105-18	40583-40585	HC	_	
105-19	40586-40587	(	_	
105-20	40587-40588	−	_	
105-21	40588-40589	)	_	
105-22	40590-40595	0.006	_	
105-23	40596-40598	26	_	
105-24	40599-40602	5.4	_	
105-25	40603-40606	4.3	_	
105-26	40607-40608	−	_	
105-27	40608-40610	18	_	
105-28	40611-40612	−	_	
105-29	40612-40614	58	_	
105-30	40615-40617	28	_	
105-31	40618-40627	Precuneus	_	
105-32	40630-40634	UPPS	_	
105-33	40635-40636	(	_	
105-34	40636-40637	−	_	
105-35	40637-40638	)	_	
105-36	40639-40642	ASN	_	
105-37	40643-40645	AD	_	
105-38	40646-40647	(	_	
105-39	40647-40648	−	_	
105-40	40648-40649	)	_	
105-41	40650-40655	0.047	_	
105-42	40656-40658	13	_	
105-43	40659-40662	4.2	_	
105-44	40663-40666	3.6	_	
105-45	40667-40668	−	_	
105-46	40668-40670	22	_	
105-47	40671-40672	2	_	
105-48	40673-40675	12	_	
105-49	40676-40683	Putamen	_	
105-50	40688-40691	3.8	_	
105-51	40692-40695	3.3	_	
105-52	40696-40697	−	_	
105-53	40697-40699	26	_	
105-54	40700-40701	−	_	
105-55	40701-40703	10	_	
105-56	40704-40705	8	_	
105-57	40706-40713	Putamen	_	

#Text=Comorbidity of other drug use and psychiatric disorders (detail)
106-1	40717-40728	Comorbidity	_	
106-2	40729-40731	of	_	
106-3	40732-40737	other	_	
106-4	40738-40742	drug	_	
106-5	40743-40746	use	_	
106-6	40747-40750	and	_	
106-7	40751-40762	psychiatric	_	
106-8	40763-40772	disorders	_	
106-9	40773-40774	(	_	
106-10	40774-40780	detail	_	
106-11	40780-40781	)	_	

#Text=Dependence\tAbuse\t \t\tcurrent\tpast\tcurrent\tpast\t \tCannabis\t2\t8\t1\t3\t \tCocaine\t0\t2\t0\t8\t \tOpioid\t0\t0\t0\t2\t \tHallucinogen\t0\t2\t0\t2\t \tAmphetamine\t0\t0\t0\t1\t \tSedative, hypnotic, or anxiolytic\t0\t0\t0\t1
107-1	40783-40793	Dependence	_	
107-2	40794-40799	Abuse	_	
107-3	40803-40810	current	_	
107-4	40811-40815	past	_	
107-5	40816-40823	current	_	
107-6	40824-40828	past	_	
107-7	40831-40839	Cannabis	_	
107-8	40840-40841	2	_	
107-9	40842-40843	8	_	
107-10	40844-40845	1	_	
107-11	40846-40847	3	_	
107-12	40850-40857	Cocaine	_	
107-13	40858-40859	0	_	
107-14	40860-40861	2	_	
107-15	40862-40863	0	_	
107-16	40864-40865	8	_	
107-17	40868-40874	Opioid	_	
107-18	40875-40876	0	_	
107-19	40877-40878	0	_	
107-20	40879-40880	0	_	
107-21	40881-40882	2	_	
107-22	40885-40897	Hallucinogen	_	
107-23	40898-40899	0	_	
107-24	40900-40901	2	_	
107-25	40902-40903	0	_	
107-26	40904-40905	2	_	
107-27	40908-40919	Amphetamine	_	
107-28	40920-40921	0	_	
107-29	40922-40923	0	_	
107-30	40924-40925	0	_	
107-31	40926-40927	1	_	
107-32	40930-40938	Sedative	_	
107-33	40938-40939	,	_	
107-34	40940-40948	hypnotic	_	
107-35	40948-40949	,	_	
107-36	40950-40952	or	_	
107-37	40953-40963	anxiolytic	_	
107-38	40964-40965	0	_	
107-39	40966-40967	0	_	
107-40	40968-40969	0	_	
107-41	40970-40971	1	_	

#Text=Psychiatric Disorders\t \t\tAD\tHC\t \t\tCurrent\tPast\tCurrent\tPast\t \tGeneralized Anxiety Disorder\t3\t1\t0\t0\t \tSocial Phobia\t1\t0\t1\t1\t \tAlcohol-Induced Mood Disorder\t5\t2\t0\t0\t \tAncohol-Induced Anxiety Disorder\t3\t2\t0\t0\t \tSubstance-Induced Anxiety Disorder\t1\t0\t0\t0\t \tAnorexia Nervosa\t0\t2\t0\t0\t \tMajor Depressive Disorder\t3\t3\t0\t1\t \tPosttraumatic Stress disorder\t9\t1\t0\t1\t \tAgoraphobia Without History of Panic Disorder\t1\t0\t0\t0\t \tSpecific Phobia\t1\t0\t0\t0\t \tDysthymic Disorder\t0\t1\t0\t0\t \tMood Disorder Due to General Medical Condition\t0\t0\t0\t1
108-1	40976-40987	Psychiatric	_	
108-2	40988-40997	Disorders	_	
108-3	41001-41003	AD	_	
108-4	41004-41006	HC	_	
108-5	41010-41017	Current	_	
108-6	41018-41022	Past	_	
108-7	41023-41030	Current	_	
108-8	41031-41035	Past	_	
108-9	41038-41049	Generalized	_	
108-10	41050-41057	Anxiety	_	
108-11	41058-41066	Disorder	_	
108-12	41067-41068	3	_	
108-13	41069-41070	1	_	
108-14	41071-41072	0	_	
108-15	41073-41074	0	_	
108-16	41077-41083	Social	_	
108-17	41084-41090	Phobia	_	
108-18	41091-41092	1	_	
108-19	41093-41094	0	_	
108-20	41095-41096	1	_	
108-21	41097-41098	1	_	
108-22	41101-41116	Alcohol-Induced	_	
108-23	41117-41121	Mood	_	
108-24	41122-41130	Disorder	_	
108-25	41131-41132	5	_	
108-26	41133-41134	2	_	
108-27	41135-41136	0	_	
108-28	41137-41138	0	_	
108-29	41141-41156	Ancohol-Induced	_	
108-30	41157-41164	Anxiety	_	
108-31	41165-41173	Disorder	_	
108-32	41174-41175	3	_	
108-33	41176-41177	2	_	
108-34	41178-41179	0	_	
108-35	41180-41181	0	_	
108-36	41184-41201	Substance-Induced	_	
108-37	41202-41209	Anxiety	_	
108-38	41210-41218	Disorder	_	
108-39	41219-41220	1	_	
108-40	41221-41222	0	_	
108-41	41223-41224	0	_	
108-42	41225-41226	0	_	
108-43	41229-41237	Anorexia	_	
108-44	41238-41245	Nervosa	_	
108-45	41246-41247	0	_	
108-46	41248-41249	2	_	
108-47	41250-41251	0	_	
108-48	41252-41253	0	_	
108-49	41256-41261	Major	_	
108-50	41262-41272	Depressive	_	
108-51	41273-41281	Disorder	_	
108-52	41282-41283	3	_	
108-53	41284-41285	3	_	
108-54	41286-41287	0	_	
108-55	41288-41289	1	_	
108-56	41292-41305	Posttraumatic	_	
108-57	41306-41312	Stress	_	
108-58	41313-41321	disorder	_	
108-59	41322-41323	9	_	
108-60	41324-41325	1	_	
108-61	41326-41327	0	_	
108-62	41328-41329	1	_	
108-63	41332-41343	Agoraphobia	_	
108-64	41344-41351	Without	_	
108-65	41352-41359	History	_	
108-66	41360-41362	of	_	
108-67	41363-41368	Panic	_	
108-68	41369-41377	Disorder	_	
108-69	41378-41379	1	_	
108-70	41380-41381	0	_	
108-71	41382-41383	0	_	
108-72	41384-41385	0	_	
108-73	41388-41396	Specific	_	
108-74	41397-41403	Phobia	_	
108-75	41404-41405	1	_	
108-76	41406-41407	0	_	
108-77	41408-41409	0	_	
108-78	41410-41411	0	_	
108-79	41414-41423	Dysthymic	_	
108-80	41424-41432	Disorder	_	
108-81	41433-41434	0	_	
108-82	41435-41436	1	_	
108-83	41437-41438	0	_	
108-84	41439-41440	0	_	
108-85	41443-41447	Mood	_	
108-86	41448-41456	Disorder	_	
108-87	41457-41460	Due	_	
108-88	41461-41463	to	_	
108-89	41464-41471	General	_	
108-90	41472-41479	Medical	_	
108-91	41480-41489	Condition	_	
108-92	41490-41491	0	_	
108-93	41492-41493	0	_	
108-94	41494-41495	0	_	
108-95	41496-41497	1	_	
